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 ABSTRACT 
 
Perfluorooctane sulfonate (PFOS) is a perfluoroalkyl substance with extensive 
historical use. Its persistence, bioaccumulation, toxicity and health concerns led to 
its incorporation in the Stockholm Convention as a persistent organic pollutant 
(POP) in 2009. Direct exposure to PFOS has been widely reported in different 
environmental and biological samples, and recent human biomonitoring studies 
indicate that levels are in decline. However, certain uncertainties remain when 
estimating its body burdens: indirect exposure to so called PFOS-precursor 
compounds – such as perfluorooctane sulfonamides (FOSAs) and perfluorooctane 
sulfonamidoethanols (FOSEs) –, followed by in vivo metabolism could contribute to 
the current levels of PFOS in human biological samples. 
To evaluate the direct and the indirect contribution to PFOS overall exposure, 
sample preparation and instrumental HPLC-MS/MS methods for the analysis of 
PFOS – linear and sum of branched isomers – and suspected PFOS precursors – three 
FOSAs, two FOSEs and three FOSAAs – in dust, food and serum samples were 
developed and validated. These methods were applied to 57 vacuum cleaner dust 
samples, 113 solid food composites, 121 liquid food composites and 60 serum 
samples from a well-established Norwegian cohort. Indoor environment 
questionnaires, food diaries and food frequency questionnaires were compared to 
the reported concentrations of PFOS – linear and branched – and PFOS precursors. 
Daily intakes for total PFOS and PFOS precursors via dust and food ingestion were 
estimated under different scenarios, and compared with reported internal exposure 
levels of PFOS. Finally, for a better understanding of the link between external and 
internal exposure, a qualitative study of the in vitro metabolism of two PFOS 
precursors – MeFOSA and MeFOSE – was conducted. 
All the dust samples were positive for, at least, one of the analysed pollutants, with 
average concentrations of 77 ng/g for ΣPFAS – average daily intakes of 4.51 pg/kg 
bw/day in mean scenario, and 59.66 pg/kg bw/day in high scenario –, presenting a 
profile dominated by EtFOSA, followed by and EtFOSE and MeFOSE. Still, diet was 
identified as the most important pathway of external exposure, with reported 
average daily intakes of 0.24 ng/kg bw/day in median bound scenario, dominated 
by FOSEs exposure. Conversely, for internal exposure PFOS was the most detected 
analyte (87 %), in an average concentration of 5.3 ng/mL and contributing more 
than 90 % to the overall internal exposure to PFASs. These results supported the 
initial hypothesis of the contribution of PFOS precursors to indirect exposure to 
PFOS, also in line with the conducted in vitro metabolism assays, which revealed the 
fast conversion of PFOS precursors to PFOS when they were incubated with human 
liver microsomes. 
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1. INTRODUCTION 
 
1.1 OVERVIEW 
Perfluoroalkyl substances (PFASs) are a family of synthetic compounds 
characterised by a fully fluorinated hydrophobic linear carbon chain, to which are 
attached different hydrophilic functional groups (Fromme et al., 2009). These 
chemicals have been manufactured since the late 1940s by 3M Company (3M, 1999) 
as well as other companies like Dupont, and have been produced and used in 
commercial products and industrial processes for over 60 years (Lindstrom, Strynar 
and Libelo, 2011). PFASs possess low molecular polarisability, short C–F bond 
length, and large C–F bond binding energy. Such characteristics govern the oil and 
water repellency, physical and chemical stability, and surfactant properties of PFASs 
(Zushi, Hogarh and Masunaga, 2011). These properties mean that PFASs have found 
wide use in a variety of applications, with historic production peaking at the end of 
the 20th century in North America and Europe (Paul, Jones and Sweetman, 2009). In 
an environmental context however, the strong C–F bond means that PFASs are 
resistant to thermal, chemical and biological degradation (Kissa, 2001) and are 
capable of bioaccumulation and long-range environmental transport, exemplified 
by their detection in the Arctic (Chaemfa et al., 2010; Sonne, 2010; Zhao, Wong and 
Wong, 2012). As a result, perfluorooctane sulfonate (PFOS) and its salts, as well as 
perfluorooctane sulfonyl fluoride (POSF) – raw material employed for the synthesis 
PFOS and other perfluoroalkyl substances, represented in Figure 01 – were in 2009 
listed as persistent organic pollutants (POPs) under the Stockholm Convention 
(Stockholm-Convention, 2009). POSF can degrade to PFOS directly or indirectly 
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through chemical or enzymatic hydrolysis, and hence POSF-derived products (other 
PFASs which synthesis require the use of POSF as raw material) can be degraded 
ultimately to PFOS (Zhao et al., 2016). 
The main applications of PFOS and PFOS derivatives included uses in inks, 
varnishes, waxes, fire-fighting foams, metal plating and cleaning products, coating 
formulations (for walls, furniture, carpeting, food packaging), lubricants, water and 
oil repellents for leather, paper and textiles (3M, 2000). Before 2003, POSF was used 
as a raw material for the synthesis of PFOS (among other perfluorooctane 
sulphonamide derivates) (Buck et al., 2011). However, 3M Company replaced POSF 
derivate products with perfluorobutane sulfonate (PFBS) after 2003, because the 
former was considered harmful to the environment (Renner, 2006). 
Over the last 15 years, a substantial weight of evidence has emerged concerning 
environmental contamination with PFOS, consequent human exposure, and its 
effects. This chapter reviews this evidence, and summarises recent developments 
that exploit the relative abundance of branched chain PFOS isomers to provide 
valuable insights into the environmental fate and behaviour of PFOS and its 
precursors. 
 
 
Figure 01. POSF structure, main substance employed as raw material for the synthesis of 
some long chain PFASs 
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1.2 SOURCES, PRODUCTION AND APPLICATIONS 
The history of perfluorochemicals (PFCs) production – hence PFASs and PFOS 
related substances – is difficult to portray accurately due to the nature of the 
available information and the successive changes in regulations and production 
lines (Lindstrom, Strynar and Libelo, 2011). Anyway, it is known that the 3M 
Company was the first main producer of perfluorooctane sulfonyl fluoride (POSF), 
product employed afterwards as the main raw material for the synthesis of PFOS 
and most of the perfluorooctane sulfonyl substances. The 3M company started POSF 
production – and subsequently, PFOS production as a second step-– in 1949 until its 
curtailment in 2002, with the total cumulative production estimated to be 
approximately 96,000 tons in the peak years between 1970 and 2002, with further 
26,500 tons of solid unwanted or wastes (Olsen et al., 2005; Paul, Jones and 
Sweetman, 2009). The 3M Company largest production sites were based in the US 
and Belgium, but another 6 plants were also located in Europe (4 in EU member 
states), 6 in Asia (of which 4 were in Japan) and one in South America (Paul, Jones 
and Sweetman, 2009). According to the US Environmental Protection Agency 
(US EPA), in addition to 3M Company, around 20 non-US companies were producing 
and supplying POSF (and PFOS). In 2002, the 3M Company discontinued its 
production; but other companies mostly based in Southeast Asia commenced its 
manufacture to meet existing market demands, with an estimated 1,000 tons being 
produced annually since 2002 (Paul, Jones and Sweetman, 2009). 
  
4 
Table 01. List of PFOS and its main precursors 
CAS 
number 
Common 
name 
Name 
Molecular 
formula 
Structure 
NA PFOS anion 
Perfluoro-1-
octanesulfonate 
C8F17SO3- 
 
754-91-6 FOSA 
Perfluoro-1-
octanesulfonamide 
C8H2F17NO2S 
  
4151-50-2 N-EtFOSA 
N-ethylperfluoro-1-
octanesulfonamide 
C10H6F17NO2S 
R = methyl for MeFOSA 
R = ethyl for EtFOSA 
 
31506-32-8 N-MeFOSA 
N-methylperfluoro-1-
octanesulfonamide 
C9H4F17NO2S 
1691-99-2 N-EtFOSE 
2-(N-ethylperfluoro-1-
octanesulfonamido)-
ethanol 
C12H10F17NO3S 
 
R = methyl for MeFOSE 
R = ethyl for EtFOSE 
 
 
24448-09-7 N-MeFOSE 
2-(N-methylperfluoro-1-
octanesulfonamido)-
ethanol 
C11H8F17NO3S 
2806-24-8 FOSAA 
Perfluorooctane 
sulfonamidoacetate 
C10H4F17NO4S 
 
R = methyl for MeFOSAA 
R = ethyl for EtFOSAA 
R = H for FOSAA 
 
 
 
2355-31-9 N-MeFOSAA 
N-methylperfluoro-1-
octanesulfonamidoacetic 
acid 
C11H6F17NO4S 
2991-50-6 N-EtFOSAA 
N-ethylperfluoro-1-
octanesulfonamidoacetic 
acid 
C12H8F17NO4S 
N/A = Not applicable. R = Substituent 
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Figure 02. Sources of PFOS and PFOS precursors according to their synthesis processes 
 
PFASs synthesis routes have been well described by Lehmler et al. (Lehmler et al., 
2010). The two main processes are electro-chemical fluorination (ECF) (3M, 1999), 
and telomerisation (Schulz et al., 2011), with POSF synthesised via ECF. In this 
process, a straight chain hydrocarbon is reacted with H and F atoms and electricity 
to substitute all of the hydrogen atoms with fluorine (Kissa, 2001) in a reaction 
common for different chain length as shown in Equation 01, where n is the number 
of carbons in the alkyl chain. Reaction yields are chain-length dependent, being 
lower as the number of carbons increases. This constitutes the main process of POSF 
synthesis (around 12 % yield), generating about 70 % of the straight chain product 
with the remainder comprised of branched and cyclic isomers (Paul, Jones and 
Sweetman, 2009). POSF can then be used in a series of reactions via N-methyl and 
N-ethyl perfluorooctane sulfonamide (N-MeFOSA and N-EtFOSA) to yield N-methyl 
and N-ethyl perfluorooctane sulfonamidoethanols (N-MeFOSE and N-EtFOSE), 
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which historically were used to produce polymeric materials and phosphate esters 
respectively, and used on surface coatings for textiles and paper products (see 
Figure 02). (Olsen et al., 2005; Paul, Jones and Sweetman, 2009; D’Eon J and Mabury, 
2011). It is important to note here that a number of possible PFOS isomers exist in 
POSF based mixtures (in which process PFOS impurities are present between 0.1 
and 5 % (Paul, Jones and Sweetman, 2009) due to the nature of the ECF process 
itself). The isomer composition of the commercial PFOS products can be up to 30 % 
of total PFOS. Moreover, some of these isomers (specifically those that are branched 
chain) are chiral, with the result that the environmental fate and behaviour of PFOS 
may vary according to its isomeric and enantiomeric composition. 
 
Equation 01 CnH2n+1SO2F + (2n+1)F-  CnF2n+1SO2F + (2n+1)H+(4n+2)e- 
 
The major applications of POSF derivatives have been: 1) in carpets to impart stain 
and dirt repellence, 2) in apparel to provide water repellence, 3) in paper and 
packaging to afford oil and grease repellence, 4) in performance chemicals such as 
hydraulic fluids for aviation, and 5) in aqueous fire-fighting foams (AFFFs). AFFFs 
are perhaps the most prominent method of widespread environmental dispersal, 
with use for oil drilling and military fire-fighting practice (Paul, Jones and 
Sweetman, 2009). 
All compounds produced from POSF are widely referred to as “PFOS equivalents” or 
just “PFOS”, due to their collective potential to degrade or transform into PFOS (Paul, 
Jones and Sweetman, 2009). In contrast, PFOS itself is extraordinarily stable in the 
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environment, with no known natural mechanism of degradation. Hence, regulatory 
bodies have been working to reduce the production and use of some PFASs (Zushi, 
Hogarh and Masunaga, 2011). The 3M Company, together with the US EPA resolved 
to decrease the production of PFOS and related compounds between 2000 and 2002 
(3M, 2008). At the same time, Significant New Use Rules (SNUR) were also put in 
place (2000, 2002, and 2007) in the US, designed to restrict the production and use 
of materials that contained PFOS or its various precursors. The US EPA then worked 
with eight leading chemical companies in the 2010-2015 PFOA Stewardship 
Program to reduce emissions and residual content of perfluoroooctanoic acid 
(PFOA) and long-chain PFCs by 95 % by 2010, with the long-term goal to work 
towards elimination of long-chain PFCs by 2015 (USEPA, 2010). 
Within the EU, PFOS and its derivatives are regulated in the market or only used as 
a substance or constituent of preparations listed as permissible (Parliament, 2006). 
Under this directive, PFOS may still be used in applications that are deemed un-
substitutable, including photolithographic processes, photographic coatings, mist 
suppressants for non-decorative hard chromium (VI), plating/wetting agents in 
controlled electroplating systems (pollution prevention and control are required), 
and hydraulic fluids for aviation. Such regulation started within the EU in June 2008 
(Zushi, Hogarh and Masunaga, 2011). 
The presence of PFOS in the environment has been attributed to two major sources: 
direct and indirect (Prevedouros et al., 2006; Armitage et al., 2009; Paul, Jones and 
Sweetman, 2009). Direct sources are derived from the manufacture and application 
of PFOS and POSF (Paul, Jones and Sweetman, 2009). By comparison, indirect 
sources are a consequence of chemical reaction impurities or breakdown of so-
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called precursors such as MeFOSE and EtFOSE (see Table 01), represented in Figure 
02. It has been estimated that 85 % of indirect emissions occur via release from 
consumer products during use and disposal (3M, 2000). 
 
1.3 HEALTH CONCERNS 
General toxicological findings associated with laboratory animals exposed to PFOS 
include hepatomegaly and hepatic peroxisome proliferation, liver, testicular (Leydig 
cell), and pancreatic (acinar cell) tumours, reproductive and developmental deficits, 
neurotoxicity, and immunotoxicity (DeWitt et al., 2012). 
Most of the reported studies concerning PFOS toxicity have been conducted on mice, 
with subsequent extrapolation to humans of observed murine effects complicated 
by interspecies variability in toxicokinetics. Adverse effects attributed to PFOS in 
rodents include decreased body weight, increased liver weight, and a steep dose-
response curve for mortality (Seacat et al., 2003), as well as an increase in 
hepatocellular and follicular cell adenomas at high exposure levels (3M, 2002). 
Human studies carried out on workers occupationally exposed to PFASs have 
generally yielded inconsistent results. While such workers have circulating blood 
levels of PFASs that are hundreds of times those of non-occupationally exposed 
individuals (Olsen et al., 2003; Steenland, Fletcher and Savitz, 2010), it is difficult to 
determine conclusive results in these studies (either positive or negative) because 
sample populations are small, historical exposure levels are uncertain, individuals 
often have had simultaneous exposures to other compounds, and they may have 
pre-existing conditions that complicate evaluations (Fletcher et al., 2013). 
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Compared to PFOS, studies of PFOA exposed workers are more numerous. Several 
studies have shown a positive association between PFOA exposure and cholesterol, 
which could have implications for the development of cardiovascular disease (Zobel 
and Olsen, 2012). PFOA has also been associated with elevated uric acid levels, 
which may in turn lead to hypertension and cerebrovascular disease (Olsen et al., 
2003; Sakr et al., 2007; Costa, Sartori and Consonni, 2009; Lindstrom, Strynar and 
Libelo, 2011). 
Based on the toxicological evidence available to date, chronic exposure guidelines 
are being developed for PFOS and PFOA by the US EPA and other jurisdictions for 
water and food, but little has been done thus far for other PFASs. A review of current 
global guidelines and regulations can be found in Zushi et al. (Zushi, Hogarh and 
Masunaga, 2011), and some especially pertinent illustrative examples are discussed 
briefly here. The continuing uncertainty surrounding the human health impacts of 
PFASs is reflected in the disparity between the values promulgated by different 
jurisdictions. The risk from PFOS for human adults has been evaluated as low based 
on the Margin of Exposure (MOE), derived from the ratio of the provisional tolerable 
daily intakes (pTDI) and the level of intake (Zushi, Hogarh and Masunaga, 2011). 
Fromme et al. (Fromme et al., 2009) estimated the average (and high end) daily 
intake of PFOS and PFOA, including the indirect contribution from their precursors, 
as 1.6 (11.0) and 2.9 (12.7) ng/kg bw/day, respectively. These exposures are 
comfortably lower than the pTDIs for the general adult population of 100 ng/kg 
bw/day for PFOS and 3,000 ng/kg bw/day for PFOA, promulgated by the German 
Federal Institute for Risk Assessment (BfR) and the UK Committee on Toxicity of 
Chemicals in Food, Consumer Products and the Environment (COT) respectively. 
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Moreover, the USEPA issued provisional short-term health advisories for PFOS (200 
ng/L) and PFOA (400 ng/L) in drinking water, on the assumption that short-term 
consumption below these levels will safeguard public health (USEPA, 2009). 
In a parallel approach to limit values for external exposure via ingestion of food and 
water, the Biomonitoring Commission of the German Federal Environmental Agency 
used the 95th percentile concentration values of two German studies (Midasch, 
Schettgen and Angerer, 2006; Fromme, Schlummer, et al., 2007), to establish 
reference values for PFOA and PFOS in plasma of children and adults. These 
reference values specify a maximum permissible presence of PFOS of 10 µg/L for 
children, 20 µg/L for adult females, and 25 µg/L for adult males (Wilhelm et al., 
2009). 
 
1.4 HUMAN EXPOSURE TO PFOS AND PFOS PRECURSORS 
PFOS is one of the most reported PFASs in literature due to its past extensive use, its 
high detection frequencies, its high persistence and its inclusion in 2009 as POP 
under the Stockholm Convention. The first report of the presence of PFOS and other 
PFASs in samples of human blood purchased from biological supply companies 
emerged in 2001 (Hansen et al., 2001), although the first paper regarding the 
presence of organofluorine compounds in biological samples dates from 1968 
(Taves, 1968a, 1968b). Since then, a considerable database inclusive biomonitoring 
and human exposure to PFASs has emerged. 
Traditionally, just direct exposure to PFOS was considered, and after the 3M 
Company phase out and the incorporation of PFOS and its salts to the list of 
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persistent organic pollutants in 2009 decreasing levels in human biomonitoring 
data were expected to occur. Different papers published recently clearly show that 
pattern (Olsen et al., 2008, 2012; Glynn et al., 2012; Nost et al., 2014), but an 
underlying concern started to grow: Why levels of PFOS are decreasing but they are 
not according to what theoretical models predicted?. According to Olsen et al. 
(Olsen, Burris, et al., 2007), PFOS half-life is serum was estimated to be 4.8 years, so 
as a consequence of its restriction after 2002, its external and internal exposure 
levels tend to decline, as recent longitudinal studies from different countries 
revealed (Nost et al., 2014; Toms et al., 2014). Still, its ubiquity in biological samples 
15 years after it was phased-out, such as serum, reveal additional external sources 
of exposure besides the direct exposure to small POSF productions in some 
countries, and the legacy PFOS still present in soil, dust, water, and wildlife. 
As a consequence of that concern, newer studies starting hypothesise on an 
additional source of PFOS exposure: Human exposure to PFOS – as for many other 
environmental pollutants – can occur via two different routes as described by 
Prevedouros et al. (Prevedouros et al., 2006; Ross, Wong and Martin, 2012): a) direct 
exposure to PFOS when it occurs via one or multiple exposure pathways (diet, 
inhalation, contact) to the target pollutant, and b) indirect exposure to PFOS when 
it happens via exposure to their precursors and subsequent biotransformation of 
these precursors to PFOS in the body. The following section will summarise past and 
present on human exposure to both, PFOS and PFOS precursors. 
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1.4.1 Direct Pathways of Human Exposure 
Non-occupational exposure – direct and indirect – to PFOS mainly occur via the 
ingestion of food and drinking water, as well via inhalation and dust ingestion. 
Overall, based on the exposure models and reviews published to date (Trudel et al., 
2008; Vestergren et al., 2008; Fromme et al., 2009; D’Eon J and Mabury, 2011; 
Ericson Jogsten et al., 2012) food contaminated via bioaccumulation, has been 
suggested by several authors as the principal pathway of direct human exposure to 
PFOS (Fromme, Schlummer, et al., 2007; Trudel et al., 2008; Vestergren et al., 2008; 
Fromme et al., 2009; Kärrman et al., 2009; Herzke et al., 2013; D’Hollander et al., 
2015). 
In 2012, Ericson Jogsten et al. (Ericson Jogsten et al., 2012) reported diet as the main 
pathway of PFOS exposure for adults and toddlers from Catalonia, Spain 
(constituting more than 70°% of the daily total intake). Ingestion of water was 
identified as the second most important human exposure pathway, with inhalation 
of air and ingestion of dust considered negligible (< 0.5 % of the total intake) in all 
scenarios except in the worst case scenario for toddlers, where the relative 
contribution was 4 %. An alternative Scenario-Based Risk Assessment approach 
(SceBRA) was used in the studies of Trudel et al. (Trudel et al., 2008) and Vestergren 
et al. (Vestergren et al., 2008). The SceBRA is a more complete risk assessment 
screening tool – compared to these just including risk quotients and ratios of 
exposure concentrations – by the inclusion of the number of exposed people. This 
new term allows differentiate among a larger number of situations and establish if 
a certain risk is restricted to concrete situations or it is widespread, as well as 
establishing relations between the number of exposed population and the risk 
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quotients (Scheringer et al., 2001). Trudel et al. (Trudel et al., 2008) and Vestergren 
et al. (Vestergren et al., 2008) reported food ingestion as one of the most important 
pathways under three different exposure scenarios (low, intermediate and high), 
although there was some divergence between the two studies about the absolute 
contribution of diet. Moreover, house dust ingestion was identified as a significant 
direct exposure pathway in both studies (though different absolute values of its 
proportional contribution to overall exposure were reported); while for some other 
pathways, e.g. direct hand contact with carpets treated with products containing 
PFOS and subsequent oral ingestion, assessment of their importance differs 
substantially between studies. Future evaluations of the relative contributions of 
different pathways to overall exposure to PFOS will benefit from recent and on-
going improvements in analytical techniques that permit detection of PFOS in 
foodstuffs and other exposure matrices at lower levels. 
 
Diet 
Available food data is broad and diverse. Several studies are focused in a reduced 
group of food items, mainly on these more likely to contain high levels of PFOS due 
to their high protein content, as meat, fish or dairies (Malinsky, Jacoby and Reagen, 
2011; Chung and Lam, 2014; D’Hollander et al., 2015), while a few are mainly 
focused in different ones where PFOS could be present due to atmospheric 
deposition or uptake from soils or water (Herzke et al., 2013; D’Hollander et al., 
2015). Many others cover a wider range of food items in order to better estimate 
daily exposure to PFOS, but differentiating among them and reporting 
concentrations product by product or for groups of them (Ericson, Martí-Cid, et al., 
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2008; Ballesteros-Gomez, Rubio and van Leeuwen, 2010; Noorlander et al., 2011; 
Guerranti et al., 2013). Other studies estimate exposure to PFOS as total diet or 
duplicated diet, where a mixture of different food items are analysed and reported 
together with a nutritional study of the mixture (Fromme, Schlummer, et al., 2007; 
Kärrman et al., 2009). Finally, some publications report levels just as concentration 
per item or mixture of items, while some others report daily intakes. 
As an overall, PFOS exposure though food ingestion has been widely studied but it 
became a very complex task to resume, due to the very different ways of presenting 
the data: part of the available information comes from the analysis of individual food 
items, while part of it comes from groups of food commodities, or from whole diet 
composites. Data can also come from raw or from cooked commodities – as 
individual cooked items or as a whole meal –. Moreover, there is no harmonisation 
on how to report the data, being sometimes presented as concentration per food 
item or meal, some others as daily intakes (body weight corrected or not), and 
usually supported by different types of food questionnaires: food diaries, food 
frequency questionnaires, including food packaging and cooking utensils or not. 
 
Drinking Water 
Data concerning concentrations of PFOS in drinking water are rather limited, and all 
published studies report concentrations in the ng/L range (see Table 02). Initially, 
Saito et al. (Saito et al., 2004) reported PFOS concentrations in tap water from Japan 
to fall between 0.1 and 12.0 ng/L. Later studies (Skutlarek, Exner and Färber, 2006; 
Lange et al., 2007; Tanaka et al., 2008; Ericson et al., 2009) have reported higher 
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concentrations however; up to 58 ng/L and 143 ng/L PFOS in tap water from Spain 
(Ericson et al., 2009) and Japan (Tanaka et al., 2008) respectively. Overall, PFOS is 
one of the most frequently detected PFASs – together with PFOA – in drinking water, 
with detection frequencies varying between 40 and 100 % in published papers. In 
2013, Eschauzier et al. (Eschauzier et al., 2013) hypothesised the link between the 
difference of tap water coming from ground water (usually PFASs free) and the one 
coming from surface water, often reporting background contamination. 
Reassuringly, maximum values reported in drinking water to date, fall below the 
US EPA’s short term advisory limit concentration for drinking water of 200 ng/L 
PFOS. 
 
Table 02. Comparison of reported PFOS concentrations and ranges in drinking water (ng/L) 
Authors Country n % DF A/GM Median1 Range 
(Ericson, Nadal, et al., 
2008) 
Spain 4 100 0.571 (GM) 0.59 0.39-0.87 
(Ericson et al., 2009) Spain 40 87 3.72 (GM) 0.51 <0.12-58.12 
(Kim, Kho, et al., 2011) Korea 15 NR NR NR <0.33-11.00 
(Loos et al., 2007) Italy 6 100 8.1 (A) NR 6.20-9.70 
(Saito et al., 2004) Japan 30 67 0.7-12.52 (GM) 0.65 <0.10-12.00 
(Skutlarek, Exner and 
Färber, 2006) 
Germany 37 35 2.091 (GM) 1 <1.00-22.00 
(Takagi et al., 2008) Japan 26 96 1.51 (GM) 1.9 <0.16-22.00 
(Tanaka et al., 2008) Japan NR NR NR NR <0.01-143.0 
1) For concentrations < LOQ, the value was assumed = 1/2 LOQ. 2) Estimated in 6 different areas 
DF: Detection frequency. A: Average. GM: Geometric mean. NR: Not reported 
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Table 03. Comparison of reported PFOS concentrations and ranges in indoor dust (ng/g) 
Authors 
Country/Microenvironment 
Category 
n % DF Average Median 1 Range 
(Björklund, Thuresson 
and De Wit, 2009) 
 
 
 
 
Sweden / Houses 10 100 49 2 39 15-120 
Sweden / Apartments 38 79 175 2 85 <8.0-1,100 
Sweden / Offices 10 100 144 2 110 29-490 
Sweden / Daycare centres 10 100 38 2 31 23-65 
Sweden / Cars 5 60 18 2 12 <8.0-33 
(Ericson Jogsten et al., 
2012) 
Spain / Houses 10 100 2.1 2.2 0.13-12.0 
(Fraser et al., 2013) 
 
Czech Republic / Offices 31 55 14.6 3 NR 6.8-98.2 
Czech Republic / Homes 30 27 26.9 3 NR 14.1-280 
Czech Republic / Vehicles 13 16 15.8 3 NR 10.1-280 
(Goosey and Harrad, 
2011) 
 
 
 
 
 
 
 
 
 
 
 
 
UK / Cars 20 100 132 97 20-1,500 
UK / Classrooms 42 100 640.7 980 22-3,700 
UK / Houses 45 100 144.7 450 3.5-7,400 
UK / Offices 20 100 182.5 370 20-1,000 
Australia / Houses 20 100 187 170 6.5-8,100 
Canada / Houses 19 100 157.8 140 42-1,300 
France / Houses 10 100 193.8 160 54-1,700 
Germany / Houses 10 100 188.9 170 47-1,000 
Kazakhstan / Houses 9 80 12.5 59 <0.03-130 
Thailand / Houses 20 100 19.5 16 3-130 
USA / Houses 10 100 318.1 310 110-930 
(Kato, Calafat and 
Needham, 2009) 
Australia / Houses 39 74 NR 480 <2.6-18,000 
(Kubwabo et al., 2005) Canada / Houses 67 67 443.7 37.8 2.3-5,065 
(Moriwaki, Takata and 
Arakawa, 2003) 
Japan / Houses 16 100 39.5 25 15.0-2,500 
(Shoeib et al., 2016) Egypt / Houses 17 58 NR 0.29 0.23 -2.16 
(Strynar and 
Lindstrom, 2008) 
USA / Houses (102) and child 
day care centres (10) 
112 95 761 201 <8.9-12,100 
(Tian et al., 2016) Korea / Houses 17 93 13.7 2 11.4 0.7-52.1 
(Xu et al., 2013) Germany / Houses 31 100 97.1 2 NR 32.2-2456 
1) For concentrations < LOQ, the value was assumed = 1/2 LOQ. 2) Arithmetic mean. 3) Geometric mean. 
DF: Detection frequency. NR: Not reported. N = number of cases. 
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Table 04. Comparison of reported PFOS concentrations and ranges in indoor and outdoor 
air (pg/m3) 
Authors Country Source n % DF Mean Median1 Range 
(Barber et al., 2007) Norway Indoor air 4 0 NR NR <LOD 
(Ericson Jogsten et al., 
2012) 
Spain Indoor air 10 33 0.3 0.1 <0.13-67.0 
(Goosey and Harrad, 
2012) 
UK Indoor air 20 90 12.4 11.5 <1.0-400.0 
UK Indoor air 12 100 49.4 55 12.0-89.0 
(Shoeib et al., 2011) Canada Indoor air 39 0 <LOD <LOD <LOD 
(Barber et al., 2007) 
UK Outdoor air 2 NR NR NR <LOD-46 
UK Outdoor air 10 NR NR NR <LOD-1.6 
(Dreyer and Ebinghaus, 
2009a) 
Germany Outdoor air 117 0 <LOD <LOD <LOD 
Germany Outdoor air 121 0 <LOD <LOD <LOD 
(Genualdi et al., 2010) 
Diff. 
Countries 
Outdoor air 20 50 NR NR 2.03-149.5 
(Goosey and Harrad, 
2012) 
UK Outdoor air 10 70 1.5 1.6 <0.1-6.1 
(Shoeib et al., 2011) Canada Outdoor air 6 0 <LOD <LOD <LOD 
1) For concentrations < LOQ, the value was assumed = 1/2 LOQ. N = number of cases.   
DF: Detection frequency. NR: Not reported. LOD = Limit of detection  
 
 
Table 05. Index of published research articles monitoring PFOS precursors in food 
commodities 
Authors Analytes Country n Matrix 
(Van Leeuwen et al., 2009) PFOS, PFOSA Netherlands Intercomparison Fish 
(van Leeuwen et al., 2009) PFOS, PFOSA Netherlands Intercomparison Water, fish 
(Gebbink et al., 2015) PFOS, FOSA, FOSAA, 
EtFOSAA, MeFOSAA 
Sweden 130 Diet 
(Ullah et al., 2014) PFOS, FOSA, EtFOSAA, 
MeFOSAA 
Sweden 21 Fish 
(Tittlemier, Pepper and 
Edwards, 2006) 
FOSA, EtFOSA, MeFOSA Canada 151 Diet 
N = number of cases. 
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Table 06. Index of published research articles monitoring PFOS precursors in indoor dust 
Authors Analytes Country n Matrix 
(Haug, Huber, Schlabach, 
et al., 2011) 
PFOS,PFOSA, EtFOSA, MeFOSA, 
MeFOSE 
Norway 41 Household dust 
(Shoeib et al., 2011) PFOS, EtFOSA, MeFOSA, EtFOSE, 
MeFOSE 
Canada 152 Household dust 
(Goosey and Harrad, 
2011) 
PFOS, FOSA, EtFOSA, MeFOSA, 
EtFOSE, MeFOSE 
Australia 20 Household dust 
  
Canada 20 Household dust   
France 9 Household dust   
Germany 10 Household dust   
Kazakhstan 9 Household dust   
Thailand 20 Household dust   
UK 45 Household dust   
US 10 Household dust   
UK 20 Cars   
UK 42 Classrooms 
    UK 20 Offices 
(Lankova et al., 2015) PFOS, FOSA, EtFOSA, MeFOSA Czech 
Republic 
18 Household dust 
(Fraser et al., 2013) PFOS, EtFOSE, MeFOSE US 30 Home. Exposed 
workers   
US 31 Offices. Exposed 
workers   
US 13 Cars. Exposed 
workers 
(Kato, Calafat and 
Needham, 2009) 
PFOS, PFOSA, EtFOSA, MeFOSA, 
EtFOSE, MeFOSE 
UK 9 Household dust 
  
Australia 10 Household dust   
Germany 10 Household dust   
US 10 Household dust 
N = number of cases. 
 
Indoor Air and Dust 
In addition to drinking water; relatively recent investigations show the indoor 
environment is a potentially important contributor to human exposure to PFASs 
including PFOS (Fromme et al., 2009; D’Hollander et al., 2010; Goosey and Harrad, 
2011; Haug, Huber, Schlabach, et al., 2011). The first paper concerning PFOS 
contamination of indoor dust was published in 2003, by Moriwaki et al. (Moriwaki, 
Takata and Arakawa, 2003) (Table 03). Sixteen samples of house dust were 
analysed, containing concentrations of PFOS between 11 and 2,500 ng/g. Since then, 
similar studies have been carried out in Canada, Japan, Sweden, USA, Australia, the 
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UK, Egypt, Germany, Czech Republic, and Spain, with wide variation in 
concentrations found. While Bjorklund et al. (Björklund, Thuresson and De Wit, 
2009) reported concentrations of PFOS in dust from 10 houses in Sweden in 2009 
to range between 15 and 120 ng/g, Tian et al. (Tian et al., 2016) reported average of 
13.7 ng/g for Korean houses and even much lower data was reported by Shoeib et 
al. (Shoeib et al., 2016) about Egyptian indoor environments with a median of 0.29 
ng/g. Strynar and Lindstrom (Strynar and Lindstrom, 2008) and Kato et al. (Kato, 
Calafat and Needham, 2009) reported substantially higher concentrations, ranging 
between 8.9 and 12,100 ng/g in the USA, and 2.6 and 18,000 ng/g in Australia. 
Median concentrations further reflect international variations, being 38 ng/g for the 
Swedish study, and 201 ng/g and 480 ng/g for the Canadian and Australian surveys 
respectively. Moreover, Goosey and Harrad (Goosey and Harrad, 2011) also 
reported statistically significant differences (p < 0.05) between concentrations of 
PFOS in dust from different countries. Specifically, UK, Australia, Canada, France, 
Germany, and US > Kazakhstan; and UK, Australia, Canada, and US > Thailand. They 
attributed such differences to lower use of products containing PFASs in Kazakhstan 
and Thailand compared to Europe, North America, and Australia. 
Moreover, recent studies have reported concentrations of PFOS and other PFASs in 
indoor air (principally vapour phase, but with some particulate phase compounds 
incorporated) (Goosey and Harrad, 2011; Ericson Jogsten et al., 2012; Shoeib et al., 
2016). In these, PFOS was the most prevalent PFASs, with a wide range of 
concentrations between countries (for example, lower values detected in Spain, 
higher in the UK). The frequency of detection for PFOS in indoor air is more variable 
than for dust (in air the range is from 0 % to 100 % c.f. 60°% to 100 % for dust). 
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Outdoor Air 
Outdoor air has also been studied, sometimes in conjunction with indoor air. Shoeib 
et al. (Shoeib et al., 2005) reported PFASs concentrations in outdoor air were 1 or 2 
orders of magnitude lower than in indoor air, as data from more recent studies in 
Table 04 corroborate. This is consistent with the hypothesis that substantial indoor 
sources of PFOS exist, with the result that indoor air likely exerts an appreciable 
influence on outdoor atmospheric contamination. While this would logically lead to 
higher atmospheric concentrations of PFOS in conurbations due to higher urban 
building densities; Barber et al. (Barber et al., 2007) reported higher detection 
frequencies of PFASs (including PFOS) than expected in outdoor air from rural areas. 
Such findings suggest the environmental distribution of PFASs is complex, and that 
indoor environments are not the only driver influencing outdoor contamination. 
 
1.4.2 Indirect Sources of Human Exposure 
POSF-derived substances may be metabolised in vivo to PFOS, constituting a 
substantial indirect source of human exposure to PFOS. The so called “POSF-derived 
substances” in general are a mixture of compounds with structures with the general 
formula C8F17SO2NRR’, that are referred to generically as “PFOS-precursors” (or 
“PreFOS” in some literature, such as Asher et al. (Asher et al., 2012)). The main PFOS-
precursor substances and its salts were listed in Table 01. 
It has been shown that some of these called PFOS-precursors are degraded to PFOS 
by in vivo metabolic processes (Xu et al., 2004; Martin et al., 2010; Chen et al., 2015). 
Some PFOS-precursors like N-EtFOSA and N-EtFOSE, have shown low conversion 
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factors < 1 % in rats and trout (Tomy et al., 2004; Xu et al., 2004), have been studied 
in earthworms (Zhao et al., 2016) or have not yet previously reported (as N-
MeFOSA, presented in later chapters). However, in 2003, Seacat et al. (Seacat et al., 
2003) reported a conversion factor to PFOS of up to 20 % in a study where rats were 
exposed long term to N-EtFOSE; an observation confirmed subsequently by Xie et 
al. (Xie et al., 2009). In 2015, Chen et al. (Chen et al., 2015) studied both, in vitro and 
in vivo (in carps) isomeric biotransformation of FOSA to PFOS, both tests moving 
towards the idea of the biotransformation of FOSA to PFOS taken place in the liver 
of the fish, differing from what was the previously observed in rats and monkeys. 
That same study also revealed the isomeric differences in the metabolism, showing 
a decrease of the percentage of the branched isomers of FOSA at the end of the 
incubation, while that percentage increased during the period of time the incubation 
was carried out. 
Although the reported levels of PFOS-precursors are generally lower and their 
physicochemical properties differ from those of PFOS, a variety of them have been 
detected in water (Dreyer and Ebinghaus, 2009b), in indoor and outdoor air 
(Taniyasu et al., 2005; Jahnke et al., 2007), in food (Tittlemier, Pepper and Edwards, 
2006; Gebbink et al., 2015), and in live organisms (from mussels to bald eagles) and 
water-bird eggs (Kannan et al., 2005; Wang et al., 2008). One of the most measured 
PFOS-precursors is perfluorooctane sulfonamide (FOSA), which is a stable 
intermediate in the pathway of PFOS-precursor degradation to PFOS (Martin et al., 
2010). Perfluorinated sulfonamide based products (PFSAm) are also important, as 
their production is associated with the presence of FOSAs and FOSEs as degradation 
or residual products. Positive correlations between the concentrations of FOSA and 
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PFOS have been found in biological samples (e.g. (Martin et al., 2004)) suggesting 
that FOSA, and maybe other PFOS-precursors, can be important contributors to 
body burdens of PFOS in animal species (Asher et al., 2012)(see Table 05 and Table 
06). 
As mentioned above, recent papers have examined the utility of human exposure 
models to evaluate the contribution of indirect exposure pathways to human body 
burdens of PFOS (Vestergren et al., 2008; Fromme et al., 2009; D’Eon J and Mabury, 
2011; Gebbink, Berger and Cousins, 2015). Such studies are still quite limited in 
number, but their general consensus is that the significance of indirect sources in 
driving human body burdens of PFOS should be taken into account, or even had 
hitherto been underestimated (e.g. (D’Eon J and Mabury, 2011)). This becomes even 
more important in the wake of the 3M Company phase out, as while direct sources 
of PFOS exposure are expected to decrease in the general population, indirect 
sources stemming from continued use of PFOS-precursors remain (see Figure 03). 
Vestergren et al. (Vestergren et al., 2008) suggested the relative contributions of 
direct and indirect exposure were dependent on the level of exposure. For them, 
while under low and intermediate exposure scenarios – when the four main 
exposure pathways were considered (diet, water, dust and air) –, direct dietary 
exposure appeared the principal pathway, intake of PFOS under a high-end 
exposure scenario was dominated by indirect precursor exposure via indoor dust 
(41 – 68 %), and indoor air (10 – 19 %). The study of Gebbink et al. (Gebbink, Berger 
and Cousins, 2015) considered comparable pathways of exposure to those studied 
by Vestergren et al: According to Gebbink et al., low exposure scenario was clearly 
dominated by direct exposure to PFOS through diet (≈ 86 %), followed by indirect 
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exposure to through air (≈ 8 %). Intermediate exposure scenario was also 
dominated by direct exposure through diet but in a smaller percentage (≈ 65 %), 
while direct exposure through dust (≈ 10 %), indirect exposure through air 
(≈ 10 %), and direct exposure through water (≈ 5 %) increased their relative 
contribution. Finally, high exposure scenario showed ≈ 60 %.of direct exposure 
from diet (≈ 50 %), dust (≈ 12 %) and water (≈ 10 %), while indirect exposure 
constituted more than 30 %, divided between dust and air, being this scenario the 
one with higher proportion of indirect exposure (PFOS precursors exposure) 
contribution. However, total exposure in the Gebbink et al. study was 1-2 orders of 
magnitude lower, with indirect exposure to PFOS making higher and lower 
contributions to overall exposure under low (11 %) and high (33 %) exposure 
scenarios respectively than estimated previously. Gebbink et al. attributed the 
differences between their observations and those of previous studies, to their use of 
recent data reporting lower levels of PFOS and PFOS-precursors in human diet 
(Ullah et al., 2014; Gebbink et al., 2015). Furthermore, other reasons such as the use 
of more recently published biotransformation factors describing the conversion of 
precursors, as well as the development of more sensitive analytical methods – with 
the quantification of PFOS precursors in much lower concentrations, or even in 
detectable levels that not sensitive instruments would not be able to reach – were 
identified as causes of the lower exposure estimates. Moreover, D’Eon and Mabury 
(D’Eon J and Mabury, 2011) critically reviewed the contribution of PFOS precursors 
to observed body burdens of PFOS, and suggested that studies to date may 
underestimate the contribution of such indirect exposure. This was principally due 
to the fact that such studies consider indirect exposure to occur only as a result of 
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exposure to PFOS precursors present as impurities or residual products from the 
manufacture of PFOS, but do not include exposure arising from manufacture and use 
of the precursors themselves. 
In summary, studies to date suggest strongly that indirect exposure to PFOS makes 
an important contribution to human body burdens, and these relative contributions 
might be strongly exposure-dependent. However, such studies are not yet 
conclusive. For example, estimates of the contribution of such exposure varies 
between 10 % and 70 % of the daily intake of PFOS in the studies of Verstergren et 
al. (Vestergren et al., 2008) and Gebbink et al. (Gebbink, Berger and Cousins, 2015) 
(based on the three different scenarios) and Fromme et al. (Fromme et al., 2009). 
Such variation is attributable to inherent uncertainties in pivotal parameters such 
as the estimated efficiency of precursor metabolism to PFOS. At the current time, 
efforts must focus on addressing: 1) the lack of data on the toxicokinetics of various 
PFOS-precursor compounds in animals, 2) the difficulty in extrapolating rodent data 
to humans, and 3) the fact that many commercially relevant PFOS precursors have 
yet to be determined in any sample (Martin et al., 2010). Overall, the uncertainties 
associated with studies to date, highlight a clear need for alternative approaches, 
and a small but growing number of studies suggests that exploitation of the chiral 
properties of some PFOS isomers and their precursors may constitute one such 
approach (Wang et al., 2009; Liu et al., 2015). 
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Figure 03. Schematic overview of the processes leading to PFOS from PFOS precursors 
exposure 
 
1.5 HUMAN BIOMONITORING DATA 
With respect to human biomonitoring, concentrations of PFASs in human blood 
(whole blood, plasma and serum) in the general population have been reviewed 
recently (Fromme et al., 2009; Angerer et al., 2011) (Table 07). Most human 
biomonitoring studies are not carried out on whole blood, but on serum. The first 
reported concentrations of PFOS in blood were published by Hansen et al. (Hansen 
et al., 2001). This study showed 100 % of the blood samples contained PFOS at 
concentrations ranging from 6.7 to 81.5 ng/mL. Following this seminal report, 
concern about how PFOS enters and remains in the human body increased, leading 
to the publication of a number of studies, each based on the analysis of a large 
number of blood samples. Amongst the most relevant of these are those of Calafat et 
al. and Kato et al. (Calafat, Kuklenyik, et al., 2007; Calafat, Wong, et al., 2007; Kato et 
26 
al., 2011) in the North American population, which each discuss results from the 
National Health and Nutrition Examination Surveys (NHANES) carried out by the US 
Center for Disease Control and Prevention (CDC), and published in the Fourth 
National Report on Human Exposure to Environmental Chemicals (CDC, 2009a, 
2009b). In these reports, the presence of a range of chemical contaminants is studied 
in blood and urine from the general population of the USA. The PFOS measurements 
reported in the two papers from Calafat et al. refer to the NHANES results from 
1999-2000 and 2003-2004, and are based on 1,562 and 2,094 serum samples, with 
a detection frequency (DF) > 96 % for PFOS in both studies, and geometric means of 
21.1 and 20.7 ng/mL respectively. One of the studies (Calafat, Wong, et al., 2007), 
also reported that geometric mean PFOS levels declined by 32 % between 
1999/2000 and 2003/2004. Moreover, the most recent (2007/2008) NHANES 
results (Kato et al., 2011), indicate that PFOS concentrations continue to decline 
(exemplified by a geometric mean of 13.2 ng/mL). This follows an earlier report 
(Olsen, Mair, et al., 2007) of a decrease on PFOS levels in human blood in the general 
American population, from a geometric mean of 33.1 ng/mL in samples collected in 
2000, to 15.1 ng/mL in samples collected in 2005. A second study (Olsen et al., 2008) 
based on a large number of human blood samples (around 600), highlighted that the 
observed ≈ 60 % decline in PFOS was consistent with its elimination half-life and the 
time period since the phase-out of PFOS by 3M Company in 2000–2002. Combined, 
these studies suggest that restrictions on the production and use of PFOS have led 
to reductions in human exposure in the US, although it remains in the environment, 
wildlife and the US population (CDC, 2009a). Other US studies document similar 
PFOS concentrations in blood, but cannot provide evidence of a temporal trend. 
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Specifically, Hansen et al. (Hansen et al., 2001), as well as Olsen et al. (Olsen et al., 
2005), published results in which median PFOS concentrations were 26.2 and 34.7 
ng/mL for samples taken in the late 1990s/early 2000s (exact sampling dates not 
given) and 1974/1989 respectively. This apparent increase in human exposure in 
the immediate aftermath of the 2002 voluntary cessation of production by 3M 
Company may be attributed to variation in the respective populations sampled in 
the two studies. 
An important point is that – in line with Taniyasu et al., (Taniyasu et al., 2003) – the 
values in Table 07 include data for both serum and whole blood. This approach is 
preferred here to the alternative format employed by others (e.g. (Kannan et al., 
2004; Yeung et al., 2006)) whereby concentrations in whole blood were converted 
to concentrations in serum by multiplying whole blood concentrations by 2, to allow 
comparison across different studies. This conversion becomes even more sensitive 
when analysing PFOS precursors, due to their different distribution between serum 
and blood (Martin et al., 2010). Notwithstanding the influence of serum versus 
whole blood basis concentrations, examination of the global database between 2004 
and 2007, reveals some differences in both median and maximum PFOS 
concentrations in human blood recorded in different studies shown in Table 07. 
Likely causes of these between-study variations in the concentrations of PFOS 
include international variations in use and exposure, as well as variations between 
sampled populations in lifestyle, age, ethnicity, and gender (Kato et al., 2011). While 
such differences in absolute concentrations of PFOS exist, they are not as marked as 
those observed for other halogenated persistent organic pollutants like 
polybrominated diphenyl ethers (Hites, 2004). 
28 
On the other side, PFOS precursors – including FOSAs beyond FOSA, FOSEs and 
FOSAAs – have been much less reported, as Table 08 shows.  
Table 09 reveals that, in addition to blood, human milk is being monitored 
increasingly. This shift towards monitoring milk may be attributed to its less 
invasive nature, greater sample availability and mass, recent improvements in the 
sensitivity and accuracy of ultra-trace analytical techniques (although these are 
likely still worse than for serum), and the dual role of human milk as an indicator of 
both the donor’s body burden, and dietary intake of nursing infants. Of course, this 
is offset to some degree by the fact that human milk as a biomonitoring tool is 
restricted to a specific sector of the population. Moreover, comparing Table 07 and 
Table 09, it is apparent that concentrations of PFOS in human blood exceed those in 
human milk. Several studies of human milk have been carried out since the first 
published reports. Most such studies show DF > 90 %, except those of Bernsmann 
and Fürst (Bernsmann and Fürst, 2008) (DF of 66 % in Germany), and Guerranti et 
al. (Guerranti et al., 2013), in which the detection frequency was below 50 % (DF of 
41 % in Italy). Median concentrations range from 0.04 to 0.33 ng/mL, except for the 
study of Roosens et al. (Roosens et al., 2010) for the Flemish general population, 
who reported a median concentration an order of magnitude higher than other 
studies (2.9 ng/mL). Some of the samples reported by Roosens et al. were collected 
from donors living near a PFOS production facility, for which the authors also 
reported high concentrations of PFOS in serum. Elevated concentrations of PFOS 
had also been reported previously in biota from the same location by Dauwe et al. 
(Dauwe et al., 2007). 
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Table 08. Index of published research articles monitoring PFOS precursors in human 
biological matrices 
Authors Analytes Country n Matrix 
(Glynn et al., 2012) PFOS, FOSA Sweden 413 Serum 
(Yeung et al., 2013) PFOS, FOSAA, EtFOSAA, 
MeFOSAA 
Germany 420 Blood 
(Lee and Mabury, 2011) PFOS, FOSAA, EtFOSAA, 
MeFOSAA 
US 50 Serum 
(Gebbink, Glynn and 
Berger, 2015) 
PFOS, FOSA, FOSAA, 
EtFOSAA, MeFOSAA 
Sweden 30 Serum 
 
PFOS, PFOSA, PFOSAA, 
FOSAA, EtFOSAA 
US 238 Serum 
(Van Leeuwen et al., 
2006) 
PFOS, PFOSA Netherlands Intercomparison Whole blood 
(Fraser et al., 2013) PFOS, PFOSA, EtFOSE, 
MeFOSE 
US 31 Home. Exposed 
workers 
N = number of cases. 
In contrast to blood and milk, only a small number of papers have reported 
concentrations of PFASs in other human matrices such as: liver, seminal plasma, and 
umbilical cord blood (Olsen et al., 2003; Inoue et al., 2004; Kuklenyik et al., 2004; So 
et al., 2006; Apelberg et al., 2007; Kärrman, Ericson, et al., 2007; Midasch et al., 2007; 
Guruge et al., 2011). 
Scientific understanding of the origins of and influences on the presence of PFOS in 
humans is complicated by a number of factors (Lindstrom, Strynar and Libelo, 
2011). Just as environmental degradation of PFOS precursors constitutes an 
important indirect source of PFOS contamination of the ambient environment; 
external exposure to PFOS precursors followed by in vivo metabolism, has been 
identified as a potentially substantial indirect contributor to human body burdens 
of PFOS (Trudel et al., 2008; Vestergren et al., 2008). Such indirect pathways are 
distinct from direct exposure via human contact with and uptake of PFOS itself. 
Moreover, PFOS (as well as other long chain PFASs) tend to accumulate in the human 
body with an estimated half-life of around 5 years (Olsen, Burris, et al., 2007). This 
slow elimination from the human body hampers efforts to determine how changes 
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in lifestyle, diet, or other exposure-related factors influence blood levels. 
Notwithstanding this, while age has been suggested to exert little influence on 
circulating PFASs concentrations, with inconsistent results in cross-sectional 
studies (Harada et al., 2007; Haug, Thomsen and Becher, 2009b), age associations 
could be consistent with dietary exposure in a post phase out situation (Nost et al., 
2014). However, as highlighted above, gender and ethnicity do seem to influence the 
accumulation of some compounds. In a recent paper, Kato et al. (Kato et al., 2011) 
attributed differences in human body burdens between ethnic groups to ethnic 
differences in exposure related to lifestyle, the use of products containing PFASs, 
and diet. Meanwhile, gender-related differences in body burden (lower 
concentrations in women than men) have been attributed to physiological 
differences (i.e. accumulation and elimination), as well as pregnancy, lactation and 
menstruation (Harada et al., 2004). 
 
1.6 ISOMER PATTERNS OF PFOS AND ITS PRECURSORS 
Historically, ΣPFOS has been quantified together (see Table 02 to Table 04, Table 07 
and Table 09). Recently however, new approaches (discussed further below) have 
been have been suggested as biomarkers of exposure and applied in efforts to 
differentiate between direct exposure to PFOS and PFOS-precursor exposure 
(Benskin, Holt and Martin, 2009; Martin et al., 2010). 
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Table 10. Linear versus branched chain composition profiles and enantiomer fractions 
(EFs) of PFOS and its precursors in various matrices 
Authors Country Study Matrix  n Analytes 
(Asher et al., 2012) Canada Lake 
Aquatic 
Species 
67 FOSA (≈57 % linear) 
     PFOS (>90 % linear) 
   Water 2 PFOS (70 % linear) 
     Sediment 3 PFOS (>90 % linear) 
(Beesoon et al., 
2011) 
Canada Human Dust 18 PFOS (≈70 % linear) 
   Serum 20 PFOS (≈64 % linear) 
   Cord serum 20 PFOS (≈54 % linear) 
(Benskin, Bataineh 
and Martin, 2007) 
Canada Human Serum 14 PFOS (≈80 % linear) 
(Haug, Thomsen and 
Becher, 2009b) 
Norway Human Serum 57 PFOS (53-78 % linear) 
(Olsen et al., 2008) Canada Niagara/Lake Fish 22 PFOS (88-93 % linear) 
   Water NR PFOS (43-56 % linear) 
(Kärrman, Langlois, 
et al., 2007) 
Sweden Human Serum/blood 17 PFOS (68 % linear) 
 UK   13 PFOS (59 % linear) 
 Australia   40 PFOS (59 % linear) 
(Ross, Wong and 
Martin, 2012) 
Canada Animals Blood 8 FOSA (≈78 % linear) 
   Blood 8 PFOS (≈77 % linear) 
   Heart 8 FOSA (≈93 % linear) 
   Fat 8 FOSA (≈86 % linear) 
(Sharpe et al., 2010) Canada - Fish NR PFOS (>70 % linear) 
(Wang et al., 2011) Canada Animals Rats 3 1mPFOS (EF≈0.5) 
  Human Serum 8 1mPFOS (EF=0.43 ) 
   Human Serum 7 1mPFOS (EF=0.35-0.43 ) 
(Zhang et al., 2013) China Human Serum 129 PFOS (48 % linear) 
N = number of cases. EF = Enantiomeric fraction 
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1.6.1 Isomer Profiles 
 
Figure 04. Structure of linear (n) PFOS isomer (1), and branched (br) FOS isomers (2 to 11) 
 
As described above, the processes via which PFOS precursors (i.e. FOSAs and FOSEs) 
are manufactured are expected to produce about 70 % of the linear isomer, with the 
remaining 30 % made up of a mixture of various branched chain isomers (see Figure 
04). In contrast, due to preferential retention of linear PFOS in humans and rats, 
PFOS isomer profiles in animal species are expected to comprise < 30 % branched 
chain isomers. While this holds true for species such as fish and gulls for which 
≥ 90 % of PFOS is the linear isomer (Houde et al., 2008; Gebbink and Letcher, 2010; 
Asher et al., 2012) (Table 10); in some human samples, the proportion of branched 
chain isomers can be 40-50 % (Kärrman, Langlois, et al., 2007; Beesoon et al., 2011; 
Zhang et al., 2013; Liu et al., 2015). Moreover, an in vitro study using human 
microsomes has showed branched chain FOSAs to be preferentially metabolised to 
PFOS relative to linear FOSA (Benskin, Holt and Martin, 2009). This provides further 
evidence that precursor exposure may account for human PFOS isomer profiles that 
are enriched in branched chain isomers. This enriched profile in some human 
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samples has been hypothesised as providing evidence of precursor exposure. 
Moreover, observed temporal and within-population variations in the relative 
abundance of branched chain PFOS isomers in humans (Kärrman, Langlois, et al., 
2007; Haug, Thomsen and Becher, 2009b), may be at least partly attributable to 
concomitant variations in precursor exposure. In fact, the study of temporal trends 
by Liu et al. (Liu et al., 2015), shows the percentage of branched isomers in the 
Swedish population has increased from 32 to 45 % between 1996 and 2010, 
suggesting that exposure to PFOS precursors is becoming more important 
compared to direct exposure, as predicted by the theoretical models discussed 
earlier. 
Current evidence to support the PFOS precursors exposure hypothesis is not clear-
cut however (Ross, Wong and Martin, 2012). While excretion in rats of branched 
chain FOSAs exceeded that of the linear isomer; a corresponding increase in the 
relative abundance of the sum of branched chain PFOS isomers was not observed in 
the same animals. More detailed analysis of the relative abundance of individual 
branched chain isomers in this study suggests a more complex situation. While the 
relative abundance in the studied rats of one branched isomer (5m-PFOS), increased 
relative to its abundance in a commercial PFOS mixture; that of another (1m-PFOS) 
decreased (Ross, Wong and Martin, 2012). This may point to a need to monitor 
relative abundances of individual branched chain isomers rather than the sum of all 
such isomers, to provide more conclusive insights into the relative contribution of 
precursor exposure. This conclusion is supported by the study of Gebbink et al. 
(Gebbink, Berger and Cousins, 2015), where an estimated isomeric pattern of 84 % 
linear PFOS was calculated for exposure via water, diet, air and dust, that contrasts 
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with isomer patterns observed in human serum samples (Beesoon et al., 2011; Haug 
et al., 2009; Benskin et al., 2007; Zhang et al., 2013). The potential feasibility of such 
a detailed isomer-specific approach is demonstrated by a study of PFOS isomer 
distributions in gull eggs from spatially distinct breeding colonies throughout the 
Laurentian Great Lakes (Gebbink and Letcher, 2010). In this study, eight individual 
branched chain PFOS isomers were detected in gull eggs, with spatial variations in 
the contribution of linear PFOS in eggs highlighted as potentially at least partly 
attributable to location-specific variations in the PFOS precursor exposure. 
 
1.7 EXTRACTION AND ANALYTICAL DETERMINATION 
In terms of sample preparation, the extraction techniques are usually determined ‒ 
together with the physical and chemical properties of the analytes of interest ‒ by 
the nature of the matrix of interest, as there are many substances which can cause 
interferences during analysis, and they differ matrix from matrix. A second aspect 
to be considered when analysing PFASs is their capability of being retained on 
glassware, as Martin et al. reported (Martin et al., 2004), fact which could lead to 
potential losses when the sample is stored or processed. 
 
1.7.1 Sample Preparation 
The extraction and analysis of PFASs, including PFOS, FOSAs, FOSEs and FOSAAs in 
the same extraction method in such variable matrices as dust, food composites and 
blood can be a challenging task. PFOS has been analysed and reported extensively 
(see Tables 02 to 04, Table 07 and Table 09), while FOSAs, FOSEs and FOSAAs have 
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been just reported in a reduced number of publications, as Table 05, Table 06 and 
Table 08 showed. 
A large number of papers reporting PFOS analysis have been published. It is 
commonly selected as representative long chain fluorinated compound to include in 
traditional targeted analysis of PFASs (Apelberg et al., 2007; Dauwe et al., 2007; 
Guruge et al., 2011; van Asselt et al., 2011; Cai et al., 2012; Glynn et al., 2012; 
Kubwabo, Kosarac and Lalonde, 2013). On the other side, available data of the PFOS 
precursors described along the introduction chapter and included in this study is 
rather limited. 
For dust sample preparation, ultrasonic solid-liquid extraction with different 
organic solvents as methanol, acetone or dichloromethane (Goosey and Harrad, 
2011; Huber, Haug and Schlabach, 2011; Shoeib et al., 2011) have been reported, 
followed by clean-up steps based on SPE purification, by the use of activated carbon 
(Shoeib et al., 2011; Fraser et al., 2013) or weak anion exchange sorbents (Goosey 
and Harrad, 2011). Newer and more efficient instrumentation for the 
automatisation of the sample preparation has been also reported, as on-line solid 
phase extraction (SPE) by Kato et al. (Kato et al., 2011). 
For food sample preparation, extractions methods have been described for fish 
tissue by the use of ultrasonic solid-liquid extraction with acetonitrile and methanol, 
followed by freezing and SPE clean-up steps (Ullah et al., 2014), or directly 
evaporated and injected into the system (Van Leeuwen et al., 2009). For a Swedish 
diet study, Gebbink et al. (Gebbink et al., 2015) described a method where the 
samples were extracted by solid-liquid extraction and the clean-up step was carried 
out by the use of weak anion exchange SPE cartridges. On the other side, Tittlemier 
38 
et al. (Tittlemier, Pepper and Edwards, 2006) described an extraction method for 
food composites based on an hexane:acetone extraction, followed by acidified silica 
purification. 
For blood extraction, Olsen et al. reported in 2004 a method based on methyl-tert-
butyl-ether serum extraction (Olsen et al., 2004). After it, some other extractions 
have been described for PFOS precursors analysis: same procedure as for food 
extraction was described by Gebbink et al (Gebbink, Glynn and Berger, 2015), while 
other authors as Yeung et al. or Lee et al. (Lee and Mabury, 2011; Yeung et al., 2013) 
reported plasma data extracted by ion-pair extraction. On the other hand, Fraser et 
al. (Fraser et al., 2013) employed on-line SPE for the serum analysis. 
 
1.7.2 Analytical Determination 
High performance liquid chromatography (HPLC) and gas chromatography (GC), 
both coupled to mass spectrometry (MS), are nowadays two of the most powerful 
tools employed for the analytical determination of environmental pollutants. They 
both combine the advantages of the analytical separation – HPLC or GC – with the 
selectivity, sensitivity and accuracy that MS determination provides. These 
techniques can provide accurate qualitative and quantitative information. 
In the targeted analysis of PFOS and PFOS precursors, the chromatographic 
separation has been dominated by liquid chromatography, commonly by the use of 
reversed phase bonded silica columns, specially C18 columns (Olsen et al., 2004; 
Yeung et al., 2013; D’Hollander et al., 2015; Gebbink et al., 2015). The 
chromatographic separation has been usually followed by mass spectrometry 
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determination, as all the methods from Table 05, Table 06 and Table 08 show. 
Electrospray negative ionisation (ESI -) has been employed through the years as the 
main source and ionisation mode for the analysis of PFASs, partly due to the need of 
strong ionisation energy that atmospheric-pressure chemical ionisation (APCI) 
sources cannot provide, and well as to the functional groups characteristic from this 
family of organic pollutants and their easy ionisability as [M-] moiety, 
 
1.8 SUMMARY 
PFOS is an environmental pollutant which has been widely studied. Significant 
manufacture of both PFOS and PFOS precursors continues today; e.g., PFOS 
production has increased in China since 2002 (with higher reported levels of PFOS 
in some regions of China than in the US, despite the small production volumes in 
China compared to reported 3M production (Olsen et al., 2012)), while PFOS and 
PFOS-precursors are still being manufactured in Europe and Asia for certain 
applications (UNEP, 2010; Paul et al., 2009; Zhang et al., 2013). 
This introduction has highlighted the potential insights into PFOS environmental 
fate that may be gained from better knowledge of the isomer specific behaviour of 
both PFOS and its precursors. Despite this, at the current time, only a few papers 
have been published reporting the relative abundance of both linear and branched 
PFOS isomers in the environment. In part, this is likely due to the fact that reference 
standards for branched chain isomers have only recently become available, and to 
the challenging nature of existing analytical methods for their measurement, 
exacerbated by the usually very low concentrations of individual branched chain 
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isomers in environmental and biological samples. Furthermore, while variations in 
precursor exposure may explain variations in PFOS isomer profiles; other factors 
such as gender and pregnancy may also be influential. Despite these obstacles, 
exploiting the isomer patterns of PFOS and its precursors offers new opportunities 
to gain insights into their environmental fate and behaviour. 
Given the potential rewards, further development, validation, and carefully targeted 
application of analytical methods for the determination of branched signatures of 
PFOS isomers are necessary. They will not be a trivial task; but they constitute 
urgent research priorities. 
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2. AIMS AND OBJECTIVES 
 
The aim of this chapter is to define the overall concept of this thesis: objectives, 
hypothesis, and approaches to achieve the established goals. 
This work presented in this thesis is part of a multidisciplinary FP7 project (A-
TEAM: advanced tools for exposure assessment and biomonitoring), so the aims and 
objectives of the project will be also presented, as well as where the work 
undertaken in this thesis fits in the overall picture of the project. 
 
2.1 IADVANCED TOOLS FOR EXPOSURE ASSESSMENT AND BIOMONITORING: 
THE A-TEAM PROJECT 
The A-TEAM is a Marie Curie Initial Training Network (ITN) project which main 
research goal was to further understanding of how and to what extent consumer 
chemicals enter humans, and of how such chemicals could be best monitored in our 
indoor environment, diet, and bodies (Figure 05). The A-TEAM vision was that such 
enhanced understanding of the underpinning science would lead to more effective 
approaches to monitoring human exposure to chemicals within Europe, thereby 
improving assessment of risk associated both with recent and current-use 
consumer chemicals, as well as those under development, and leading ultimately to 
more sustainable approaches to the use of chemicals. Eight partners from five 
different countries were involved: University of Birmingham and University of 
Reading from the UK, University of Antwerp and Flemish Institute for Technological 
Research from Belgium, University of Amsterdam from The Netherlands, Swedish 
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Environmental Research Institute and Stockholm University from Sweden, and 
Norwegian Institute of Public health from Norway. 
The principal objectives of the A-TEAM project were to provide robust scientific 
information that would allow better understanding of: 
- The identification at an early stage of chemicals likely to accumulate in 
Europeans. 
- To monitor chemicals in the external environment in a way that best reflects 
what accumulates in the body. 
- The relative importance of different exposure pathways to overall exposure 
for selected consumer chemicals of toxicological concern. 
- How contact with chemicals in our external environment translates into their 
presence in our bodies and how best to monitor this presence. 
 
To achieve these objectives, four families of environmental contaminants widely 
employed in different applications in consumer products were selected and studied 
by the different partners involved in the project: 
- Perfluoroalkyl substances (PFASs), used in consumer applications that 
exploit their strong surfactant properties such as surface treatment agents. 
- “Emerging” brominated flame retardants (EBFRs), employed to impart fire 
safety to consumer goods and materials. 
- Organophosphate esters (OPEs) used both, as plasticisers and flame 
retardants. 
- Phthalate esters (PEs) used as plasticisers. 
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2.2 PFOS PRECURSORS AS INDIRECT SOURCES OF INTERNAL EXPOSURE TO 
PFOS WITHIN THE A-TEAM PROJECT 
Within the whole project context, the aim of the research project this thesis is 
addressed to, was to increase the knowledge base and experience of the PhD 
candidate in different research areas (i.e. analytical and environmental chemistry, 
and exposure assessment) that are relevant to the challenge of achieving accurate 
and easily applicable approaches to monitoring human exposure to perfluoroalkyl 
substances (PFASs). 
This research proposal was designed to assess the extent to which PFOS precursors 
such as perfluorooctane sulfonamides (FOSAs) and sulfonamidoethanols (FOSEs) 
contribute significantly to human body burdens of PFOS. 
The project also involved: 
- Exposure to complementary methods of PFASs analysis and in vitro methods 
for studying contaminant metabolism. 
- Training in monitoring human exposure to PFASs. 
- Collaboration with other research teams to incorporate precursor 
metabolism into PFASs PK exposure modelling. 
 
To achieve the overall project aim, the development and the validation of analytical 
methods for the determination of concentrations and branched signatures of PFOS 
isomers was required. These techniques meant to be applied to a variety of 
appropriate samples to provide insights into the contribution of PFOS precursors to 
human body burdens of PFOS. This included the development and the application of 
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LC-MS/MS techniques to determine concentrations and signatures of PFOS isomers 
and relevant PFOS precursors in environmental samples. In this way, the hypothesis 
that human exposure to PFOS precursors makes a significant contribution to human 
body burdens of PFOS would be tested. 
 
2.3 AIMS AND OBJECTIVES OF THIS PhD THESIS PROPOSAL 
The aims of this thesis are: 1) to characterise external exposure to PFOS, FOSAs, 
FOSEs and FOSAAs – suspected to be PFOS precursors –, 2) to characterise internal 
exposure to PFOS, and 3) to link external exposure to PFOS precursors to internal 
exposure to PFOS by the use of in vitro studies (see Figure 6). 
External exposure examined in this research include the two most important routes 
of external exposure to environmental pollutants: diet – by the study of solid and 
liquid food ingestion, including drinking water –, and indoor dust, while internal 
exposure includes human serum samples as representative matrix. In vitro study 
include the incubation of selected PFOS precursors with human liver microsomes. 
The main hypothesis of this thesis is: 
“PFOS precursors – such as FOSAs and FOSEs – contribute significantly to current 
body burdens of PFOS, as indirect sources of external exposure” 
 
To test the main hypothesis, I will develop analytical methods for the analysis of 
selected PFASs suggested to be PFOS precursors, such as FOSAs, FOSEs and FOSAAs, 
and for PFOS branched isomers. I will also develop sample preparation 
methodologies for the suitable analysis of the selected PFASs in solid food 
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composites, liquid food composites and serum. I will also report their concentration 
in the representative matrices. I will study the in vitro metabolism of selected PFOS 
precursors and propose pathways for their internal conversion to PFOS. Finally, I 
will combine all the exposure data and I will evaluate whether the levels at which 
PFOS and PFOS precursors are present in external matrices contribute to the body 
burdens of PFOS. 
 
 
Figure 05. Graphical overview of the main objectives of the A-TEAM project 
 
 
 
Figure 06. Graphical overview of the main goals of the present thesis project 
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Within the framework of the main hypothesis, more specific hypotheses are 
proposed: 
1. Indoor home dust is a significant source of exposure to long chain PFASs such 
as PFOS, FOSAs and FOSEs. 
2. FOSAs and FOSEs contribute to the overall external exposure to PFASs via 
indoor dust ingestion. 
3. Diet is a significant source of exposure to long chain PFASs such as PFOS, 
FOSAs, FOSAAs and FOSEs. 
4. FOSAs, FOSEs and FOSAAs contribute to the overall external exposure to 
PFASs via food consumption. 
5. PFOS is ubiquitous in serum. 
6. PFOS branched isomer ratios in serum differ from the reported for 
environmental external exposure. 
7. FOSAs and FOSEs are rapidly metabolised to PFOS. 
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3. METHODOLOGY 
 
3.1 INTRODUCTION 
All samples for this study were collected as part of the A-TEAM project cohort, which 
is composed of 61 participants, all of them workers at the Norwegian Institute of 
Public Health (NIPH) in Oslo, Norway. The overall objective of the A-TEAM project 
was to enhance knowledge of external and internal human exposure to certain 
consumer chemicals, PFASs included. The sampling campaign was conducted 
between November 2013 and April 2014, and each set of samples was collected over 
the same 48 hour period, in two consecutive visits (one per day). Indoor air, 
personal air, floor dust, settled dust, hand wipes, food, drinks, blood, urine, saliva 
and finger nail samples were collected to cover the main external and internal 
exposure media. Detailed protocols are provided later in this chapter. 
Questionnaires were also collected, including information related to sample 
collection, lifestyle, frequented indoor and outdoor environments, food records and 
lifestyle habits of each participant. The samples were aliquoted and stored in pre-
cleaned polypropylene (PP) containers at NIPH, and shipped to the laboratories 
involved in their analysis (Papadopoulou et al., 2016). At Birmingham, 57 house dust 
from vacuum cleaner bags, 113 solid food composites, 121 drink composites and 60 
blood serum samples were received. 
The selected compounds among the PFASs to be monitored are: PFOS, 
perfluorooctane sulfonamides (FOSA, MeFOSA and EtFOSA), sulfonamide alcohols 
(MeFOSE and EtFOSE), and sulfonamide acetic acids (FOSAA, MeFOSAA and 
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EtFOSAA) listed in Table 11. PFOS was chosen due to its persistence in the 
environment, its long half-life in the human body (around 5 years) (Olsen, Mair, et 
al., 2007), and its stability as end-product resulting from degradation and 
metabolism of other PFASs like FOSAs, FOSEs and FOSAAs (Vestergren et al., 2008; 
Plumlee, McNeill and Reinhard, 2009; Zhao et al., 2016). PFOS, FOSAs and FOSEs 
have been added to different products and formulations: inks, varnishes, waxes, fire-
fighting foams, metal plating and cleaning products, coatings (for walls, furniture, 
carpeting, food packaging), lubricants, water and oil repellents for leather, paper 
and textiles (3M, 2000) and its presence in environmental and biomonitoring 
samples has also been reported (Noorlander et al., 2011; Gebbink et al., 2015; 
Gebbink, Berger and Cousins, 2015; Miralles-Marco and Harrad, 2015; Shoeib et al., 
2016), FOSAAs were included due to their presence in food and biological matrices 
as oxidation products of FOSEs (Xie et al., 2009; Benskin et al., 2013). 
Many analytical papers including a wide list of representative PFASs have been 
published in the last 15 years (Wolfa and Reagenb, 2011; Tang et al., 2014; Pérez-
Ortega et al., 2016; Zacs and Bartkevics, 2016; Harrington, 2017), revealing PFOS – 
together with PFOA – to be one of the most relevant PFASs due to its high detection 
levels and frequencies. In contrast, the number of publications and available 
methods for the determination of PFOS precursors is markedly lower. Moreover, 
most such papers include only FOSA as an intermediate metabolite, with only a sub-
set including FOSAs, FOSEs and FOSAAs together (see Table 05, Table 06 and Table 
08) (Kato, Calafat and Needham, 2009; Goosey and Harrad, 2012; Fraser et al., 2013; 
Gebbink, Glynn and Berger, 2015; Lankova et al., 2015). 
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The extraction method initially used for dust samples was adapted from existing 
methods (Taniyasu et al., 2005; Young and Tran, 2006; Goosey and Harrad, 2011). 
On it, acetone was used as the extraction solvent because PFOS was found to be more 
soluble in polar organic solvents (Takagai and Igarashi, 2002). For the remaining 
matrices –solid food, liquids and serum – the extraction method were modified and 
specifically adapted to the nature of every matrix, in order to remove matrix specific 
interferences without analyte looses. The clean-up step for dust samples was first 
adapted and validated from a previously reported method (Goosey and Harrad, 
2011), to be later applied to the rest of the matrices included in this study. A basic 
description of the complete sample treatments are given in Figure 07 to Figure 10. 
The analytical methods were modified from previously published methods (Goosey 
and Harrad, 2011; Benskin et al. 2007). An evaluation and optimisation of all 
parameters and conditions to enhance method sensitivity and specificity in target 
matrices was conducted. 
 
3.2 SAMPLING CAMPAIGN 
The sampling campaign protocol was approved by the Regional Committee for 
Medical and Health Research Ethics in Norway (2013/1269). 
The participants were contacted around two weeks before the date of the first visit, 
and PP pre-cleaned containers of different sizes were distributed to them, together 
with instructions on how to weigh and collect some of the samples. They were also 
requested to complete and return the following forms and questionnaires: a) 
Consent form to be signed prior to the collection of the samples, where the 
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participants agreed to the collection and use of these samples; b) Food diary (FD), 
containing detailed information about the individual food sample content 
(ingredient by ingredient), amount, packaging materials, cooking methods and 
utensils, etc. used for every meal collected during the two consecutive days of food 
sample collection period; c) Food frequency questionnaire (FFQ), containing generic 
information about the average consumption and frequency of a wide range of food 
items (n = 225) of the participants during the last whole year (Brantsæter et al., 
2008); and d) Indoor environment questionnaire (IEQ), which collected information 
about house and other frequent indoor environments, lifestyle, habits, daily used 
products as well as basic personal information. 
Finally, three appointments were scheduled with every participant. These 
comprised: a) two visits in two consecutive days to their homes to collect all the 
samples but blood; and b) one extra appointment with a research nurse at NIPH to 
collect blood samples. 
 
3.2.1 Dust Samples 
Participants were told when contacted to not discard their vacuum cleaner bags 
until the sampling appointment. During the second visit, the bags were collected 
from the vacuum cleaner by the researchers, wrapped in aluminium foil and kept in 
a plastic bucket at room temperature. In case the participants needed to replace the 
bag before the appointment, they had to wrap it themselves in aluminium foil and 
keep it at room temperature until its collection. 
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The bags were cut with scissors and tweezers and the dust was sieved with a 500 
µm mesh sieve. 2 g of sieved dust were placed in 30 mL pre-cleaned PP containers 
and kept at 4 °C until they were shipped to Birmingham. 
For blanks, six empty pre-cleaned 30 mL PP containers were sent to Birmingham. 
Once there, 2 g of clean sodium sulphate were added to each bottle, shaken for 2 
minutes and stored together with the dust samples. The purpose of these blanks was 
the identification of potential cross-contamination from the PP bottles, as well as 
from the storage places. 
 
3.2.2 Food Samples 
Food samples were divided in two groups: Solid and liquid. 
The food sampling protocol was established following duplicate diet method (Shim, 
Oh and Kim, 2014) during a period of two consecutive days. In it, a duplicate portion 
of all food consumed by the participant over a specific period of time is weighed (by 
the use of a kitchen scale measuring ± 0.1 g), recorded in a food diary, and mixed. In 
this study, participants received instructions on how to collect the food samples, and 
four bottles were given to them: Two for solid food samples (relating to day 1 and 
day 2 of the sampling), and another two for the liquid food samples (also relating to 
day 1 and day 2 of the sampling); as well as two food diaries to complete relating to 
day 1 and day 2.  Samples and food diaries were collected during the second visit to 
be homogenised within the following 24 hours. 
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All the solid food samples were weighed and homogenised in a food processor 
(Robot-coupe Blixer 3) for 2 minutes. Then, 100 g were weighed, placed in 250 mL 
pre-cleaned PP containers and stored at - 20 °C until they were shipped to 
Birmingham. All the liquid food samples were homogenised by shaking for 1 minute. 
Then, 100 g were weighed and stored following the same procedure as solid food 
samples. 
For solid food blanks, six pre-cleaned 2 L PP bottles were each filled with 100 g of 
diatomaceous earth, shaken for 1 minute, emptied into the food processor, 
homogenised for 2 minutes and placed in 250 mL pre-cleaned PP containers. The 
purpose of these blanks was the identification of potential cross-contamination 
from the food processor, as well as from the storage places. 
For liquid food blanks, six empty pre-cleaned 2 L PP bottles and six empty PP pre-
cleaned 125 mL containers were sent to Birmingham. Once there, 100 mL deionised 
water were added to each 2 L PP bottle, shaken for 1 minute and placed in the 250 
mL PP containers. The purpose of these blanks was the identification of potential 
cross-contamination from the PP bottles, as well as from the storage places. 
 
3.2.3 Blood Samples 
Blood samples were collected by a research nurse at the NIPH and placed in 10 mL 
plastic Vacutainer® serum tubes. The samples were left to coagulate for 1 hour and 
centrifuged at 2,500 rpm for 15 minutes. The supernatant serum fractions were 
transferred into 2 mL PP cryogenic vials and stored at - 80 °C until they were 
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shipped to Birmingham. Once there, the samples were kept at -20 °C until their 
analysis. 
For blanks, six empty pre-cleaned 2 mL tubes were sent to Birmingham. Once there, 
2 mL of calf serum were added to each tube, shaken for 2 minutes and stored 
together with the blood samples at - 20 °C. The purpose of these blanks was the 
identification of potential cross-contamination from tubes, as well as from the 
storage places. 
 
3.2.4 Sample Storage 
All the material used during the sampling campaign (including PP bottles and 
containers) was rinsed with methanol, dried at room temperature and kept closed 
or wrapped in aluminium foil until its use. 
Dust samples were shipped to Birmingham at room temperature and stored at 4°°C 
until their analysis. Food samples were sent to Birmingham in expanded 
polystyrene containers filled with dry ice. Once in Birmingham, liquid food samples 
were placed in the freezer at – 20 °C until their analysis, while the solid food samples 
were weighed, freeze-dried, weighed again and homogenised with a coffee blender 
prior to storage at – 20 °C in 125 mL pre-cleaned glass containers until their 
analysis. Serum samples were sent to Birmingham in expanded polystyrene 
containers filled with dry ice. They were stored there at – 20 °C until their analysis. 
All blanks were stored together with the corresponding samples. 
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All samples were removed from the fridge (4 °C) or freezer (- 20 °C) and allowed to 
reach room temperature before commencing sample treatment. Any remaining 
sample was replaced in the fridge or freezer until the end of the project. 
The concentrated extracts to be injected into the high performance liquid 
chromatography coupled to tandem (triple quadrupole) mass spectrometer (HPLC-
MS/MS(QqQ)) system were kept in low volume amber glass screw neck vials (200 
µL) with screw neck cap and PTFE/silicone septum, purchased from Waters® Corp. 
These vials were stored at – 20 °C before the analysis. Once the samples were 
analysed, the screw cap was replaced and the vials were stored back at – 20 °C until 
the end of the project. 
 
3.3 STANDARDS AND REAGENTS 
All standards were supplied by Wellington Laboratories Inc. Individual stock 
solutions, working solutions (WS) and mass labelled standard addition solutions 
(Sad) were prepared in methanol (Table 12 and Table 13), and stored in Certan® 
vials (Supelco), which have a very low solvent evaporation rate that maintains 
standard integrity, at -20 °C. HPLC grade methanol (MeOH), acetone and hexane, 
analytical grade iso-octane and tetrahydrofuran (THF) were provided by Fisher 
Scientific UK Ltd, while trielthylamine (TEA) was supplied by Sigma Aldrich. 
Ammonium acetate (NH4Ac), ammonium formate (NH4COOH), ammonium 
hydroxide (NH4OH), sodium acetate (NaAc), hydrochloric acid (HCl), formic acid 
(HCOOH), sodium sulphate (Na2SO4) and celite chemicals were purchased from 
Fisher Scientific UK Ltd. Newborn calf serum was provided by Gibco Life 
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Technologies Ltd. Nitrogen used for evaporation was supplied by BOC Gases. Oasis 
WAX (weak anion exchange) cartridges for SPE were supplied by Waters® Corp. 
Calibration curves were prepared by addition of increasing amounts of native 
standards, followed by a constant amount of mass labelled standards (internal 
calibration). 
Native standards were employed in the validation stages – spiking multiple samples 
at different levels – and in QA/QC – spiking the matrices prior the extraction process 
– when no standard reference materials were available. 
Mass labelled standards were added to all the samples – spiked with native 
standards or not – prior the extraction process as recovery standards. 
 
3.4 SAMPLE PREPARATION 
The initial sample preparation method (extraction and clean-up steps), which was 
applied to the dust samples was previously reported by Goosey and Harrad (Goosey 
and Harrad, 2011), being itself a combination of the extraction originally developed 
by Taniyasu et al. (Taniyasu et al., 2005), some tips from an application note from 
Waters® (Young and Tran, 2006) and based on the sample preparation developed 
by Kubwabo et al. (Kubwabo et al., 2005). For the rest of the matrices included in 
this research, the extraction methods were modified and validated according to each 
matrix requirements, keeping in common the subsequent solid phase extraction as 
clean-up step for all of them. Explanations about the specific sample preparation 
procedures and validation measures are detailed in the following sections. 
 
57 
 
58 
 
  
59 
3.4.1 Dust 
The dust sample preparation is summarised in Figure 07. As mentioned above, this 
method was applied to dust samples by (Goosey and Harrad, 2011) having been 
originally reported by other authors (Kubwabo et al., 2005; Taniyasu et al., 2005; 
Kubwabo, Kosarac and Lalonde, 2013). 
For the extraction, 5 mL of acetone were added to a 15 mL centrifuge tube containing 
100 mg of sieved dust (previously spiked with the mixture of mass labelled 
standards employed as recovery standards, shaken and let rest for an hour). The 
mixture was shaken for 5 min, followed by 10 min sonication and 5 min 
centrifugation (3,500 rpm). This process was repeated 3 times, collecting all the 
supernatants together in a new glass tube (15 mL as final volume). 3 drops of iso-
octane were added to the solution and it was evaporated until an approximate 
volume of 0.5 mL under nitrogen stream. Then, 9 mL of a solution of 0.2 % HCOOH 
in water was added to the content of the glass tube. At this step, if some particulate 
matter was visible, 1 g of celite was added to the mixture and it was filtered through 
a grade 1 filter. 
For the SPE clean-up, Waters® Oasis WAX cartridges (6 cc, 150 mg, 30 µm) and a 
Phenomenex® SPE 24-Position vacuum manifold coupled to a Charles Austen, Capex 
L2X diaphragm pump, at a pressure of 20 kPa, were used. The WAX cartridges 
contain a mixed phase sorbent which is able to retain strong acids, as well as 
perfluoroalkyl sulfonates. The cartridges were first conditioned with 4 mL of 0.1 % 
NH4OH in methanol, followed by 4 mL of methanol and 4 mL of 0.1 % HCOOH in 
water. The samples were then loaded into the cartridge. They were washed with 4 
mL of 25 mM acetate buffer adjusted to pH 4 and vacuum was applied for 30 min, to 
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ensure all the water was removed. The samples were eluted with 4 mL of methanol, 
followed by 4 mL of 0.1 %  NH4OH in methanol. 
The extract was finally evaporated under a mild nitrogen stream, and reconstituted 
in 150 µL of methanol. 
 
3.4.2 Solid Food 
For the solid food sample preparation, different solvents were tested as extraction 
solvents: acetone (as for dust), acetonitrile (generic solvent), methanol (Padilla-
Sánchez and Haug, 2016) and a mixture of THF:H2O (70:30 v/v) (Ballesteros-Gomez, 
Rubio and van Leeuwen, 2010; Luque et al., 2012). Additionally, due to the 
complexity of the matrix represented by the 24 h duplicate diet homogenates; more 
specific clean-up steps to ensure an efficient lipid removal, such as fat precipitation 
by cooling the sample, previously reported for substances where acid wash with 
sulphuric acid was not suitable (Castillo, González and Miralles, 2011), and the use 
of active carbon (Ballesteros-Gomez, Rubio and van Leeuwen, 2010) were also 
tested. 
As representative matrix for all the tests, dry cat food (Purina One® adult) was 
crushed and spiked with native and mass labelled standards in triplicate at two 
different levels. Recoveries and relative standard deviation (% RSD) were compared 
for all the solvents and the proposed additional clean-up steps, together with the 
clarity of the final extracts. The results corresponding to these tests showed that: a) 
fat precipitation by cooling after the extraction step decreased slightly the 
recoveries for all the experiments carried out, but the clarity of extracts increased 
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substantially; b) the use of active carbon as a post clean-up step was discarded due 
to the poor recoveries (up to 0 %) for FOSEs; and c) acetone and acetonitrile were 
the most effective extraction solvents, with recoveries ranging between 65-110 % 
and RSD (%) < 30 % for all the analytes included in the method. Acetone was chosen 
due to its lower vapour pressure and its consequent faster evaporation after the 
extraction step. The sample treatment finally applied to the solid food samples is 
summarised in Figure 08 and detailed below. 
For the extraction, 5 mL of acetone were added to a 15 mL centrifuge tube containing 
2.5 g of dry food (previously spiked with the mixture of mass labelled standards, 
shaken and allowed to rest for an hour). The mixture was shaken for 5 min, followed 
by 10 min sonication and 5 min centrifugation (3,500 rpm). This process was 
repeated 3 times, collecting all the supernatants together in a new PP tube (15 mL 
as final volume). The solution was kept overnight in the fridge at 4 °C. The morning 
after, the sample was transferred to an ice bath, fast filtered through a grade 1 filter 
and rinsed with 1 mL of cold acetone. 3 drops of iso-octane were added to the 
solution and it was evaporated until an approximate volume of 0.5 mL under 
nitrogen stream. Then, 9 mL of a solution of 0.2 % HCOOH in water was added to the 
content of the glass tube and the extracted is ready for the clean-up step. 
The SPE clean-up, evaporation and reconstitution steps remained as explained 
above for dust samples. 
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Figure 07. Schematic overview of the sample treatment employed for the analysis of dust 
samples. The shadowing indicates which parts of the sample preparation and acquisition 
methods have been improved and optimised from previously published methods, or 
developed for the first time 
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Figure 08. Schematic overview of the sample treatment employed for the analysis of solid 
food samples. The shadowing indicates which parts of the sample preparation and 
acquisition methods have been improved and optimised from previously published 
methods, or developed for the first time 
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Figure 09. Schematic overview of the sample treatment employed for the analysis of liquid 
food samples. The shadowing indicates which parts of the sample preparation and 
acquisition methods have been improved and optimised from previously published 
methods, or developed for the first time 
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Figure 10. Schematic overview of the sample treatment employed for the analysis of serum 
samples. The shadowing indicates which parts of the sample preparation and acquisition 
methods have been improved and optimised from previously published methods, or 
developed for the first time 
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3.4.3 Liquid Food 
For the liquid food sample preparation, a protein precipitation approach was 
proposed, similar to the commonly reported ones for blood samples, milk samples 
or in vitro studies (Mosch et al., 2010; Luque et al., 2012; Antignac et al., 2013). Two 
alternatives were suggested: a) organic solvent precipitation and b) acidic 
precipitation. The sample treatment finally applied to the liquid food samples was 
as follows (also see Figure 09). 
For the extraction, 10 mL (previously spiked with the mixture of internal standards, 
shaken and let rest for an hour) of the liquid sample was mixed with 50 µL of HCOOH 
in a 15 mL centrifuge tube. The mixture was shaken for 10 min, followed by 10 min 
centrifugation (3,500 rpm). The supernatant was collected in a new glass tube. 2.5 
mL of 0.1 % HCOOH in H20 were added to the remaining solid and the extraction 
process was repeated two more times, collecting all the supernatants together in a 
new glass tube (15 mL as final volume) which are subsequently passed though the 
SPE cartridges. 
The SPE clean-up, evaporation and reconstitution remained as explained above for 
dust samples. 
 
3.4.4 Serum 
Serum samples are a relatively clean sample compared to those previously 
described. It is for this reason that quite simple extraction steps or even no 
extraction steps have been reported (Kuklenyik et al., 2004; Poothong et al., 2017). 
After checking the clarity of the serum extracts, it was decided that no extraction 
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step was required. 2 mL of serum sample (previously spiked with the mixture of 
internal standards, shaken and let rest for an hour) were added to a centrifuge tube 
containing 5 mL of 0.1 % HCOOH in H2O. The mixture was vortex mixed and was 
ready to be introduced into the SPE cartridges. 
SPE elution, evaporation and reconstitution remained the same as for the rest of the 
matrices. 
The entire sample treatment is described in Figure 10. 
 
3.5 ANALYSIS BY HPLC-MS/MS 
Three different analytical methods were developed and optimised in Birmingham 
for the analysis of: a) total PFOS and PFOS precursors – including three FOSAs and 
two FOSEs – for the analysis of dust samples; b) total PFOS and PFOS precursors – 
including three FOSAs, two FOSEs, and three FOSAAs – for the analysis food and 
serum samples; and c) PFOS branched isomers for the analysis of selected extracts. 
All such methods were run on a Shimadzu HPLC system, coupled to an SCIEX API 
2000 triple quadrupole mass spectrometer (MS/MS(QqQ)). The MS/MS(QqQ) 
operated in negative ion mode, using electrospray ionisation (ESI). 
 
3.5.1. Mass Spectrometry Optimisation 
In order to enhance to the maximum the sensitivity of the methods, different 
parameters from the instrument were manually adjusted or optimised by design of 
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experiments (DoE) as Plackett-Burman and Central Composite Design (CCD), by the 
use of Minitab statistical software: 
- Declustering potential, focusing potential, entrance potential and collision 
cell entrance potential were adjusted individually for every parent 
compound or precursor in a given working range of the instrument. Collision 
energy and collision cell exit potential were adjusted for every chosen 
transition. All these parameters were manually adjusted by direct injection 
of individual solutions of standards at a concentration of 2,000 ng/mL and 
tuning the signals to their maximum intensity. Two transitions were selected 
for every target compound, except for MeFOSE and EtFOSE, for which just 
one quantitative transition was found. One transition was selected for every 
internal standard. 
- Ion source gas pressures were set initially at an intermediate value 
recommended by the engineers. These parameters were discarded for an 
optimisation by CCD after a preliminary Plackett-Burman experimental 
design. 
- Curtain gas pressure, ion spray voltage, heater temperature and collision gas 
pressure were optimised by the use of a CCD experiment, a response surface 
designed experiment where central and axial values of the four parameters 
were defined (according to the user manual) and different experiments 
(n = 31) were carried out in a specific running order. All signals were tuned 
to their maximum intensity, and a compromise on sensitivity – optimal 
conditions for each analyte was achieved, in order to optimise the MS/MS 
method. 
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For the PFOS branched isomers the CCD experiment where the maximum sensitivity 
was achieved for PFOS transitions was selected. 
 
Table 14. Liquid chromatography parameters for the analysis of PFOS, FOSAs and FOSEs in 
dust samples 
Parameter Value 
 
Mobile phase A (MPA) 2 mM NH4Ac in H2O 
 
Mobile phase B (MPB) MeOH 
 
Injection volume 20 µL 
 
Guard column Agilent C18, 4 x 3.0 mm 
 
Column Agilent C18 Metasil Basic, 5 μm Si, 10 cm x 2.1 mm, 100 Å 
 
Gradient 
    
 
Time (min) MPA (%) MPB (%) Flow (mL/min) 
 
 
0.0 70 30 0.4 
 
 
2.0 0 100 0.4 
 
 
15.0 0 100 0.4 
 
 
17.0 70 30 0.4 
 
  20.0 70 30 0.4 
 
 
Table 15. Generic mass spectrometry parameters for the analysis of PFOS and PFOS 
precursors 
Parameter Units Value 
 
Ion source gas 1 Psi 45 
 
Ion source gas 2 Psi 30 
 
Curtain gas pressure Psi 23.9 
 
Ion spray voltage V -3,000 
 
Heater temperature °C 450 
 
Collision gas pressure Psi 7 
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Table 18. Liquid chromatography parameters for the analysis of PFOS branched isomers 
Parameter Value 
 
Mobile phase A (MPA) 10 mM NH4COOH in H2O adjusted to pH 4 
 
Mobile phase B (MPB) 10 mM NH4COOH in MeOH adjusted to pH 4 
 
Injection volume 20 µL 
 
Guard column Agilent C18, 4 x 3.0 mm 
 
Column ES Industries FluoroSep-RP Octyl, 5µm, 15 cm x 2.1 mm, 60 Å 
 
Gradient 
    
 
Time (min) MPA (%) MPB (%) Flow (mL/min) 
 
 
0 50 50 0.18 
 
 
3.9 30 70 0.18 
 
 
35 22 78 0.18 
 
 
40 15 85 0.18 
 
 
41 0 100 0.18 
 
 
49 0 100 0.18 
 
 
50 50 50 0.18 
 
  55 50 50 0.18 
 
 
  
Table 17. Liquid chromatography parameters for the analysis of PFOS, FOSAs, FOSEs and 
FOSAAs in food and blood samples 
Parameter Value 
 
Mobile phase A (MPA) 0.1°% HN4OH in H2O 
 
Mobile phase B (MPB) 0.1°% HN4OH in MeOH 
 
Injection volume 20 µL 
 
Guard column Agilent C18, 4 x 3.0 mm 
 
Column Agilent C18 Metasil Basic, 5 μm Si, 10 cm x 2.1 mm, 100 Å 
 
Gradient 
  
 
Time (min) MPA (%) MPB (%) Flow (mL/min) 
 
 
0.0 70 30 0.4 
 
 
9.0 0 100 0.4 
 
 
15.0 0 100 0.4 
 
 
17.0 70 30 0.4 
 
  20.0 70 30 0.4 
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Table 19. Generic mass spectrometry parameters for the analysis of PFOS branched isomers 
Parameter Units Value 
 
Ion source gas 1 Psi 45 
 
Ion source gas 2 Psi 30 
 
Curtain gas pressure Psi 32.5 
 
Ion spray voltage V -2,000 
 
Heater temperature °C 412 
 
Collision gas pressure Psi 9 
 
 
 
3.5.2. LC-MS/MS Analysis of PFOS and PFOS Precursors in Dust Samples: PFOS, 
FOSAs and FOSEs 
The mobile phases for the HPLC separation were composed of 2 mM NH4Ac in H2O 
as aqueous phase and 2 mM NH4Ac in MeOH as organic phase. The column used for 
the analysis was a C18 Metasil Basic, 5 μm Si, 100 x 2.1 mm (Agilent Technologies), 
100 Å, attached to an Agilent C18 4 x 3 mm guard column. The flow was set to 0.4 
mL/min. The gradient is described in Table 14. 
Details regarding the MS/MS conditions are detailed in Table 15 and Table 16. 
 
3.5.3. LC-MS/MS Analysis of PFOS and PFOS Precursors: PFOS, FOSAs FOSEs 
and FOSAAs in Food and Serum Samples 
A second chromatographic method was developed for the analysis of PFOS 
precursors in food and serum samples. On it, the mobile phases were modified from 
the previous method in order to achieve good separation and sensitivity for FOSAAs, 
due to their poor elution with the previously used modifiers. In this case, the mobile 
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phases were composed of 0.1 % NH4OH in H2O and 0.1 % NH4OH in MeOH. The 
column was a C18 Metasil Basic, 5 μm Si, 100 x 2.1 mm, 100 Å (Agilent 
Technologies), attached to an Agilent C18 4 x 3 mm guard column. The gradient used 
can be found in Table 17. 
Details regarding the MS/MS conditions are the ones previously detailed in Table 15 
and Table 16. 
 
3.5.4. LC-MS/MS Analysis of PFOS Branched Isomers 
The mobile phases for the HPLC separation were composed of 10 mM NH4COOH in 
H2O as aqueous phase and 10 mM NH4COOH in MeOH as organic phase, both 
adjusted to pH 4. The column used for the analysis was a FluoroSep-RP Octyl, 5 µm, 
15 cm x 2.1 mm, 60 Å (ES Industries), attached to an Agilent C18 4 x 3 mm guard 
column. The flow was set to 0.18 mL/min. The gradient used can be found in Table 
18. 
Details regarding the MS/MS conditions are detailed in Table 19. 
 
3.6 QUALITY ASSURANCE / QUALITY CONTROL 
Reliability of analytical data is mandatory in order to ensure that all the reported 
data is accurate and reproducible. All the presented methods were carefully 
validated before being applied to the reported samples, and quality control 
requirements were checked every sequence to ensure the validity of the data. 
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Within this section, all quality assurance / quality control (QA/QC) procedures that 
have been applied to the entire batch of samples and procedures will be explained 
in detail. 
 
3.6.1. Method Validation and Quality Control Criteria 
All the analytical methods, as well as the sample treatments were validated before 
being applied to the real samples. This means the reported methods had to satisfy 
certain pre-established criteria in terms of precision, accuracy, sensitivity and 
relative response factors. All the methods were validated at, at least, two levels of 
the calibration standards. Absolute and relative recoveries, precision and accuracy 
were evaluated. Linear intervals and limits of detection and quantification were 
established according to these results. Table 20 to Table 23 summarise the main 
validated parameters. 
 
Relative Response Factors 
Six calibration points were used with concentrations ranging from 10 to 1,000 
ng/mL (concentration in samples can be found in Table 20 to Table 23). The 
response of each calibration was checked for all the native standards by the 
calculation of the relative response factor (RRF), defined as the instrument response 
for a unit amount of target pollutant relative to the instrument response obtained 
for the same amount of the mass labelled standard. It can be calculated as shown in 
Equation 02, where ANAT is the area of the native standard, AIS is the area of the mass 
labelled standard, CNAT is the concentration of the native standard and CIS is the 
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concentration of the mass labelled standard. Calculation of RRFs for each of the 
standards comprising the multi-point calibration should reveal them to be 
essentially identical for each concentration level. The relative standard deviation 
(% RSD) of RRFs for a given target compound should not exceed 10 %. 
However, the use of a single internal standard for the quantification of more than 
one native standard (MeFOSA-IS for MeFOSA and EtFOSA, MeFOSE-IS for MeFOSE 
and EtFOSE, and MeFOSAA-IS for FOSAA, MeFOSAA and EtFOSAA) resulted in RRF 
values exceeding this 10 % RSD. The difference in the masses is responsible for the 
difference in the analytical response. Despite this variation between the native and 
the mass labelled standard, the results from the calibrations were consistent during 
the study and remained within 25 % of the original calibration RRFs, so these values 
were still accepted. 
Equation 02  𝑅𝑅𝐹 =
𝐴𝑁𝐴𝑇
𝐴𝐼𝑆
𝑥
𝐶𝐼𝑆
𝐶𝑁𝐴𝑇
 
 
Precision and Accuracy 
Blank and spiked samples were used in all validation exercises, together with 
previously reported samples or standard reference materials (SRM) when available. 
For dust samples, cleaned sodium sulphate (for blanks), SRM 2585 developed by the 
National Institute of Standards and Technology (NIST) and dust samples from the 
UK and Australia were used. For liquid food samples, methanol (for blanks) and an 
in-house spiked mixture of water:milk:juice (80:10:10) were used. For solid food 
samples, diatomaceous earth (for blanks), different brands of spiked dry cat food 
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and inter laboratory fish samples were used. For blood samples, methanol (for 
blanks) and spiked calf serum were used. 
Each sample was prepared in triplicate (as a minimum) and on two different days. 
Percent recoveries (% Rec) (Equation 03 for solid samples, and Equation 04 for 
liquid samples) and relative standard deviation (% RSD) (Equation 05) both intra 
and inter day were calculated in order to evaluate accuracy – defined as closeness 
to the true value – and precision – defined as statistical variability related to 
reproducibility and repeatability- of the validated methods. In the equations below, 
AIS is the area of mass labelled standard in every sample; ANAT is the peak area of 
target pollutant in every sample, RRF is the relative response factor for the target 
pollutant (see Equation 02), MIS is mass of mass labelled standard added to sample 
(pg), SS is the sample size (g), VV is the final sample extract volume in the vial (mL), 
VLS is the initial volume of liquid sample (mL) and σn-1 is the standard deviation of 
the analysed batch of samples. 
 
Equation 03 𝐶𝑜𝑛𝑐 (𝑛𝑔/𝑔) =
𝐴𝑁𝐴𝑇
𝐴𝐼𝑆
𝑥
1
𝑅𝑅𝐹
 𝑥
𝑀𝐼𝑆
𝑆𝑆
 
Equation 04 𝐶𝑜𝑛𝑐 (𝑛𝑔/𝑚𝐿) =
𝐴𝑁𝐴𝑇
𝐴𝐼𝑆
𝑥
1
𝑅𝑅𝐹
 𝑥 𝐶𝐼𝑆 𝑥 
𝑉𝑉
𝑉𝐿𝑆
 
Equation 05 % 𝑅𝑆𝐷 =
𝜎 𝑛−1
𝐴𝑣𝑒𝑟𝑎𝑔𝑒
𝑥 100 
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Limits of Detection and Quantification 
The instrumental detection limit (LOD) was defined as the quantity of the analyte 
providing a signal to noise ratio of 3:1 and it was calculated by extrapolation of the 
lowest concentration standards (10 mg/mL) in the calibration standards injected 
during the validation process for each analyte. In the majority of cases, the blank 
concentrations were not expected to exceed 30 % above the LOD, but in cases where 
the blanks contained concentrations above this level, the blank concentration would 
be used as the LOD. The sample detection limit or limit of quantification (LOQ) was 
determined as the lowest measurable concentration in the extracted sample, with 
respect to the LOD, final extract volume (VFE), volume of final extract injected (VFEI), 
sample size (SS) and percentage of mass labelled standard recovery (% IS Rec), and 
is calculated as shown in Equation 06. 
 
Equation 06 𝐿𝑂𝑄 =
𝐿𝑜𝐷 ×𝑉𝐹𝐸
𝑉𝐹𝐸𝐼 ×𝑆𝑆
𝑥
100
𝐼𝑆 𝑅𝑒𝑐𝑜𝑣𝑒𝑟𝑦 (%)
 
 
Mass Labelled Standards 
The mass labelled standards (IS) were added to every sample in a specified amount 
of 200 ng/mL in vial to all the native standards, blanks and samples. They are 
commonly used in analytical chemistry to avoid recovery corrections when 
calculating concentrations in samples. Recovery values between 30 and 150 % were 
accepted. The acceptance of this wide interval is mainly due to matrix effect reasons, 
which could enhance or suppress heavily the intensity of the target analytes. Their 
signal to noise ratio was also measured and a minimum value of 20:1 was required. 
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Blanks 
Two types of blank samples were defined: field blanks and matrix blanks. Field 
blanks were used to evaluate the lack of cross contamination during the sampling, 
storage and sample manipulation steps and they were usually solvents or inorganic 
reagents. Meanwhile, matrix blanks were used (when possible) to better mimic the 
real sample composition, as well as to evaluate the lack of cross contamination 
during the sample treatment steps. 
Field blank and matrix blanks were prepared and run five consecutive times each at 
the beginning of every validation sequence. Internal standards were also added to 
them at the beginning of the sample treatment. Values below 30 % of the LOD were 
accepted for field blanks. For matrix blanks, concentrations below 30 % of the LOQ 
were accepted if the field blanks prepared together with them met their previously 
mentioned criteria and the RSD was below 30 %. Matrix blanks were later used as 
spiked samples during the analysis of real samples when a suitable SRM was not 
available. 
 
3.6.2. Monitoring of Method Performance 
After every method validation, real samples were analysed and reported, following 
all the QA/QC parameters defined and established on that matrix. These were 
applied to all the analysed samples and in the event of the failure of one QA/QC 
parameter, the rejection and repetition of the sample. 
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Relative Response Factors 
The six point calibration curve (see Table 20 to Table 23) was injected at least once 
at the beginning of every sequence, and RRF values were calculated for every 
analyte. An RSD value below 10 % was accepted when the analytes matched the 
mass labelled standard, and 25 % when they did not, provided the obtained values 
were repeatable. 
 
Precision and Accuracy 
As an on-going measure of accuracy and precision, Standard Reference Materials 
(for dust samples) or spiked matrix blank samples (for the rest of the matrices) – as 
previously reported during the validation stage – were prepared every sequence 
and run together with the samples. Two of these well-characterised samples were 
injected every 20 samples. Accuracy should range between 60-120 % and precision 
should not exceed 30 %. These numerical values were stored for an on-going 
monitoring of reproducibility and long term repeatability. 
SRM 2585 used for dust samples has been previously analysed and reported 
together with dust samples for some PFASs (Björklund, Thuresson and De Wit, 
2009). In 2013, Reiner et al. (Reiner et al., 2013) published an inter-laboratory study 
where PFASs in different abiotic reference materials were analysed. Five 
laboratories were involved in the analysis of SRM 2585, and 23 PFASs were 
included. PFOS was analysed in all of them with concentrations ranging from 2,000 
to 2,410 ng/g, while FOSA was just analysed in two of them with concentrations 
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ranging from 7.78 to 11.6 ng/g. Finally, MeFOSAA and EtFOSAA were analysed in 
just one of the laboratories, with values of 150 and 675 ng/g respectively. 
 
Blanks 
Field blanks were prepared every sequence and run every five samples. Values not 
exceeding 30 % above the LOD were accepted. Any blank exceeding that established 
value required re-injection of the sample. If a second injection showed a decrease to 
the acceptance criteria, contamination from the HPLC system had to be checked, and 
the entire batch re-analysed. If a second injection still showed an unacceptable 
value, the entire batch was rejected and repeated. 
Matrix blanks were injected at the beginning of every sequence. Their values had to 
meet the criteria previously defined in the validation stage. Where they did not, the 
entire batch was rejected and repeated. 
During sample analysis, no blank samples (both, field and matrix) exceeded QA/QC 
parameters and therefore no transformations or rejections were required. 
 
Mass Labelled Standards 
A specific amount of a mix of mass labelled standards according to a final 
concentration of 200 ng/mL in vial was added to all the samples, blanks and 
controls. Mass labelled standard recovery values between 30 and 150 % with a 
minimum signal to noise ratio of 20 were accepted. Any sample identified to have a 
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mass labelled standard recovery outside the acceptable range or with a signal to 
noise ratio lower than 20:1 was discarded and repeated. 
 
Limits of Detection and Quantification 
Samples in which concentrations were below the LOD were reported as “ND” or not 
detected. For descriptive statistics purposes Equation 07 was later used for all these 
non-detected samples. 
Samples for which concentrations were between LOD and LOQ values, were 
reported as “<LOQ”. For descriptive statistic purposes, Equation 08 will be used for 
the samples with these values between LOD and LOQ. 
 
Equation 07  𝐶𝑜𝑛𝑐 (< 𝐿𝑂𝐷) =
1
√𝐿𝑜𝐷
 
Equation 08  𝐶𝑜𝑛𝑐 (𝐿𝑂𝐷 < 𝑋 < 𝐿𝑂𝑄) =
1
√𝐿𝑜𝑄
 
 
Relative Retention Time 
The relative retention time (RRT) of all peaks was required to remain within 0.2 % 
of the average calibration RRT calculated from the calibration standards run at the 
beginning of that batch of samples. If this parameter was not satisfied, the 
quantification was not valid as a positive sample and was removed from the 
reported list. 
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3.7. SOFTWARES 
All software used for the analysis of the samples included in this study are: 
 Microsoft EXCEL 2010 and 2013 for sample quantification and descriptive 
statistics. 
 IBM SPSS Statistics 22 and 24 for Windows for post-acquisition statistical 
analysis. 
 Analyst 1.4.2 and Mass Spectrometry toolkit v3.3 for data acquisition. 
 Minitab 16 for Plackett-Burman and Central Composite Design for the 
MS/MS optimisation. 
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4. PFOS AND PFOS PRECURSORS IN INDOOR DUST 
 
The main objectives of this chapter are a) to report concentrations of PFOS and PFOS 
precursors, and to check how a specific indoor microenvironment ‒ homes ‒ 
contributes significantly to direct exposure to PFOS and PFOS precursors. b) to 
estimate daily intakes for the participants and for toddlers and children, and c) to 
compare current levels of the selected pollutants in house dust with those 
previously reported for Norwegian (Haug, Huber, Schlabach, et al., 2011) and 
English (Goosey and Harrad, 2011) populations. 
 
4.1 INTRODUCTION 
According to previously reported papers, dust has been highlighted as one of the 
major pathways of  external exposure to some persistent environmental chemicals 
(Jones-Otazo et al., 2005; Harrad et al., 2010; Ross Wilson et al., 2013; von Lindern 
et al., 2016). PFOS tends to be present in indoor environments as a combination of 
different sources such as a) fibres from textiles and fabrics from indoor furniture, b) 
abrasion from water and stain-proofed textiles, and c) abrasion from diverse 
coatings as food packaging materials. All of them then deposit to dust, as some 
publications have reported for diverse families of organic pollutants (Webster et al., 
2009; Beesoon et al., 2012; Fraser et al., 2013; Tian et al., 2016). Many studies have 
been published – reviewed in the introduction chapter and summarised in Table 03 
– reporting levels and detection frequencies of indoor PFOS in several countries 
around the world (Kubwabo et al., 2005; Shoeib et al., 2005, 2011, 2016; Strynar and 
Lindstrom, 2008; Kato, Calafat and Needham, 2009; Goosey and Harrad, 2011; Haug, 
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Huber, Schlabach, et al., 2011; Ericson Jogsten et al., 2012; Fraser et al., 2013; Tian 
et al., 2016; Karásková et al., 2016). Moreover, it is also known that PFOS precursors 
as FOSAs and FOSEs included on this study tend to be present as impurities, 
secondary and/or intermediate products from the synthesis of POSF related 
products, such as PFOS and some of their derivatives, so their origins in indoor dust 
are closely linked to those of PFOS. They have not been so widely reported as PFOS 
itself, but the currently available levels have been described and reviewed in the 
introduction chapter of this thesis. These facts suggest they are a major contributor 
to PFOS internal exposure when levels in blood, breast milk, or other non-invasive 
matrices have been detected. 
In a more specific way when reviewing PFAs as an overall, both direct (Trudel et al., 
2008; D’Eon J and Mabury, 2011; Ericson Jogsten et al., 2012) and indirect (Gebbink, 
Berger and Cousins, 2015) exposure to PFOS are influenced by dust ingestion and is 
frequently underestimated. Dust ingestion rates have been previously reported 
(Jones-Otazo et al., 2005; R. Wilson et al., 2013) and established, whereby adults 
ingest an average of 4.15 mg of dust per day in mean scenario, while this rate 
increases up to 100 mg per day for kids and toddlers in mean scenario (USEPA, 
2011). The US EPA report on Child Specific Exposure Factors (USEPA, 2008) 
elaborates how children are more exposed to certain organic pollutants due to hand-
mouth behaviour, suggesting their exposure patterns to differ from those for adults 
(Calafat, Wong, et al., 2007). 
As an average people spend around 90 % of their time indoors (Shoeib et al., 2011), 
with this time mostly divided between working hours and home. This factor is 
especially relevant when considering this study was carried out in Norway during 
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the cold period from November 2013 to April 2014, when the average time spent 
outdoors is much lower than during the summer season. According to the indoor 
questionnaires related to this study, just one participant reported spending less 
than 10 hours per day at home (4 hours), while the rest spent ten or more hours (up 
to 21 for one participant) at home, with a mean value for the 61 participants of 13.2 
hours (55 %) at home per day.  
 
This chapter will present indoor vacuum cleaner bag dust data collected from 57 
Norwegian homes, all of them belonging to the participants of the A-TEAM cohort. 
Six PFASs – PFOS, FOSA, EtFOSA, MeFOSA, EtFOSE and MeFOSE – are quantified. The 
differences within the participants from this cohort and among the similar studies 
cited above (Norway and UK) will be reported here for the first time. 
 
4.2 INDOOR AND DEMOGRAPHIC QUESTIONNAIRES DESCRIPTION 
An indoor environment questionnaire was given to all the participants during the 
first of the two agreed sampling appointments, and it was collected during the 
second visit. The data extracted from the questionnaires was provided by the NIPH. 
Among all the questions, a rough screening of the relevant ones to evaluate PFASs 
indoor exposure was done. From the 61 participants, just 57 vacuum cleaner bags 
were collected and shipped to Birmingham, so all the data presented onwards will 
be relative to these 57 participants, including the information extracted from the 
questionnaires provided along this chapter. 
In terms of age, the participants ranged from 20 to 66 years old (average = 41.7 
years), with75.5 % female and the remaining 24.5 % male. The average distance 
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from residence to the institute, was 12 km (range 0.3 – 77.3 km). Houses were also 
quite diverse; they ranged from small apartments of 30 m2 surface to family houses 
of more than 200 m2 surface area. The age they were built ranged from 1892 (the 
oldest one built) to newly built ones (2013 was the newest). Moreover, 13 
participants gave a positive answer when they were asked about living close to busy 
traffic roads, and four of them declared they were living close to an industrial area. 
This overview gives a general idea about the broad range of differences in terms of 
environment, sources of exposure and daily routines the participants described here 
have. 
For the indoor exposure itself, house facilities and cleaning habits varied as much as 
the environmental ones or the location of the residences. 44 % of the participants 
have separate kitchen and living rooms in their houses, while the other 56 % were 
living in houses with open kitchens, facilitating the cross contamination between 
sources coming from both rooms. The number of people living in the same residence 
was variable: some people lived alone while in the highest occupied house three 
adults and three children were living in. The overall number of children living in the 
sampled residences ranged from 0 to 3 children per house (51 kids in total from the 
included 57 participants). On the other hand, 14 participants owned pets, a fact 
which could enhance the dust transport around the house as well as in and out from 
the residence, besides significant alteration of the dust composition. Regarding to 
ventilation habits, 39 % of the participants ventilated their living rooms by opening 
the windows during the period of the sampling campaign, while 56 % of the 
participants ventilated their bedrooms over the same sampling period. More than 
the 50 % of the participants said they refurbished their living rooms (51 %), 
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kitchens (59 %) or bedrooms (58 %) recently. The average number of times the 
participants vacuum cleaned their living rooms was 4.5 times per month, with a 
wide range starting from 1 up to 15 times per month. The average value for 
bedrooms was slightly lower (3.6 times per month), while minimum and maximum 
values nearly remained the same. The participants were also asked about Gore-Tex® 
and Gore-Tex®-like clothing and shoes, with 48 “yes” for clothing and 51 for shoes. 
A detailed graphical description of the main parameters discussed are available in 
Figure 11 and Figure 12. These values were grouped in three groups of consumption 
for ANOVA test analysis: low, intermediate and high. 
 
4.3 CONCENTRATIONS IN INDOOR DUST 
Indoor dust samples from 57 Norwegian homes were collected and processed as 
explained in the methodology chapter. 
In this section, PFOS – linear and branched isomers – and PFOS precursors – FOSAs 
and FOSEs – concentrations will be reported and compared with the information 
collected from the participants and extracted from the indoor environment 
questionnaires. Daily average intakes will be calculated. Significant differences and 
correlations will be presented too. 
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Figure 11. Box plots relative to the answers given by the participants for some of the indoor 
environment questionnaire questions 
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Figure 12. Percentages (yes/no) for participant answers related to some of the indoor 
environment questionnaire questions 
 
4.3.1 Total PFOS and PFOS Precursors 
Descriptive statistics from the vacuum cleaner dust samples where PFOS and PFOS 
precursors were analysed are shown in Table 24. Individual sample results are 
detailed in Table SM01. 
PFOS was detected at measurable levels in the 100 % (n = 57) of the dust samples 
analysed (average =  8.95 ng/g), with concentrations in a range between 0.41 and 
70.7 ng/g. FOSA and MeFOSA were also identified in very high detection frequencies 
– 96 % for both of them – in average concentrations of 0.43 (<LOD – 2.5 ng/g) and 
30.94 ng/g (<LOD – 142.8 ng/g) respectively. Both FOSEs were detected in a range 
between 30 – 35 % of the dust samples, with an average concentration of 24.46 ng/g 
(<LOD – 839.1 ng/g) for MeFOSE, and 11.98 ng/g (<LOD – 231.7 ng/g) for EtFOSE. 
Finally, MeFOSA was the pollutant reported the lower number of samples – 9 
0% 20% 40% 60% 80% 100%
Open kitchen
Pets
Close traffic road
Close industry
Vent. Living room
Vent. Bedroom
Living room…
Kitchen refurbishment
Bedroom refurbishment
Gore-Tex® clothes
Gore-Tex® shoes
Yes No
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positive samples, 16 % of the total– , with a reported average concentration of 0.41 
ng/g (<LOD – 5.7 ng/g). 
The pattern for dust exposure is clearly dominated by EtFOSA, followed by both 
FOSEs, even though these last two compounds are detected in around 1/3 of the 
analysed samples. On the other side PFOS, which is present in all the analysed 
samples, would contribute around a 10 % to the overall exposure to the presented 
PFASs. Same for FOSA, highly detected in percentage of samples, which would 
contribute to the overall exposure to PFASs less than 1 %. 
 
Table 24. Concentrations (ng/g) of PFOS and PFOS precursors in vacuum cleaner bags 
(n = 57) 
  PFOS FOSA MeFOSA EtFOSA MeFOSE EtFOSE ΣPFAS 
Average 8.95 0.43 0.41 30.94 24.46 11.98 77.17 
Mean 5.07 0.34 0.08 21.72 3.75 1.95 47.83 
Median 4.45 0.39 0.05 26.06 1.74 0.88 50.90 
Min 0.41 < LOD < LOD < LOD < LOD < LOD 4.04 
Max 70.7 2.5 5.7 142.8 839.1 231.7 1122.4 
Q1 3.27 0.22 0.05 12.23 1.74 0.88 28.37 
Q3 8.53 0.52 0.05 39.70 4.39 2.87 73.50 
5th 0.90 0.12 0.05 4.31 1.74 0.88 15.19 
95th 31.26 0.88 3.13 70.58 70.50 84.20 148.86 
SD 12.5 0.3 1.2 24.7 111.7 37.4 147.3 
% RSD 140 80 298 80 457 312 191 
n > LOQ 57 55 9 55 18 20 57 
DF (%)  100 96 16 96 32 35 100 
n = number of dust samples included in the statistics. DF = Detection frequency. Q1 =  25th percentile. 
Q3 =  75th percentile. SD = Standard deviation. RSD = Relative standard deviation 
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Table 25. Statistical differences in ANOVA and t-test for the analysis of PFOS and PFOS 
precursors in dust samples (p = 0.05) 
Parameter Test Variable PFOS FOSA MeFOSA EtFOSA MeFOSE EtFOSE ΣPFAS 
Age of the 
participants 
ANOVA 1 
Below 30 
30-49 
Over 50 
      
Industries less 
than 500 m 
T-test 2 Yes/No       
Renovation 
kitchen 
T-test 3 Yes/No       
1)With Scheffe post-hoc test. 2) Equal variances not assumed for PFOS and EtFOSE (p < 0.05 for Levene 
test) 3) Equal variances not assumed for EtFOSA and MeFOSE (p < 0.05 for Levene test) 
 
 
For statistical analysis of the indoor dust samples from this study, a cut-off value of 
50 % positive samples was ideally required. In this case, just PFOS, FOSA and 
EtFOSA met the criteria, so the percentage was reduced to a minimum of 30 % 
positive samples for a full statistical analysis – so, MeFOSE and EtFOSE could be also 
included – and to minimum of 10 % for t-test and ANOVA when they were used for 
mean comparison with preceding studies. 
The Shapiro-Wilk test for normality of data distribution was firstly applied to the 
dataset, showing skewed data. A comparison between non-parametric statistics and 
parametric statistics with logarithmic transformed data was conducted, showing no 
significant differences on the data analysis. As a consequence of it, logarithmic 
transformed data was selected and used for data normalisation and subsequent 
statistical analysis of the dust samples. All the ANOVA tests were run with Scheffe 
post-hoc test with a significance level 95 % (p = 0.05). All the t-tests were also run 
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with a significance level of 95 % (p = 0.05). In all the correlations the significance 
level is specified (p = 0.01 or p = 0.05). 
The age of the participants and their gender, the number of hours spent home, the 
type of residence, their location (distance) from the NIPH, from industrial areas and 
from busy traffic roads, the age, size and distribution of the residence, the presence 
of pets and smokers, the ventilation frequency, the recent renovation of the different 
rooms in the residence, the frequency the residence was vacuum cleaned, and the 
use of Gore-Tex® clothing of the participants (shoes and clothes) were considered. 
A summary of the statistical significances identified among the evaluated indoor 
parameters and the detected concentrations of the analytes is shown in Table 25 and 
they will be detailed one by one along this section. 
The age of the participants seemed to play a role in the detected levels of PFOS, 
MeFOSE and ΣPFAS when ANOVA test was conducted, as Figure 13 and Figure SM01 
show. In case of PFOS, significant higher concentrations in houses of the participants 
over 50 years old were determined (mean log PFOS = 1.01) when compared with 
those in the range of 30-49 years old (mean log PFOS = 0.59). For ΣPFAS, the trend 
pattern was similar (mean concentrations for 30-49 < Below 30 < Over 50), but 
showing significant differences among the three groups of ages, while for MeFOSE 
the pattern was different, showing a significant differences for participants aged 
below 30 (see Figure SM01). Interestingly, other detected PFASs, such as FOSA – 
with high detection frequencies, low concentrations and no statistical differences – 
showed same pattern as PFOS and ΣPFAS (see Figure SM02). These statistical 
differences could be caused by a combination of differences related to trends in 
lifestyle associated to age, such as the cleaning and ventilation frequencies, the age 
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of the Gore-Tex® or Teflon® utensils in the residence, the number of hours spent 
indoors, the age of the house and/or refurbishments, etc., even though they did not 
show statistical significances as individual parameters. 
The proximity (less than 500 metres) of the main residence of the participants to 
industrial areas also showed statistical differences in detected concentrations of 
EtFOSA and EtFOSE (see Figure 14 and Figure SM03). Nevertheless, the overall sum 
of PFASs showed no statistical differences. Especially relevant is the fact that 
extreme values for EtFOSE concentrations were found in residences presumably not 
exposed to PFASs by industrial areas nearby. For EtFOSE, the mean concentration 
was lower (log EtFOSE = 0.895) for those reporting living close to an industrial area 
than those who answered they did not (log EtFOSA = 1.368). These facts suggest the 
statistical difference identified for this parameter occurs by chance. 
The third indoor parameter – recent renovation of the kitchen shown in Figure 15 – 
showing significant differences for some of the compounds of study here, showed 
higher levels of ΣPFAS (mean log ΣPFAS = 1.8660) for not recently renovated 
kitchens than for the renovated ones (mean log ΣPFAS = 1.5729). This trend was 
also observed for EtFOSA concentrations, with mean (logarithmic scale) values of 
1.5165 for the not renovated ones in comparison to the renovated ones, with values 
of 1.25. 
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Figure 13. Box plots showing significant differences (p < 0.01) found among the three 
groups of ages when the concentrations of individual PFOS and the sum of PFOS precursors 
were considered 
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Figure 14. Box plots showing significant differences (p < 0.01) between the participants 
whose residences were close to industrial areas the ones not when the concentrations of 
individual EtFOSA and the sum of PFOS precursors were considered 
 
100 
 
 
Figure 15. Box plots showing significant differences (p < 0.01) between the participants 
whose kitchens were recently renovated and not, when the concentrations of individual and 
the sum of PFOS precursors were considered 
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Figure 16. Scatter plots with significant positive correlations (p < 0.01) between indoor 
dust levels of the pairs PFOS and FOSA, and EtFOSE and MeFOSE 
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Correlations for PFOS, FOSA, EtFOSA, MeFOSE and EtFOSE and MeFOSE were also 
analysed. Significant positive correlations were found for the pairs PFOS and FOSA 
(p < 0.01) with a regression coefficient of 0.26, between EtFOSE and MeFOSE (p < 
0.01) with a regression coefficient of 0.37 and between EtFOSA and PFOS (p < 0.05). 
Figure 16 shows graphical representations of the two positive correlations at the 
level of 0.01. 
 
 
Figure 17. Percentages of linear and branched PFOS isomers identified in the positive 
vacuum cleaner dust samples from the A-TEAM cohort, where the yellow lines represent 
the theoretical percentage of the commercial PFOS mixture (70 % linear and 30 % branched 
isomers) 
 
Besides the generic evaluation of the indoor and demographic parameters of the 
entire dataset, some abnormally high concentrations were found for two samples 
(at least one of the precursors exceeded 100 ng/g), so they were individually 
checked for further evaluation. The first sample corresponded to a participant who 
was a non-smoker living alone, around 20 km from the NIPH in a wooden semi-
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detached house, not close to busy traffic roads or industrial areas. The house was 70 
m2 surface, recently renovated entirely and it was not ventilated during the 
sampling period. The participant owned Gore-Tex® clothing and shoes, but not 
waterproof sprays. On the other hand, the second one corresponded to a non-
smoker living with another adult, 5 km from the NIPH in a brick apartment built 
within the last ten years, far from busy roads and industrialised areas. The 
apartment was 60 m2 surface and the participant ventilated the bedroom during the 
sampling campaign period. The participant used Gore-Tex® shoes, clothing and 
sprays, and cooked with Teflon pans and utensils. 
 
4.3.2 PFOS Branched Isomers 
The expected ratio between linear:branched isomers for external exposure to PFOS 
is 70:30 (%), as in the manufactured product (Houde et al., 2008; Buck et al., 2011; 
Beesoon and Martin, 2015a). In order to verify or discard isomer specific 
degradation of the monitored PFOS precursors to PFOS in the environment, all the 
positive samples for total PFOS analysis, were re-analysed using the second of the 
methods detailed in the methodology chapter. As not all the individual isomers 
could be elucidated and identified from the standard mixture, the sum of the 
branched isomers (ΣBr-PFOS) versus the linear one (n-PFOS) was used. These ratios 
were used to check if the initial premise was confirmed. 
Descriptive statistics from the vacuum cleaner dust samples where PFOS and PFOS 
precursors were analysed are shown in Table 26 and represented in Figure 17. 
Individual sample results are detailed in Table SM02. As expected, mean value of the 
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experimental ratio (expressed as n-PFOS / ΣBr-PFOS) was 2.26, which 
corresponded to 69 % n-PFOS and 31 % ΣBr-PFOS, as expected from the technical 
mixture. 
 
Table 26. Linear (n) and branched (Br) PFOS isomers (%) in vacuum cleaner bags (n = 57) 
  n-PFOS / ΣBr-PFOS n-PFOS (%) ΣBr-PFOS (%) 
 
Average 2.29 69 31 
 
Mean 2.26 69 31 
 
Median 2.22 69 31 
 
Min 1.67 63 23 
 
Max 3.41 77 37 
 
Q1 (25th percentile) 1.96 66 28 
 
Q3 (75th percentile) 2.51 72 34 
 
SD 0.40 4 4 
 
% RSD 17.67 5 12 
 
SD = Standard deviation. RSD = Relative standard deviation. n = number of dust samples included in the 
statistics 
 
 
4.4 DAILY INTAKES OF PFOS AND PFOS PRECURSORS VIA DUST INGESTION 
Vacuum cleaner dust concentrations were used to estimate the daily exposure of the 
participants to the selected organic pollutants. Mean and high intake rate scenarios 
were selected. Estimated daily intakes (EDI) were calculated according to Equation 
09: 
Equation 09  𝐸𝐷𝐼 = 𝐶 𝑥
𝑅𝑑𝑢𝑠𝑡
𝑊
 𝑥 𝐹 
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Where C is the concentration of the specified pollutant (ng/g), R is the daily dust 
ingestion rate (mg/day) set as 4.16 (mean scenario) and 55 (high scenario) for 
adults (USEPA, 2011), W is the body weight (kg) reported by the participants, and F 
is the uptake fraction. This last parameter was assumed to be F = 1 (100 % 
absorbed) as for other exposure studies (Fromme et al., 2009; Goosey and Harrad, 
2011; Xu et al., 2013; Tian et al., 2016), and as representation of the highest uptake 
scenario. No dermal absorption was considered. 
Descriptive statistics of the estimated daily intakes of PFOS and PFOS precursors 
according to mean and high scenarios, and normalized by body weight for the 
participants are shown in Table 27 and Table 28, respectively, while individual 
results are detailed in Table SM03 and Table SM04. Daily intake values in mean 
scenario, which would represent exposure for most of the population, showed mean 
values ranged from 0.03 pg/bw kg/day for FOSA and MeFOSA to 1.88 for EtFOSA 
(ΣPFAS = 2.33 pg/bw kg/day). Meanwhile, in the high scenario, these values ranged 
from 0.35 pg/bw kg/day for FOSA and 24.80 for EtFOSA (ΣPFAS = 30.8 pg/bw 
kg/day). 
 
4.4.1. Daily Intakes in Adults 
For PFOS, daily intakes were estimated to be 0.56 and 7.37 pg/bw kg/day for mean 
and high scenarios, respectively. These values are significantly lower than the 
tolerable daily intakes of 150 ng/kg bw/day promoted by the European Food Safety 
Authority (EFSA) (EFSA, 2008), and for the 100 ng/kg bw/day promulgated by the 
German Federal Institute for Risk Assessment (BfR) (Miralles-Marco and Harrad, 
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2015), both established for PFOS exposure. Still, when considering direct and 
indirect exposure to PFOS, assuming same uptake fraction for PFOS and for its 
precursors, and according to the concentrations presented in this paper, external 
exposure to PFOS via FOSAs and FOSEs direct exposure would contribute 
significantly to the overall exposure to PFOS. These findings are in line with 
previously reported models based on Scenario-Based Risk Assessment approaches 
in which indirect exposure to PFOS via indoor dust in high exposed scenarios was 
estimated to contribute up to 68 % according to Vestergren et al. (Vestergren et al., 
2008), and up to 11 % (low exposure scenario) and 33 % (high exposure scenario) 
according to Gebbink et al. (Gebbink, Berger and Cousins, 2015). 
 
Table 27. Daily intakes of total PFOS and PFOS precursors (pg/kg bw/day) through dust 
ingestion for adults in mean scenario (4.15 mg dust/day) (n = 57) 
  PFOS FOSA MeFOSA EtFOSA MeFOSE EtFOSE ΣPFAS 
Average  0.52 0.03 0.03 1.93 1.30 0.71 4.51 
Mean  0.30 0.02 < 0.01 1.31 0.23 0.12 2.88 
Median  0.29 0.02 < 0.01 1.60 0.12 0.06 2.94 
Min  0.03 < 0.01 < 0.01 0.05 0.08 0.04 0.26 
Max  3.59 0.19 0.42 10.61 43.63 12.05 58.36 
Q1 0.16 0.16 0.01 0.00 0.75 0.10 0.05 
Q3 0.56 0.56 0.03 0.00 2.63 0.28 0.12 
5th percentile  0.05 0.01 < 0.01 0.29 0.08 0.04 0.92 
95th percentile  1.86 0.04 0.15 4.68 3.82 5.80 10.23 
SD  0.67 0.03 0.08 1.71 5.81 2.15 7.78 
RSD (%)  129.87 95.17 317.47 88.79 445.27 302.08 172.52 
Q1: 25th percentile..Q3: 75th percentile. SD = Standard deviation. RSD = Relative standard deviation. n = 
number of dust samples included in the statistics 
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Table 28. Daily intakes of total PFOS and PFOS precursors (pg/kg bw/day) through dust 
ingestion for adults in high scenario (55 mg dust/day) (n = 57) 
  PFOS FOSA MeFOSA EtFOSA MeFOSE EtFOSE ΣPFAS 
Average  6.87 0.35 0.34 25.46 17.25 9.39 59.66 
Mean  4.03 0.27 0.06 17.27 2.98 1.55 38.04 
Median  3.82 0.30 0.04 21.16 1.59 0.80 38.89 
Min  0.40 0.02 0.02 0.61 1.01 0.50 3.47 
Max  47.43 2.55 5.59 140.24 576.88 159.28 771.65 
Q1 2.12 2.12 0.19 0.04 9.92 1.37 0.69 
Q3 7.44 7.44 0.40 0.05 34.81 3.76 1.54 
5th percentile  0.72 0.09 0.03 3.86 1.08 0.54 12.17 
95th percentile  24.64 0.56 2.01 61.83 50.52 76.67 135.26 
SD  8.92 0.34 1.07 22.60 76.81 28.37 102.92 
RSD (%)  129.87 95.17 317.47 88.79 445.27 302.08 172.52 
Q1: 25th percentile..Q3: 75th percentile. SD = Standard deviation. RSD = Relative standard deviation. n = 
number of dust samples included in the statistics 
 
 
4.4.2. Daily Intakes in Children 
In a second approach, PFOS and PFOS precursors concentrations were employed to 
estimate EDIs for toddlers (1 to < 3 years old) and children (3 to < 6 years old). On 
this approach, mean (100 mg/day) and high (200 ng/day) intake rate scenarios 
were selected, as well as three concentration levels (5th percentile, 50th percentile, 
and 95th percentile) (Karásková et al., 2016). 
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Table 29. Estimated daily intakes of total PFOS and PFOS precursors (ng/kg bw/day) 
through dust ingestion for toddlers and children 
 PFOS FOSA MeFOSA EtFOSA MeFOSE EtFOSE ΣPFAS 
1 to <2 years old        
Mean intake scenario       
5th percentile 0.008 0.001 <0.001 0.038 0.015 0.008 0.133 
50th percentile 0.044 0.003 0.001 0.191 0.033 0.017 0.420 
95th percentile 0.274 0.008 0.027 0.619 0.618 0.739 1.306 
High intake scenario       
5th percentile 0.016 0.002 <0.001 0.076 0.031 0.015 0.267 
50th percentile 0.089 0.006 0.001 0.381 0.066 0.034 0.839 
95th percentile 0.548 0.015 0.055 1.238 1.237 1.477 2.612 
2 to <3 years old        
Mean intake scenario       
5th percentile 0.007 0.001 <0.001 0.031 0.013 0.006 0.110 
50th percentile 0.037 0.002 0.001 0.157 0.027 0.014 0.347 
95th percentile 0.227 0.006 0.023 0.511 0.511 0.610 1.079 
High intake scenario       
5th percentile 0.013 0.002 0.001 0.062 0.025 0.013 0.220 
50th percentile 0.073 0.005 0.001 0.315 0.054 0.028 0.693 
95th percentile 0.453 0.013 0.045 1.023 1.022 1.220 2.157 
3 to < 6 years old        
Mean intake scenario       
5th percentile 0.005 0.001 <0.001 0.023 0.009 0.005 0.082 
50th percentile 0.027 0.002 <0.001 0.117 0.020 0.010 0.257 
95th percentile 0.168 0.005 0.017 0.379 0.379 0.453 0.800 
High intake scenario       
5th percentile 0.010 0.001 <0.001 0.046 0.019 0.009 0.163 
50th percentile 0.055 0.004 0.001 0.234 0.040 0.021 0.514 
95th percentile 0.336 0.009 0.034 0.759 0.758 0.905 1.601 
Mean intake scenario = 100 mg/day. High intake scenario = 200 mg/day 
Weights: 1-2 years old = 11.4 kg. 2-3 years old = 13.8 kg. 3-6 years old = 18.6 kg 
5th percentile, 50th percentile (mean) and 95th percentile concentrations (ng/g) as calculated in Table 
27 and Table 28 (n = 57) 
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In the case toddlers and children, hand to mouth dust ingestion is more relevant 
than in adults (25 times higher exposure in mean exposed scenario, while four times 
higher for the higher exposed one). According to the personal questionnaires, 26 % 
of the participants reported the presence of at least one child up to 6 years old living 
in the sampled residences, and so, exposed to same concentrations of PFOS and 
PFOS precursors as the participants. For the calculation of the daily intakes, the data 
was also normalised to body weight according to the range of ages considered (1 to 
6): 1 to <2 years old (11.4 kg), 2 to <3 years old (13.8 kg), and 3 to < 6 years old (18.6 
kg) (USEPA, 2011). EDIs (ng/bw kg/day) for children in mean and high dust intake 
scenarios for three exposure levels are represented in Table 29. Daily intake values 
in mean intake scenario (50th percentile) ranged from ΣPFAS = 0.26 ng/bw kg/day 
for 3 to 6 years old children to 0.42 for 1 to 2 years old toddlers, while same 
percentile (50th) in high exposed scenario showed values from 0.51 to 0.84 ng/bw 
kg/day, respectively. In case of worst case scenario (high intake, 95th percentile), 
values ranged from 1.6 to 2.6 ng/bw kg/day for ΣPFAS, and from 0.34 to 0.55 ng/bw 
kg/day when just considering PFOS, being both values two orders of magnitude 
higher than the previously estimated in the high exposed scenario for adult 
population. This fact evidence how lower body weights – younger children –, besides 
the higher ingestion of dust due to hand to mouth contact, contribute to higher daily 
intake of dust, and so, to the associated risk assessment concerns. As for adult 
population, these values are significantly lower than tolerable daily intakes, even 
when considering ΣPFAS instead of just PFOS. However, even knowing dust is not 
the only source of internal levels of PFOS but a relevant contributor, dust exposure 
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has to be carefully considered for the estimation of the overall body burdens of 
PFOS, especially for children. 
 
4.5 COMPARISON WITH PREVIOUS STUDIES 
Two previously reported datasets were used for statistical comparison with the data 
reported in this paper. The Norwegian study conducted by Haug et al. (Haug, Huber, 
Schlabach, et al., 2011) analysed the same PFOS precursors as those selected in this 
study for another Norwegian population, while the British study conducted by 
Goosey and Harrad (Goosey and Harrad, 2011) employed the same instrumentation 
and laboratory presented here, and in both cases, there was available raw data for 
the comparison. The importance of this comparison relies in two different aspects: 
- Trends in PFOS and PFOS precursors tend to decline 
- Settled dust is usually less contaminated with PFAS than floor dust 
 
The cohort from this study included 57 dust samples of vacuum cleaner bags 
collected as described along the methodology chapter. The study by Goosey and 
Harrad included 45 floor dust samples collected from homes in the UK, collected by 
the procedure described in the mentioned paper. The study by Haug et al. included 
41 settled dust samples collected and analysed as specified in the referenced paper. 
In a first general overview, Figure 18 shows the individual percentage contributions 
of individual target PFASs to PFAS ‒ study by study ‒ for PFOS and PFOS 
precursors. One of the charts (Haug, Huber, Becher, et al., 2011) differs from the 
other two because EtFOSE was not measured in that study, but the other two studies 
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also differ substantially in the PFASs profile. A second comparison is shown in Figure 
19, where relative percentages are shown next to each other, and EtFOSE was 
excluded. In there, the different profiles are clearly visible. The study presented here 
(A-TEAM) is clearly dominated by the presence of EtFOSA (as percentage of amount 
of individual PFASs versus ΣPFAS), and followed by PFOS and MeFOSE, while for 
Goosey & Harrad the exposure was clearly dominated by PFOS followed by MeFOSE, 
and in case of Haug et al., it was equally dominated by PFOS and MeFOSE. In all cases, 
the lowest contributors to dust exposure are FOSA and MeFOSA. 
In terms of percentage of positive samples, the three studies revealed 100 % of 
positive samples for PFOS, followed by FOSA as another compound detected in a 
high percentage of samples (76 % for Goosey & Harrad, 24 % for Haug et al. and 
96 % for this study). MeFOSA was in all three cases the compound detected in the 
lowest percentage of samples (29 % for Goosey & Harrad, 2 % for Haug et al. and 
16 % for this study). On the other hand, larger diversity was found for EtFOSA and 
MeFOSE, with much higher detection frequencies for Goosey & Harrad (89 % for 
both of them) when they were compared to this study (96 and 35 % respectively) 
and to Haug et al. (15 and 10 % respectively). 
Figure 20 gives an individual and more detailed overview of the different exposure 
patterns beyond just percentages or detection frequencies. The figure shows the box 
plots relative to the t-test - significance level of 95 % (p = 0.05) – in case of EtFOSE 
(not included in Haug et al.) and MeFOSA (detection frequency lower than 10°% in 
Haug et al.), and the ANOVA tests ‒ Scheffe post-hoc test with a significance level 
95 % (p = 0.05) ‒ for PFOS, FOSA, EtFOSA and MeFOSE. Significant differences for 
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all the studied pollutants were found when comparing the determined 
concentrations from the three cohorts. 
For both compounds, PFOS and for FOSA, significant higher concentrations were 
identified in the UK study of Goosey & Harrad, while statistically comparable values 
were detected in Haug et al. when compared to this study. For EtFOSA, significant 
differences were found among the three studies, with statistically higher 
concentrations for Goosey & Harrad, followed by Haug et al. with this study 
displaying the lowest concentrations. A similar trend was identified for MeFOSE, 
with significant higher concentrations in Goosey & Harrad, but no significant 
difference between Haug et al. and this study, even though higher concentrations 
were detected for the Norwegian one. Data for MeFOSA and EtFOSE was just 
compared to the UK cohort, and the two compounds showed two different patterns. 
MeFOSA concentrations were significantly higher, while EtFOSE concentrations 
were significantly lower in this study when both were compared to the British data. 
In addition to the differences due to the nature of the cohort itself, there are other 
factors which could lead to differences in exposure patterns related to the 
concentrations of PFOS precursors (especially EtFOSE and MeFOSE, the most 
volatile ones): 
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Figure 18. Different exposure profiles, expressed as percentage of ΣPFAS, for PFOS, FOSAs 
and FOSEs , where n = 45 (Goosey & Harrad), n = 41 (Haug et al.) and n = 57 (this study). 
The relative abundances differ substantially among the three studies 
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- Different populations and locations: especially when considering two of the 
studies were carried out in Norway and the third one in England. 
- Different sampling methods: Haug et al. collected settled dust samples from 
living rooms, Goosey & Harrad collected floor dust from a specific area (1 m2) 
of the houses, while this study collected vacuum cleaner bag dust samples 
representatives from the entire house. 
- Seasonal variations: Goosey & Harrad carried out the sample campaign for 
two entire years, Haug et al. between February and May, and this study 
between November and April. 
 
 
 
Figure 19. Different exposure profiles, expressed as percentage of ΣPFAS, for PFOS, FOSAs, 
and FOSEs from this study (n = 57) UK (n = 45), and Norway (n = 41) studies. (EtFOSE 
omitted as not measured by Haug et al. (2011)) 
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Figure 20. Comparison of three different studies where PFOS, FOSAs and FOSEs have been 
analysed. Significant differences (p = 0.05) were observed between the concentrations of 
the six analysed pollutants in the three studies 
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4.6 SUMMARY AND CONCLUSIONS 
This study has shown that PFOS and PFOS precursors are still detectable in a high 
percentage of samples from indoor dust samples in Norwegian population (100 % 
positive samples for PFOS) , even though their use was restricted in 2002 and PFOS 
was included as a POP under the Stockholm convention in 2009 (UNEP, 2010). After 
more than 15 years of restriction, they remain present at measurable concentrations 
in indoor dust samples (average concentration ΣPFAS reported in this study of 77.2 
ng/g). This fact indicates that indoor environments are still a source, or a reservoir, 
for PFASs. 
Since the early 2000s, PFOS has been measured in indoor dust samples by many 
authors (Moriwaki, Takata and Arakawa, 2003; Björklund, Thuresson and De Wit, 
2009; Kato, Calafat and Needham, 2009; Ericson Jogsten et al., 2012; Fraser et al., 
2013; Xu et al., 2013; Shoeib et al., 2016) in different indoor microenvironments like 
homes, offices and cars. Since then, trends in average values have been decreasing 
from the average value of 443.7 ng/g detected by Kubwabo et al. (Kubwabo et al., 
2005) for Canadian home dust, 640.7 ng/g by Goosey & Harrad (Goosey and Harrad, 
2011) for English classrooms, or 175.2 ng/g by Bjorklund et al. (Björklund, 
Thuresson and De Wit, 2009) for Swedish homes, but all of them reporting different 
orders of magnitude data depending on the location of the study (see Table 03). 
More recent studies reported lower concentrations for these indoor micro 
environments, as Tian et al. (Tian et al., 2016) who reported average values of 13.7 
ng/g for Korean houses or Shoeib et al. (Shoeib et al., 2016) who reported median 
values of 0.29 ng/g for Egyptian homes, but still relevant in terms of both, 
concentrations and detection frequencies. Average values found in this study for 
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PFOS (average = 8.95 ng/g), are in line with the decreasing trends, much lower than 
the reported by Goosey and Harrad (Goosey and Harrad, 2011) for the UK 
(average = 144.7 ng/g), and slightly lower than the value reported by Haug et al. 
(Haug, Huber, Schlabach, et al., 2011) for the Norwegian population (average = 10.9 
ng/g), even though this last ones corresponded to settled dust (sampled in 2010) – 
usually presenting lower concentrations of PFASs – versus the analysed vacuum 
cleaner bags dust (sampled in 2014) reported in this thesis. 
Interestingly, as Figure 18 and Figure 19 revealed, the overall indoor exposure to 
PFOS and PFOS precursors in this study is not dominated by PFOS, although this is 
the most frequently determined PFASs from those included in this study. Instead, 
the profile was: EtFOSA (40 %), followed by MeFOSE (32 %), EtFOSE (15 %) and 
PFOS (12 %). It is well known that perfluorinated substances like EtFOSA – among 
other FOSAs – were employed in grease and water repellent coatings (Tittlemier, 
Pepper and Edwards, 2006). As a consequence of it, its presence in indoor 
microenvironments is feasible due to its release from coatings and later deposition 
in dust particles. On the other hand, FOSA was present in most of the samples 
(DF = 96 %) but in much lower concentrations, contributing around 1 % to the 
overall PFASs contribution. These findings are in agreement with recently reported 
papers where the underestimation of PFOS precursors was suggested when 
evaluating the overall exposure to PFOS, and its consequent body burdens 
(Vestergren et al., 2008; D’Eon J and Mabury, 2011; Gebbink, Berger and Cousins, 
2015). Moreover, statistical regression analysis showed significant positive 
correlations between PFOS and FOSA, EtFOSE and MeFOSE, as well as EtFOSA and 
PFOS, suggesting common sources of indoor contamination with these PFASs, in 
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agreement with previous published studies (Strynar and Lindstrom, 2008; 
Björklund, Thuresson and De Wit, 2009; Shoeib et al., 2016). This information is also 
in agreement with the need to further investigate the sources of contamination by 
PFOS and its precursors. 
Concentrations for FOSAs and FOSEs have been reported by Goosey & Harrad 
(Goosey and Harrad, 2011), Haug et al. (Haug, Huber, Schlabach, et al., 2011), Shoeib 
et al. (Shoeib et al., 2016) and Fraser et al. (Fraser et al., 2013). Different patterns of 
exposure were identified when comparing this study with the English and 
Norwegian cohorts, which could be partially attributed to differences between the 
participants, seasonal differences leading to air/dust distribution changes and 
ventilation habits, and the origin of the collected dust. Still, all of the studies revealed 
appreciable concentrations of EtFOSA, MeFOSA, and MeFOSE. 
The sources of PFOS and PFOS precursors could not be determined from 
correlations with personal data, indoor questionnaires and room contents, besides 
the age of the participants, the proximity to industrial areas and the renovation of 
the house. Some other parameters like age and origin of the furniture, carpets or 
waterproof clothing were not included in the indoor questionnaires, some of which 
could contribute to a deeper knowledge of indoor exposure origin. 
Average estimate daily intake of ΣPFAS for the investigated cohort was estimated to 
be 4.51 pg/kg bw/day in mean scenario, and 59.7 pg/kg bw/day for the highest one. 
In case of children population, worst case scenario (high intake scenario, 95th 
percentile) showed an estimated daily intake of 2.6 ng/kg bw/day, two orders of 
magnitude higher than the values reported for adult population. Still, these values 
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are significantly lower than the tolerable daily intakes of 150 ng/kg bw/day (EFSA, 
2008), and 100 ng/kg bw/day (BfR) promulgated by European food authorities. 
Moreover, indirect exposure pathways and their certain contribution to the overall 
body burdens of PFOS remain partially unknown. Metabolic pathways and 
conversion ratios, discussed later in this thesis, need further research to better 
model, and understand the link between external and internal exposure to PFOS 
precursors, which nowadays are present in Norwegian indoor environments in 
higher levels (88 %) than the historically reported PFOS (12 %). 
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5. PFOS AND PFOS PRECURSORS IN FOOD SAMPLES 
 
The main hypothesis of this chapter is that the diet contributes to: a) direct exposure 
to PFOS and b) direct exposure to PFOS precursors which might contribute to 
indirect exposure to PFOS via subsequent metabolism of FOSAs and FOSEs – 
discussed briefly in the conclusions from this chapter, and in the later chapter 
focused on in vitro metabolism – for the Norwegian A-TEAM cohort. A secondary 
aim is to find correlations between different groups of food items and food 
packaging with the presence or absence of PFASs and identify those contributing 
substantially to human body burdens. 
 
5.1 INTRODUCTION 
As mentioned in the introduction chapter, diet – as solid food and drinking water - 
has been suggested by some authors as the main, or one of the most important 
routes of external exposure to PFOS (Tittlemier, Pepper and Edwards, 2006; D’Eon 
J and Mabury, 2011; Gebbink, Berger and Cousins, 2015; Miralles-Marco and Harrad, 
2015), with its presence extensively reported in food items and water for the last 
years (Martin et al., 2004; Ericson, Nadal, et al., 2008; Kärrman et al., 2009; Haug et 
al., 2010; Noorlander et al., 2011; van Asselt et al., 2011; Domingo, 2012; Klenow et 
al., 2013; Rahman, Peldszus and Anderson, 2014; Gebbink et al., 2015). In a 
previously reported study from Norway (Haug et al., 2010), total dietary intake for 
the 16 perfluorinated substances was measured, reporting estimated intakes of 100 
ng/day for the sum of the 16 compounds, with around 50 % of that contribution due 
to PFOS and PFOA combined. PFOS was detected in all food matrices except in tea. 
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Other European authors, such as Fromme et al. (Fromme, Midasch, et al., 2007) 
reported in 2007 median values for PFOS intakes in German population of 1.4 
ng/kg/day, while in 2010, Schuetze et al. (Schuetze et al., 2010) estimated – also for 
German samples - concentrations up to 225 µg/kg ww in wild fish from populated 
regions. In Sweden, Berger et al. (Berger et al., 2009) also identified fish from 
polluted water systems as a potential source of PFOS exposure. Moreover, in 
Denmark, Halldorsson et al. (Halldorsson et al., 2008) highlighted meats and snacks 
as predictors of blood levels of PFOS. 
While direct exposure has traditionally been suggested as the main route of 
exposure humans can be exposed to PFOS – and to PFASs in general – directly or 
indirectly, with indirect exposure a consequence of external exposure to PFOS 
precursors and the subsequent metabolism. In recent years, the growing concern 
about PFOS precursors, the number of papers also including data on some of these 
PFOS precursors have increased in number, as mentioned in the introduction and 
dust chapters. Still, the number of papers reporting levels of PFOS precursors in food 
items remains rather limited (Tittlemier, Pepper and Edwards, 2006; Ericson, Nadal, 
et al., 2008; Ullah et al., 2014; Krafft and Riess, 2015). 
The presence of PFOS (and potentially of PFOS precursors) in food items is a 
combination of a mixture of two different pathways: a) bio-concentration though 
the food chain and b) contact with contaminated food packaging materials. The first 
one is observed when moving up within the food chain and trophic levels (Krafft and 
Riess, 2015), this is especially relevant for long chain PFASs – as PFOS and its 
precursors – due to their low elimination rate and high persistence in the body 
(Houde et al., 2008; Loi et al., 2011). The second one likely arises from the presence 
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of PFOS precursors in food items, where such precursors incorporated within 
coatings of paper products migrate to the food items they are in contact with 
(Skutlarek, Exner and Färber, 2006; Tittlemier, Pepper and Edwards, 2006; Ericson, 
Martí-Cid, et al., 2008; Jogsten et al., 2009; Shoeib et al., 2016). 
Among the broad spectrum of food items included in common human diets, fish, 
meat, egg, and dairy products have been considered as the most important food 
items constituting sources of PFASs by bioaccumulation (Tittlemier, Pepper and 
Edwards, 2006; Ericson et al., 2009; Haug, Huber, Becher, et al., 2011; Vestergren et 
al., 2012), while pre-packed food and the number of paper and plastic wrapping 
items was added to the list of variables of interest when considering migration from 
food packaging as a source of PFOS related contamination. 
 
5.2 FOOD DIARIES DESCRIPTION AND COMPOSITION OF THE FOOD SAMPLES 
An empty food diary, a food frequency questionnaire, and a kitchen scale were given 
to every participant when the food collection bottles were given to them. 
Instructions on how to fill the questionnaires were also attached. In total, 113 solid 
food samples and 121 liquid food samples were received and analysed in 
Birmingham from the 61 participants. 
A brief introduction describing the main nutritional parameters extracted from both 
types of questionnaires – FD and FFQ – will be introduced in this section, with the 
purpose to evidence differences in the food composition and the extracted 
nutritional data when the two types of questionnaires were compared. 
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5.2.1. Food Diaries Versus Food Frequency Questionnaires 
The average weight of solid and liquid food composites collected and reported in the 
FDs (≈ 2,500 g/day) was lower than the one calculated from the information 
extracted from the FFQs (≈ 2,800 g/day). Same pattern was observed when the 
energy intakes (kcal/day) were compared, as Figure 21 shows. 
 
 
Figure 21. Box plots showing weights of food and amount of energy (kcal) – calculated per 
day – reported and extracted from the food diaries (FD) and from the food frequency 
questionnaires (FFQ) 
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Figure 22. Box plots showing carbohydrates, fats, starch, sugars, fibre and proteins – 
calculated per day – reported and extracted from the food diaries (FD) and from the food 
frequency questionnaires (FFQ) 
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Main nutritional groups (carbohydrates, fats, starch, sugars, fibres and proteins) 
were compared, as shown in Figure 22. Five of six of the parameters evaluated 
presented lower values in the food diaries, while fibre was the only one for which 
the participants reported a much lower values in the long term exposure 
questionnaires (≈ 22 g/day) than in the food diaries linked to the food composites 
(≈ 60 g/day). Besides fibre, starch consumption varied from an average of ≈ 20 
g/day in the food diaries to an average of ≈ 100 g/day for the food frequency 
questionnaires, same as for sugars, with averages of ≈ 15 and ≈40 g/day, 
respectively. 
As a consequence of these differences, just the parameters from the food diaries 
were included in the statistical analysis of the food samples, while the food 
frequency questionnaires – linked to long term exposure – will be employed for 
statistical purposes in a later chapter of this thesis. 
 
5.2.2. Food Diaries 
Main descriptive statistics derived from the food diaries provided by the NIPH 
according to the information obtained from the participants included in the study, 
are showed in Table 30. 
As a general overview, solid food composites were a mixture ranging from 4 to 47 
(average = 17) food items combined and blended, while the liquid food samples 
were a mixture of 3 to 27 (average = 9) different liquids combined in the same bottle. 
When combining solid food and liquid food samples, the average weight of a single 
day (24 hours) total food sample was 2,627 g, being the minimum amount collected 
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670 g and the maximum 5,665 g. An average of 86 % of it was water, while the 
remaining 14 % was a mixture of nutrients. For the nutritional study, the average 
for daily food energy intake was 1,502 kcal (within a range of 418 – 3,670 kcal), 
while the averages for fat, carbohydrates, starch, sugar, fibre and protein were 60, 
169, 101, 21.1, 20.6 and 62 g respectively. Some of these parameters are 
represented in Figure 23. 
The participants also had to include some information about cooking and 
consumption of the food items, as well as the material of all cookware and storage 
containers. 
 
5.3 CONCENTRATIONS IN FOOD COMPOSITES 
113 duplicate diet solid food samples and 121 liquid ones from the Norwegian 
participants were collected and processed as explained in the methodology chapter. 
In this section, PFOS – total – and PFOS precursors – FOSAs, FOSEs and FOSAAs – 
concentrations are given. 
Descriptive statistics from the solid and liquid food samples where PFOS and PFOS 
precursors were analysed are shown in Table 31 and Table 32 respectively. 
Individual sample results are detailed in Table SM05 and Table SM06. 
PFOS was detected in 7 solid food samples (average = 0.005 ng/kg) in a range 
between <LOQ and 0.054 ng/kg, while FOSA was detected in 18 samples 
(average = 0.004 ng/kg) in a range between <LOQ and 0.051 ng/kg, MeFOSE in 9 
samples (average = 1.437 ng/kg) in a range between <LOQ and 42.302 ng/kg, 
EtFOSE in 19 samples (average = 3.683 ng/kg) in a range between <LOQ and 53.125 
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ng/kg and MeFOSAA in 3 samples (average = 0.005) in a range between <LOQ and 
0.045 ng/kg. MeFOSA, EtFOSA and EtFOSAA were not detected in any sample. 
For the liquid food samples, PFOS was detected in 4 samples (average = 0.029 ng/L) 
in a range between <LOQ and 3.195 ng/L, while FOSA was detected in 3 samples 
(average = 0.031 ng/L) in a range between <LOQ and 3.67 ng/L, same number as for 
MeFOSA (average = 0.044 ng/L) in a range between <LOQ and 0.131 ng/L. EtFOSA 
was detected in one sample with a value of 0.011 ng/L, and another positive sample 
was identified for MeFOSE, with a value of 0.080 ng/L. FOSAA and MeFOSAA were 
both detected in two samples, with values of 0.0217 and 2.77 ng/L for FOSAA and 
0.0147 and 0.0038 ng/L for MeFOSAA. No positive samples were found for EtFOSE 
and EtFOSAA. 
As with dust samples, the Shapiro-Wilk test for normality of data distribution was 
applied, showing skewed data. A comparison between non-parametric statistics and 
parametric statistics with logarithmic transformed data was conducted, showing no 
significant differences on the data analysis. As a consequence of it, logarithmic 
transformed data was selected and used for data normalisation and subsequent 
statistical analysis of the food composite samples. For further statistical analysis of 
the samples from this study, a cut-off value of 50 % positive samples was ideally 
required. None of the target compounds were detected in such high frequency, and 
even the cut-off value of 30 % positive samples – applied for dust samples – was not 
enough for a full statistical analysis of individual analytes, regardless their 
importance in dust and serum exposure. 
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Figure 23. Stacked column chart showing individual solid food samples and how the 
distribution between ΣPFAS daily exposure (as percentage when the daily intakes were 
body weight corrected calculated) from day 1 and 2 are distributed 
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Figure 24. Stacked column chart showing individual liquid food samples and how the 
distribution between ΣPFAS daily exposure (as percentage when the daily intakes were 
body weight corrected calculated) from day 1 and 2 are distributed 
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In case of the solid food samples, just ΣPFAS (36 % of the samples were positive for 
at least one of the PFASs included in the study) was analysed by SPSS, while no 
statistical analysis could be conducted for the liquid samples. ANOVA tests for ΣPFAS 
in solid food samples were run with Scheffe post-hoc test with a significance level 
95 % (p = 0.05). All the t-tests were also run with a significance level of 95 % 
(p = 0.05). 
No statistical differences were identified when ΣPFAS were grouped by age and 
gender. For correlations, just the positive samples (i.e. concentration > detection 
limit) were considered and the significance level was  specified (p = 0.01 or p = 0.05) 
later on in the specific analysis. No positive correlations were found for group of 
nutrients (energy, water, proteins, fats, carbohydrates, starches, sugars and fibres), 
so individual food items were selected for the correlations. Butter, margarine, 
different types of cheese, low and high fat fish, shellfish, low and high fat meat 
(chicken, beef, pork, bacon, lamb, turkey, game and organs), eggs, mayonnaise, jam, 
honey, nuts, cereals, bread, yogurt, chocolate, sweets, potatoes, mustard, olive oil, 
beans, green salads, vegetables (raw and cooked), mushrooms, corn, berries, 
common and exotic fruits, onion and leak, tomatoes and cucumbers, spirits, rice, 
flour, and pasta were tested as individual products. Sauces and gravies, ice creams, 
waffles, cakes, puddings, pizzas, casseroles, salty snacks, cookies, sweets, tomato 
based sauces, soups, prepared meals and food complements were also included in 
the statistical analysis as processed products. Positive correlations were found for 
ΣPFAS and the consumption of fish with high content in fat (p < 0.01), raw 
vegetables (p < 0.01), tomatoes and cucumbers (p < 0.05). On the other side, no 
significant correlations were found for food packaging (plastics, paper, etc.), cooking 
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(Teflon® pans, plastic or wooden utensils, etc.) and storage (plastic, glass, etc.) of the 
solid food items. 
Milk, juices, soya drinks, yogurt drinks, beer, wine, coffee and spirits were excluded 
from the list of food items, as they were part of the liquid food composites, not the 
solid ones, and no statistical analysis was conducted due to the low detection 
frequencies. 
 
5.4 DAILY INTAKES OF PFOS AND PFOS PRECURSORS VIA FOOD INGESTION 
Daily intakes of ΣPFAS for solid and for liquid composites were calculated for all the 
participants (except for one liquid sample, excluded due to the lack of complete 
information on the total weight of the food composite), per day and body weight 
corrected, for lower and medium bounds (see Table SM07 and Table SM08). For the 
lower bound approach, a value of zero was assigned for the samples which 
concentrations were below the LOQ, while in the medium bound the LOQ of each 
compound divided by the square root of two was employed (Tennant et al., 2017). 
No calculations were conducted for the higher bound, as they are strongly 
dependent on the instrumental LOD and LOQ of the instruments, so less 
representative to real intakes (Kettler et al., 2015). 
Estimated daily intakes were calculated according to Equation 10: 
 
Equation 10  𝐸𝐷𝐼 = 𝐶 𝑥
1
𝑊
 𝑥 𝑊𝐹 
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Where C is the concentration of the specified pollutant (ng/kg for solid composites 
and ng/L for the liquid ones), W is the body weight (kg), and WF is the weight of 
ingested food per day (kg). The uptake fraction was assumed to be 100 % absorbed 
as representation of the worst uptake scenario. 
Descriptive statistics of the estimated daily intakes of ΣPFAS are shown in Table 33 
for solid food samples, and in Table 34 for the liquid ones. 
An average intake of ΣPFAS of 16.7 ng/day (0.25 ng/kg bw/day) was obtained for 
the lower bound in solid food composites. For the medium bound, an average intake 
of ΣPFAS of 17.2 ng/day (0.23 ng/kg bw/day) was obtained, with a median value of 
0.53 ng/day (0.007 ng/kg bw/day) and an extreme value of 417 ng/day (6.96 ng/kg 
bw/day) for one of the participants. Figure 23 and Figure 24 show relative 
contributions (%) in terms of exposure by participant for the medium bound, when 
the two sampled solid food and liquid food composites were compared. 
An average intake of ΣPFAS of 0.46 ng/day (5.73 pg/kg bw/day) was calculated for 
the medium bound for the liquid food composites, with a median value of 0.08 
ng/day (1.10 pg/kg bw/day). The maximum intake calculated for the entire dataset 
of liquid samples was 41.09 ng/day (483.4 pg/kg bw/day). Figure 24 shows relative 
contributions (%) in terms of exposure by participant, when the two sampled solid 
food composites were compared. For the lower bound, an average value of 0.39 
ng/day (5 pg/kg bw/day) was calculated. 
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Table 33. Calculated daily intakes ΣPFAS for lower and medium bounds (ng/day and ng/kg 
bw/day) through solid food consumption (n = 113) 
 Intake (ng/day) 
Lower bound 
Intake (ng/kg 
bw/day)  
Lower bound 
Intake (ng/day) 
Median bound 
Intake (ng/kg 
bw/day)  
Median bound 
Average 16.79 0.252 17.24 0.258 
Mean NR NR 1.07 0.015 
Median <0.01 <0.001 0.53 0.007 
Min <0.01 <0.001 0.12 0.002 
Max 417.35 6.956 417.79 6.963 
5th percentile <0.01 <0.001 0.24 0.003 
25th percentile <0.01 <0.001 0.38 0.006 
75th percentile 0.04 0.001 0.70 0.010 
95th percentile 110.89 1.47 111.60 1.479 
SD 53.56 0.85 53.54 0.85 
%RSD NR NR 310.63 328.82 
NR = Not reported. SD = Standard deviation. RSD = Relative standard deviation. n = number of samples 
included in the statistics 
 
Table 34. Calculated daily intakes ΣPFAS for lower and medium bounds (ng/day and ng/kg 
bw/day) through liquid food consumption (n = 120) 
 Intake (ng/day) 
Lower bound 
Intake (ng/kg 
bw/day)  
Lower bound 
Intake (ng/day) 
Median bound 
Intake (ng/kg 
bw/day)  
Median bound 
Average 0.387 0.005 0.465 0.0057 
Mean NR NR 0.082 0.0012 
Median <0.001 <0.001 0.079 0.0011 
Min <0.001 <0.001 0.021 0.0003 
Max 41.044 0.483 41.087 0.4834 
5th percentile <0.001 <0.001 0.033 0.0005 
25th percentile <0.001 <0.001 0.057 0.0008 
75th percentile <0.001 <0.001 0.097 0.0014 
95th percentile 0.039 0.001 0.180 0.0025 
SD 3.761 0.044 3.757 0.0442 
%RSD NR NR 808.14 771.0840 
NR = Not reported. SD = Standard deviation. RSD = Relative standard deviation. n = number of samples 
included in the statistics 
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Table 35. Calculated daily intakes of ΣPFAS for lower and medium bounds (ng/day and 
ng/kg bw/day) through combined solid and food consumption (n = 94) 
 Intake (ng/day) 
Lower bound 
Intake (ng/kg 
bw/day)  
Lower bound 
Intake 
(ng/day) 
Median bound 
Intake (ng/kg 
bw/day)  
Median bound 
Average 18.771 0.280 19.294 0.287 
Mean NR NR 1.278 0.018 
Median <0.001 <0.001 0.599 0.008 
Min <0.001 <0.001 0.173 0.002 
Max 417.347 6.956 417.974 6.966 
5th percentile <0.001 <0.001 0.291 0.005 
25th percentile <0.001 <0.001 0.460 0.007 
75th percentile 0.055 0.001 0.886 0.012 
95th percentile 139.532 1.797 140.246 1.806 
SD 58.025 0.920 58.020 0.921 
% RSD NR NR 300.72 320.78 
NR = Not reported. SD = Standard deviation. RSD = Relative standard deviation. n = number of samples 
included in the statistics 
 
Table 36. Calculated daily intakes of ΣPFAS for lower and medium bounds (ng/day and 
ng/kg bw/day) through combined solid and food consumption when the average 
concentrations of day 1 and day 2 were considered (n = 47) 
 Intake (ng/day) 
Lower bound 
Intake (ng/kg 
bw/day)  
Lower bound 
Intake (ng/day) 
Median bound 
Intake (ng/kg 
bw/day)  
Median bound 
Average 15.181 0.232 15.652 0.239 
Mean NR NR 2.083 0.030 
Median 0.026 <0.001 0.607 0.008 
Min <0.001 <0.001 0.280 0.004 
Max 139.358 1.991 140.013 2.000 
5th percentile <0.001 <0.001 0.318 0.004 
25th percentile 0.002 <0.001 0.472 0.007 
75th percentile 17.418 0.259 17.912 0.266 
95th percentile 76.882 1.277 77.375 1.285 
SD 29.773 0.456 29.820 0.457 
% RSD NR NR 190.518 191.349 
NR = Not reported. SD = Standard deviation. RSD = Relative standard deviation. n = number of samples 
included in the statistics 
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Table 34 and Table 35 show two different ways of presenting the estimated daily 
intakes as a sum of solid and liquid food ingestion. In the first approach, represented 
in Table 35, concentrations of solid and liquid food composites were combined, and 
the calculation of the daily intakes was performed per sample/day (n = 94, two for 
each participant). On the other hand, the second approach represented in Table 36, 
reported concentrations of combined solid and liquid composites and averaged the 
data from day one and from day two, as well as the food weights corresponding to 
the specific samples. For both approaches, average and mean results for the 
estimated daily intakes were comparable, despite maximum and minimum ones 
differed substantially. In view of these results, the second approach was selected to 
be employed in later chapters of this thesis, due to its higher representability – more 
food items, so more realistic of real diet – when comparing both approaches to long 
term exposure data. Averaged individual daily intakes for the participants are 
detailed in Table SM09. 
On the other hand, lower and medium bounds also showed comparable daily intakes 
of PFASs (see Table 34 to Table 36), especially when they were body weight 
corrected. As a consequence of it, medium bound approach (substitution of the 
concentrations <LOQ for their LOQ value divided the square root of two) will be 
employed in later chapters for the calculation of the total estimated intakes for 
external exposure, and for the correlation with internal exposure levels. 
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5.5 SUMMARY AND CONCLUSIONS 
This study shows that PFOS is present in only some food items (around 6 % positive 
samples and contributing less than 5 % to the overall exposure to ΣPFAS). It also 
shows that some PFOS precursors – i.e. FOSA (16 % positive samples) and FOSEs 
(both EtFOSE (8 % positive samples and MeFOSE (17 % positive samples)) are 
present in food items and constitute an additional potential source of indirect 
exposure to PFOS. Combined, PFOS and PFOS precursors are present in around 1/3 
of the food composites (35 %) resulting an average concentration of 5.2 ng/g wet 
weight for solid food composites. In view of these results, it can be concluded that 
PFOS and PFOS precursors remain present in every day diet, indicating that diet is 
still a potential source for external – and mainly indirect – exposure to PFASs. 
Even though the number of positive samples was not ideal for statistical analysis, 
three positive correlations were found and were described in previous sections of 
this chapter. The first of them was related to the overall consumption of fatty fish, 
widely consumed in Scandinavian countries. This finding is in agreement with the 
higher than average reported levels in fish samples by other authors (Berger et al., 
2009; Haug et al., 2010; Hrádková et al., 2010) when they were compared to other 
studies or to other food items within the same study, reporting them as high 
potential sources of PFOS dietary exposure. For Haug et al., meat, fish and seafood 
products, together with milk and dairy produce represented between 50 – 70 % of 
the overall daily dietary exposure The main suggested reason for fatty fish to be a 
source of PFOS and PFOS related compounds is bioaccumulation by the trophic 
chain. 
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The second of the relationships identified was related to the amount of raw 
vegetables ingested. Among the questions from the questionnaires, some of them 
were related to the habit of washing or not washing raw fruits and vegetables before 
consumption. No correlation was found for washed vegetables, while it was for 
unwashed vegetables. The third of the correlations was found for the daily ingestion 
of tomatoes and cucumbers, two food items usually ingested without cooking or 
peeling. This combination of factors suggest the contamination from these specific 
items is most likely to migration from their original envelopes or bags. The number 
of studies where packed and non-packed food items have been investigated together 
is not large in number (Tittlemier, Pepper and Edwards, 2006; Ericson, Martí-Cid, et 
al., 2008; Halldorsson et al., 2008; Jogsten et al., 2009; Noorlander et al., 2011; 
Herzke et al., 2013) despite food packaging having been suggested as an important 
source of indirect exposure to PFOS by several papers. 
For liquid food samples, no comparison could be conducted due to the reduced 
number of positive samples. This fact, could be attributed to the large volume of 
water necessary to carry out the analysis, suggesting that water exposure could be 
better addresses if sampled and analysed as an independent sample instead of as a 
liquid food composite. 
Estimated daily intakes of 15.6 ng ΣPFAS/day (0.24 ng/kg bw/day) were obtained 
in medium bound approach when concentrations and food diaries data for the four 
samples collected from each participant were combined. This study was compared 
to the previous dietary report by the Norwegian Institute for Public Health in 2010 
(Haug et al., 2010), where total dietary intake for 16 perfluorinated substances was 
measured. When comparing the results obtained here with the ones obtained from 
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the Norwegian cohort, many differences are apparent. The main one is the nature of 
the food items, as the previously reported in 2010, was not carried out by the 
duplicate diet method of sampling, but on an individual food item basis. Although in 
this study, no statistical differences were identified between age groups and gender, 
Haug et al. found significant differences in daily ingestion by age. Haug et al. 
estimated average daily exposure around 100 ng/day for all the measured 
compounds, with around 50 % of that due to PFOS and PFOA combined. In this 
study, the average daily intake reported for PFOS, FOSAs, FOSEs and FOSAAs was 
17.3 ng/day. Here it is necessary to point out the smaller number of PFASs included 
in this study when compared to Haug et al, while FOSAs, FOSEs and FOSAAs were 
not included for identification by Haug et al. In terms of comparison, PFOS daily 
intake from Haug et al. should be equated to the ΣPFAS presented here, as all of the 
pollutants included in this thesis are susceptible to be metabolised or degraded to 
PFOS. That way, Haug et al. reported an intake of 18 ng/day for PFOS, while this 
study reports 15.6 ng/day for PFAS. 
A second relevant comparison has been done with duplicate diet studies for the 
Japanese population by Kärrman et al. (Kärrman et al., 2009) and for the German 
population by Fromme et al. (Fromme, Schlummer, et al., 2007). In Fromme et al., 
214 food composites were collected from 30 different participants, reporting a 
mean value for PFOS intake of 123.4 ng/day. Clearly, present reported levels in 
Norwegian food composites are significantly lower than the ones presented ten 
years ago for the German population. The Japanese study reported by Kärrman et al. 
also presented higher exposures to total PFOS in food composites (average values 
of 85.5 and 88 ng/day for Osaka and Miyagi respectively), and identified in 100 % 
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of the food composites. Decreasing trends in direct exposure to PFOS, as well as in 
overall exposure to long chain PFASs, can be identified from the reported values 
from both dietary papers. But as mentioned for Haug et al., patterns of exposure 
have changed drastically since the 3M Company phase out of PFOS, fitting much 
better with current indirect exposure estimations (Vestergren et al., 2008; Gebbink, 
Glynn and Berger, 2015): Total PFOS direct exposure – i.e. as PFOS itself – has 
decreased significantly relative to levels of FOSAs, FOSEs and FOSAAs. This does not 
mean the exposure to these precursors is increasing, but that their contribution to 
PFAS has increased due to the decline in PFOS. 
When the reported values are compared to the tolerable daily intakes (TDI) for PFOS 
established by the European Food Safety Authority (EFSA, 2004, 2008), it shows – 
as an overall – values much lower than the TDI of 150 ng/kg bw/day. This is not a 
fixed value per participant, so when average daily intake (calculated as ng/day) 
from this study is converted to ng/kg bw by the assumption of an average weight of 
75 kg, the TDI is 11.25 µg/day. Even for extreme values presented in this study (daily 
intake = 418 ng/day), the daily ingested amount of PFOS and PFOS precursors for 
the participant represents just 4.6 % of the TDI (9 µg/day for 60 kg weight). 
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6. IN VITRO METABOLISM OF PFOS PRECURSORS 
 
The main objectives of this chapter are: a) to elucidate if the PFOS precursors 
MeFOSA, MeFOSE and MeFOSAA are in vitro metabolised by human liver 
microsomes (HLM) to PFOS or to other intermediate products susceptible to further 
metabolism leading to PFOS as an end-product, b) to suggest in vitro metabolism 
pathways for MeFOSA, MeFOSE and MeFOSAA leading to PFOS, and c) to evaluate 
the significance of indirect exposure to PFOS via exposure to FOSAs, FOSEs and 
FOSAAs. 
 
6.1 INTRODUCTION 
Metabolism occurs in different organs and tissues, with liver as the most important 
one. It is well known that liver is rich in heme-containing enzymes (CYP 450), which 
play a major role in phase I oxidation reactions. In vitro assays with human liver-
derived experimental systems have constituted the most effective approach to 
estimate the human metabolic fates in vivo (Li, 2004). Within the available models, 
hepatocytes, S9 fractions, liver slices and human liver microsomes have been 
employed. Specifically, human liver microsomes have been the most popular model 
in the study of drugs metabolism and environmental pollutants due to their low cost, 
simplicity in use, easy storage, and rich concentration in many drug-metabolizing 
enzymes like cytochrome P450s, flavin monooxygenases, carboxyl esterases and 
epoxide hydrolase, and UDP glucuronyl transferases (Asha and Vidyavathi, 2010). 
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FOSAs, FOSEs and FOSAAs are listed among the organic pollutants suggested as 
PFOS precursors. Recently, papers reporting in vitro studies of potential PFOS 
precursors including FOSA (Benskin, Holt and Martin, 2009; Ross, Wong and Martin, 
2012; Chen et al., 2015), EtFOSA (Tomy et al., 2004; Fu et al., 2015) and EtFOSE (Xu 
et al., 2004; Zhao et al., 2016; Chang et al., 2017) have been published. Moreover, a 
few in vivo studies and results have been reported showing different conversion 
rates for these same compounds (Xie et al., 2009; Chen et al., 2015; Chang et al., 
2017). Nevertheless, some other substances listed in Table 01 still require further 
study to confirm them as sources of human exposure to PFOS. For that reason, in 
this study MeFOSA, MeFOSE and MeFOSAA were chosen for a qualitative study of 
phase I & II metabolism and plausible conversion to PFOS; and also to see if any 
other intermediate metabolites were detected by the use of UHPLC-HRMS(QTOF) 
analysis. These experiments were conducted by the author in collaboration with 
Luisa Lucattini at the Institute for Environmental Studies (IVM) of the Vrije 
Universiteit Amsterdam (VU) in the Netherlands during the months of September 
and October 2015. 
 
6.2 IN SILICO PREDICTION 
In silico approaches for the theoretical study of metabolism pathways are becoming 
a conventional tool to be used together with experimental observations and 
measurements. Nowadays, specific software such as MetaSite (Molecular Discovery 
Ltd Middlesex, UK), MetaDrug (Thomson Reuters, NY, USA), or Meteor (Lhasa 
Limited, Leeds, UK) are commercially available and frequently used as theoretical 
support when metabolism studies are carried out. The advantages conferred by use 
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of such software, the increasing number of database sets available, together with the 
availability of HRMS techniques and methodologies allow the identification of: a) 
predicted metabolites generated by the in silico software by a targeted 
quantification or targeted screening approaches, and b) “unpredicted” metabolites 
by non targeted screening and even retrospective screening (Ballesteros-Gómez et 
al., 2015; Negreira et al., 2016). 
The growing in silico approaches together with the current uncertainties related to 
the metabolism of the selected perfluoroalkyl compounds provide evidence about 
the need to further study of these PFOS precursors substances. However, to date 
only a few papers examining in vitro and in vivo metabolism pathways of FOSAs and 
FOSEs leading to PFOS have been published. On this paper, qualitative evaluation of 
phase I and phase II metabolism of MeFOSA, MeFOSA and MeFOSAA incubated with 
human liver microsomes is presented (see Figure 25). 
 
 
Figure 25. General workflow used for the study of phase I & II metabolism for MeFOSA, 
MeFOSE and MeFOSAA incubated with human liver microsomes 
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In this study, the Meteor Nexus (Lhasa Limited) software ‒ whose use was possible 
thanks to the University of Antwerp ‒ was employed for the in silico predictions. It 
enables the fast prediction of accurate metabolism of chemicals based on their 
molecular structure and the Lhasa metabolism database (see Table 37). In it, phase 
I and phase II metabolism were selected for the three analytes of interest, and the 
conditions of the in vitro experiments specified: the use of human liver microsomes 
(HLM) for phase I; and the use of human liver microsomes (HLM) and human liver 
cytosols (HLCyt) for phase II metabolism, including glucuronidation and sulfonation 
products as the expected phase II metabolites. With these premises, the software 
predicted: 
- 60 theoretical possible metabolites for MeFOSA 
- 59 theoretical possible metabolites for MeFOSAA 
- 68 theoretical possible metabolites for MeFOSE 
 
An extended description of them is provided in Table SM10, Table SM11 and Table 
SM12, while an abstract of them is shown in Table 38. The software discriminated 
among analytes being probable, plausible or equivocal, according to the specified 
conditions selected during its design. Data obtained by the software was used 
afterwards to generate three complete databases – one per parent compound – with 
all the molecular structures and accurate masses from the suspected intermediates 
and metabolites generated according to the selected enzymes and cofactors, 
together with their capability to catalyse these reactions in the human body. 
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These databases, including all the generated metabolites and end products, were 
imported to the processing methods for proper identification – target and suspect 
screening analysis – after the analytical acquisition. 
 
Table 37. Selected PFOS precursors for the study of in vitro metabolism, their molecular 
formula and their monoisotopic masses 
Compound Name 
Molecular 
formula 
Monoisotopic 
mass 
Average 
mass 
log Kow 
2-(N-methylperfluoro-1-
octanesulfonamido)-ethanol 
N-MeFOSE C11H8F17NO3S 556.99536 557.2240 7.29 * 
N-methylperfluoro-1-
octanesulfonamide 
N-MeFOSA C9H4F17NO2S 512.96912 513.1710 8.05 * 
N-methylperfluoro-1-
octanesulfonamidoacetic acid 
N-MeFOSAA C11H6F17NO4S 570.97461 571.2075 NF 
 
Table 38. Abstract from the Meteor predictions relatives to the three analytes of interest 
Compound 
Total 
metabolites 
Stage 
Number 
metabolites 
Probable Plausible Equivocal 
N-MeFOSE 68 
Phase I 37 
13 9 46 
Phase II 31 
N-MeFOSA 60 
Phase I 23 
11 14 35 
Phase II 37 
N-MeFOSAA 59 
Phase I 26 
13 5 41 
Phase II 33 
 
 
6.3 ANALYTICAL METHOD BY UHPLC-HRMS 
All the in vitro assays were carried out at the Institute for Environmental Studies – 
IVM (University of Amsterdam, The Netherlands), where no chromatographic 
method was already set up for the analytes of interest. As a consequence of it, a new 
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analytical method including MeFOSA, MeFOSE and MeFOSAA as well as their 
corresponding metabolites needed to be rapidly developed. Different modifiers, 
pHs, and combinations of both of them were tested in order to optimise the mobile 
phases: HCOOH (0.01 – 0.1%), HH4Ac (5 – 10 mM), NH4COOH (5 – 10 mM). The 
column was selected based in previously published research from IVM staff, where 
other PFASs were analysed (Ballesteros-Gomez, Rubio and van Leeuwen, 2010). The 
gradient, the flow and the oven temperature were optimised based on the 
separation of the available standards, together with the consideration of the 
detection of early elution of polar metabolites generated during the incubation 
stages. 
For the analytical separation, a UHPLC system (Nexera, Shimadzu, Den Bosch, the 
Netherlands) was employed. The mobile phases were composed of 5 mM NH4COOH 
in H2O and methanol as aqueous and organic phase respectively, both adjusted to 
pH 4. The column used for the analysis was a FluoroSep-RP Octyl, 5 µm, 15 cm x 2.1 
mm, 60 Å (ES Industries). The flow rate was set to 0.4 mL/min, the oven set to 35 °C 
and the injection volume was 5 µL. The elution gradient started at 10 % MeOH set 
isocratically for 3 minutes, followed by a linear gradient up to 89 % MeOH at minute 
25 to allow the elution of the predicted metabolites. Then, the flow was kept 
isocratic at 87 % MeOH for another 5 minutes. For cleaning purposes, the gradient 
was raised to 100 % MeOH at minute 33 and kept isocratic at 100 % for a further 7 
minutes. 
For the HRMS acquisition, a high-resolution time of flight (QTOF) instrument (maXis 
4G, Bruker Daltonics, Bremen, Germany) attached to an electrospray ionization 
(ESI)-ion booster source operating in negative mode were employed. The 
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acquisition was set to full scan mode in m/z scan range from 0 to 1,000 Da. The 
source parameters were selected as from previous methods from that same 
instrument: capillary 1 kV; end plate offset, 400 V; charging voltage, 500 V; nebulizer 
gas, 4.1 bar; dry gas, 3.0 L/min; dry temperature, 200 °C; and vaporizer 
temperature, 320 °C (Ballesteros-Gómez et al., 2016). 
 
6.4 PHASE I & II IN VITRO METABOLISM ASSAYS 
Out of all the possible metabolism reactions, just the most likely to happen in human 
liver microsomes and commonly studied were selected. For that reason, 
nicotinamide adenine dinucleotide phosphate (NADPH) was added to the HLM as 
co-enzyme for the phase I metabolism. For the phase II, uridine 5'-diphospho-
glucuronic acid (UDPGA) – together with the addition of alamatechin (Alam) as 
membrane permeabilizing – was selected as co-enzyme for the uridine 5'-
diphospho-glucuronosyltransferase (UGT) in the study of glucuronidation with 
HLM, and 3'-phosphoadenosine-5'-phosphosulfate (PAPS) as chosen co-enzyme for 
the sulfotransferases (SULTs) in the study of sulfonation with HLCyt. 
 
6.4.1 Reagents and Solutions 
All the solutions and reagents needed to be prepared carefully and stored following 
the instructions given below to ensure the reagents are active and the metabolic 
reactions were not inhibited or stopped. 
 152 
- Buffer TRIS 50 mM as reaction medium with adjusted pH to 7.73 at 25 °C 
(with 0.1 M HCl or NaOH) and stored in the fridge at 4 °C. The pH was checked 
prior to every experiment to be 7.4 at the incubation temperature (37 °C). 
- HLM 10 mg/mL in buffer used in phase I and phase II metabolism stages and 
freshly prepared for every batch of experiments. HLM solutions were just 
agitated by hand, not vortex mixed. 
- NADPH 100 mM in buffer as phase I metabolism co-enzyme solution freshly 
prepared for every batch of experiments and stored in the fridge during 
them. 
- HLCyt 10 mg/mL in buffer used in phase II metabolism stages and freshly 
prepared for every batch of experiments. HLCyt solutions were just agitated 
by hand, not vortex mixed. 
- UDPGA 100 mM in buffer as phase II glucuronidation co-enzyme solution 
freshly prepared for every batch of experiments and stored in the fridge 
during them. 
- Alamethicin 1 mg/mL in DMSO as membrane permeabilizing in 
glucuronidation tests and freshly prepared every day. 
- PAPs 10 mM in buffer as phase II sulfonation co-enzyme solution freshly 
prepared for every batch of experiments and stored in the freezer (- 20 °C) 
for the day. 
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6.4.2 Incubation Stage: Experimental Design and Preparation 
As previously established during the in silico approach stage, the number of 
experiments was limited to three analytes (MeFOSA, MeFOSE and MeFOSAA) and to 
HLM and HLCyt with specific co-enzymes. As a consequence of the limited time 
available to prepare and run the experiments, just a selection of the most important 
controls were selected and tested, and they included the following: 
- Uridine glucuronic acid transferase (UGT) and sulfotransferase (SULT) 
enzymes substrate negative controls, where all the reagents but the 
substrates were added. 
- UGT and SULT enzyme negative controls, where nothing but buffer and 
substrates were added. 
- UGT and SULT positive controls where all the reagents and substrates were 
added. 
 
Prior to phase I &II metabolism assays, just phase I assays were carried out to ensure 
the process (including the later extraction stage) was reliable and the recoveries 
were sufficient to avoid quantitation or identification problems during the injection 
of the samples in the UHPLC-HRMS system. These experiments were carried out in 
triplicate and the incubation time was set as two hours. 
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Table 39 and Table 40 show schematic abstracts of how the experiment was 
designed for both phases after the optimisation attempts. In them, test tubes 1 to 3 
are UGT substrate negative controls, while tubes 22 to 24 are the SULT ones. These 
controls were set as background chromatograms for the correct identification of 
peaks coming from the analytes and not from residual matrix from the microsomes. 
They could be also used for subtracted chromatograms and the identification of non-
target compounds Test tubes 4 to 12 are enzyme negative controls, where just buffer 
and standards were added. These controls were included to identify and discard as 
metabolism products, hydrolysis products coming from reactions due to the 
medium (buffer) itself. Finally, test tubes 13 to 21 and 25 to 33 are the positive 
controls for both glucuronidation and sulfonation processes. Every experiment was 
prepared in triplicate, and the total incubation time was two hours for phase I 
metabolism, followed by another two for phase II. 
A covered water bath with mild agitation was used for the incubation step. The 
water was held at a constant 37 °C, as well as the tris buffer solution before the 
beginning of every experiment. The 2 mL Eppendorf vials were numbered as 
indicated above and the specified amount (see Table 39 and Table 40) of buffer was 
added to all of them, followed by 10 µL of substrate and vortex mixed for 10 sec 
(when proceeded). Then, 50 µL of HLM were added to the specified vials and lightly 
hand mixed. At this point the timer was started when finally 10 µL of NADPH were 
added to the first vial containing HLM, with an interval of 10 sec. between one 
addition and the next one. During that 10 sec. slot, the vials were sealed, hand mixed 
and placed in the incubation bath. At minute 60, a second addition of 10 µL of NADPH 
was carried out in the same order and with the same interval of 10 seconds for 
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opening, adding, hand mixing and closing the vial. A third addition was made at 
minute 120, in this case of 50 µL of HLM, and 10 µL of alamethicin and UDPGA 
solutions for the glucuronidation vials; and of 50 µL of HLCyt and 10 µL of PAPs 
solutions for the sulfonation ones. A fourth addition was made at minute 180 of 10 
µL of UDPGA or PAPs solutions. Finally, at minute 240 the reactions were quenched 
by the addition of 200 µL of cold (4 °C) MeOH followed by 15 µL of cold HCOOH and 
vortex mixed for 10 sec. 
 
6.4.3 Sample Preparation 
A new extraction method was developed, so, different approaches were tested. All 
of them included a liquid-liquid extraction to transfer all the analytes and 
metabolites from the aqueous phase – where the incubation was carried out – to the 
organic solvent and concentrated before LC-MS analysis. 
In this case, three different extraction solvents were tested: acetonitrile (ACN), ethyl 
acetate (EtAc) and dichloromethane (DCM). The addition of ammonium acetate to 
enhance the salting-out process was also tested, as well as the removal or not – via 
precipitation – of the denatured proteins from the incubation step before the 
extraction stage. 
The first and major difference among all the different tests, was the higher 
recoveries obtained when the precipitant proteins were not removed by 
centrifugation, a step commonly carried out for many other organic pollutants after 
the incubation (Van den Eede et al., 2015). PFOS ‒ and so PFOS precursors or 
another intermediate substances ‒ tend to bind to proteins (Beesoon and Martin, 
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2015b), leading to poor extraction recoveries (even not detected when analysed) as 
target compounds were not present in the aqueous phase, they were attached to the 
solid fraction. Among the three solvents tested, DCM showed similar recoveries to 
EtAc for the precursor compounds (MeFOSA, MeFOSE and MeFOSAA) as well as for 
PFOS, but DCM was discarded due to its higher density compared to water and the 
added complication it posed to the extraction. Acetonitrile recoveries were lower 
than those calculated for the other two solvents, so EtAc was finally selected as 
extraction solvent. Finally, the salting-out process slightly enhanced recoveries for 
all the tested solvents, but led to lower signal to noise ratios due to ion suppression 
caused by the remaining salts from the extraction in the final extract. 
The selected extraction to carry out after the reaction was stopped was as follows: 
- 700 µL of EtAc were added to the Eppendorf tubes. They were vortex-mixed 
for 1 min. and ultra-centrifuged (8,000 rpm) for 30 sec. 
- After the phase-separation by salting-out with ammonium acetate, the ethyl 
acetate layer was separated and transferred into a new glass tube. 
- After the phase-separation, the upper layer (organic phase) was separated 
and transferred into new glass tubes. The liquid-liquid extraction was 
repeated for another three times by adding new aliquots of 0.5 mL of EtAc. 
- The supernatants were combined and evaporated to dryness under a mild 
nitrogen stream (30 °C). 
- The extracts were reconstituted in 100 µL of methanol. 
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6.5 EXPERIMENTAL RESULTS 
In this section, the specific qualitative results coming from the in vitro experiments 
detailed above will be presented. As previously explained in this chapter, the 
established workflow for the entire procedure, is described in Figure 25. 
 
For the proper identification of suspected intermediate metabolites, three databases 
with the accurate mass of all the compounds generated by the theoretical software, 
together with data reported in previous papers including common intermediates 
(Benskin, Holt and Martin, 2009; Ross, Wong and Martin, 2012; Chen et al., 2015), 
were created – one for each analyte investigated ‒ and uploaded to the processing 
methods. During the processing stage, two different approaches were considered: 
- “Target screening” (TS), for the metabolites predicted by the software and/or 
previously identified in the literature, and for which standards were 
available. 
- “Suspect screening” (SS) for any additional compound experimentally 
identified and suspected to be a PFOS precursor or intermediate metabolite 
not predicted by the in silico approach and/or not identified previously by 
the literature. 
Besides, three different levels of identification were defined: 
- “Confirmation” for these compounds for which standards were available and 
their relative retention times (RRT) were set as a confirmation parameter 
when injected together with the samples within an m/z tolerance of 5 ppm. 
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- “Identification” for these compounds predicted by the software or previously 
identified in the literature for which no standards were available within an 
m/z tolerance of 5 ppm. 
- “Suspect” for any additional compound experimentally identified and 
suspected to be a PFOS precursor or intermediate metabolite not predicted 
by the in silico approach and not identified previously by the literature within 
an m/z tolerance of 5 ppm from the monoisotopic accurate mass. 
 
Moreover, extracted chromatograms were processed in the same way as the original 
sequence to verify the occurrence of the suspected peaks was not due to matrix 
interferences or organic solvent impurities employed during the process. 
Out of all the possible metabolism reactions, just the most likely to happen and 
commonly studied for HLM were selected. With these premises, the software 
predicted 60 theoretical possible metabolites for MeFOSA, 59 for MeFOSAA, and 68 
for MeFOSE, as shown in Table 38 (see Tables S109, Table SM11 and Table SM12 for 
detailed databases). The software discriminated among analytes being probable, 
plausible or equivocal, according to the specified conditions selected during its 
design. Data obtained by the software was used to generate a complete database 
with all the molecular structures and accurate masses from all the suspected 
intermediates and metabolites generated according to the selected enzymes and 
cofactors, together with their capability to catalyse these reactions in the human 
body. 
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Table 41. Predicted origin for the theoretically detected MeFOSE intermediate products 
and the reactions leading to them 
Formula 
Nominal 
Mass (Da) Name Parent 
Biotransformation 
Name 
Phase Enzyme 
C11H8F17NO3S 557 
A 90507 
(Query) 
    
C8H2F17NO2S 499 M9 M32 
Oxidative N-
Dealkylation 
Phase I CYP450 
C8H2F17NO2S 499 M9 M6 
Oxidative N-
Dealkylation 
Phase I CYP450 
C8H2F17NO2S 499 M9 M2 
Oxidative N-
Demethylation 
Phase I CYP450 
C9H4F17NO2S 513 M2 M32 
Decarboxylation of 
alpha-Amino, 
Aromatic and beta-
Keto Carboxylic Acids 
Phase I 
Decarboxylase/
AAAD 
C9H4F17NO2S 513 M2 M25 
Oxidative N-
Demethylation 
Phase I CYP450 
C9H4F17NO2S 513 M2 M5 
Oxidative N-
Dealkylation 
Phase I CYP450 
C9H4F17NO2S 513 M2 
90507 
(Query) 
Oxidative N-
Dealkylation 
Phase I CYP450 
C10H6F17NO3S 543 M6 
90507 
(Query) 
Oxidative N-
Demethylation 
Phase I CYP450 
C11H6F17NO4S 571 M5 
90507 
(Query) 
Oxidation of Primary 
Alcohols 
Phase I ADH 
 
 
Table 42. Predicted origin for the theoretically detected MeFOSA intermediate products 
and the reactions leading to them 
Formula 
Nominal 
Mass (Da) Name Parent 
Biotransformation 
Name 
Phase Enzyme 
C9H4F17NO2S 513 
A 3034468 
(Query) 
    
C8H2F17NO2S 499 M1 
3034468 
(Query) 
Oxidative N-
Demethylation 
Phase I CYP450 
C14H8F17NO8S 673 M29 M3 
Oxidation of 
Secondary (Alicyclic) 
Alcohols 
Phase I ADH 
C14H8F17NO8S 673 M29 M10 
Oxidative N-
Demethylation 
Phase I CYP450 
C14H10F17NO8S 675 M3 M1 
N-Glucuronidation of 
Amides and Related 
Compounds 
Phase I UGT 
C14H10F17NO8S 675 M3 M2 
Oxidative N-
Demethylation 
Phase I CYP450 
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Table 43. Predicted origin for the theoretically detected MeFOSAA intermediate products 
and the reactions leading to them 
Formula 
Nominal 
Mass (Da) 
Name Parent 
Biotransformation 
Name 
Phase Enzyme 
C11H6F17NO4S 571 
A 
22286931 
(Query) 
    
C10H4F17NO4S 557 M11 
22286931 
(Query) 
Oxidative N-
Demethylation 
Phase I CYP450 
C8H12O9 252 M23 M6 
Glucuronidation of 
Carboxylic Acids 
Phase II UGT 
 
 
For MeFOSE, three compounds were identified from the entire predicted metabolite 
list, while four were identified for MeFOSA and two for MeFOSAA. Besides these, 
PFOS was also identified for the three of them. The metabolite names assigned by 
the software, molecular formulae and names of the reactions leading to them are 
described in Table 41 for MeFOSE, Table 42 for MeFOSA and Table 43 for MeFOSAA. 
For MeFOSA and MeFOSE mechanisms could be suggested, while for MeFOSAA, the 
possible pathways could not be identified when combining the in silico predictions 
and the experimental results obtained after the analysis by HPLC-HRMS. As 
consequence of it, along the next sub sections discuss only those results related to 
MeFOSA and MeFOSE. 
 
6.5.1 MeFOSE 
According to the processed Phase I and Phase II sequences for MeFOSE, four 
compounds were identified by their RRT and/or exact mass. Three of them were 
predicted by the software (see Table 41), while a fourth one was not present in the 
theoretical approach. Despite this fact, the fourth compound was easily identified as 
 163 
PFOS, widely reported as the stable end product for other FOSAs and FOSEs. Even 
though the main database of predicted MeFOSE metabolites was originally created 
by the Meteor software, some other compounds previously identified or suggested 
in literature as intermediates from FOSA were added to the processing list. 
Three of the four standards were available and they were included in the sequence 
together with the reported experiments. All of them satisfied the accurate mass (5 
ppm) and RRT criteria. For the remaining compounds, no standard could be 
injected, so just the exact mass identification criteria could be applied. 
Figure 26 shows the overlapped extracted ion chromatogram (XIC) of these 
compounds, named as MeFOSE M5 (or MeFOSAA), M6, M9 (or FOSA) according to 
the Meteor software nomenclature, all of them formed during the phase I incubation 
step. MeFOSE metabolite M5 (C11H6F17NO4S) was predicted to be formed by the 
alcoholic oxidation of the parent compound (C11H8F17NO3S – MeFOSE). MeFOSE M6 
metabolite (C10H6F17NO3S) by its oxidative demethylation and metabolite MeFOSE 
M9 (C8H2F17NO2S) by three different oxidative reactions, all of them coming from 
other intermediate metabolites. 
Figure 27 shows a schematic abstract of the three hypothetical routes of PFOS 
formation from MeFOSE according to the experimental results. In the first one, 
MeFOSE M5 – detected – would be directly formed by the oxidation of the precursor 
to be metabolised afterwards to MeFOSE M9 – detected – via another intermediate 
(MeFOSE M2 – C9H4F17NO2S) which could not be detected chromatographically. A 
second route could lead as well to MeFOSE M9 intermediate via MeFOSE M2 
metabolite, but metabolised in this case straight from the parent compound 
(MeFOSE). A third proposed metabolic pathway suggested the formation of MeFOSE 
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M9 intermediate by an oxidative dealkylation of MeFOSE M6 intermediate – 
detected – formed as a consequence of a previous demethylation of the parent 
compound. 
 
 
Figure 26. Overlapped XIC chromatograms of the main metabolites detected for MeFOSE 
 
 
 
Figure 27. Suggested possibilities for the observed metabolism of MeFOSE 
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Dealkylation reactions during the incubation process have been previously reported 
for EtFOSE in rat and human cytochromes by Xu et al. (Xu et al., 2004) and in vivo 
experiments with rats (Xie et al., 2009), supporting the mechanisms presented here, 
which are expected to be similar but with a methylated group instead of the ethyl 
reported. Once MeFOSE M9 (FOSA) is formed, different published papers (Tomy et 
al., 2004; Xu et al., 2004; Riddell et al., 2009; Ross, Wong and Martin, 2012; Chang et 
al., 2017) support its transformation to PFOS. 
 
6.5.2 MeFOSA 
Five peaks were identified when processing the data relative to MeFOSA incubation. 
Four of them were predicted by the software (see Table 42) while the fifth one was 
identified as PFOS. As per MeFOSE, two available standards lead to the confirmation 
of MeFOSA M1 ‒ or FOSA ‒ and PFOS, but no standards were available for the rest 
of the intermediate identified, being just characterised by their accurate mass. 
Figure 28 shows the overlapped XIC for the identified peaks predicted by Meteor 
software, named MeFOSA M1, M3 and M29. Metabolite MeFOSA M1 (C8H2F17NO2S, 
– FOSA) was formed directly by the oxidative dealkylation of the parent compound 
(C9H4F17NO2S – MeFOSA), while M3 (C14 H10F17NO8S) could be present due to an 
oxidative demethylation of an unidentified metabolite or a glucuronidation. 
MeFOSA 29 (C14H8F17NO8S) was formed by oxidation of secondary alcohols, but 
even identified, was present in much lower proportion than the rest of metabolites, 
and no further information about later metabolism could be found. The fifth 
 166 
identified compound did not seem to have relation with the other discovered 
metabolites, so was discarded. 
 
 
Figure 28 Overlapped XIC chromatograms of the main metabolites detected for MeFOSA 
 
 
Figure 29. Suggested possibilities for the observed metabolism of MeFOSA 
 
Figure 29 shows the scheme of the two suggested routes for MeFOSA metabolism, 
one of them leading to PFOS as end-product, and the second one leading to a second 
product M29, without possibility to track its possible conversion to PFOS. For the 
 167 
first route ending in the formation of PFOS, the suggested pathway seems easier to 
define and characterise. MeFOSA M1 was directly formed from the parent 
compound and it is metabolised, same way as for MeFOSE, to PFOS. This mechanism 
would be in agreement with the study carried out in 2015 by Fu et al. (Fu et al., 
2015)., in which an in silico approximation was performed to investigate the 
metabolism of certain PFOS precursors catalysed by cytochrome P45 enzymes. 
Moreover, Tomy et al. (Tomy et al., 2004) already reported dealkylation and 
deamination reactions for the proposed metabolism of EtFOSA in fish liver 
microsomes. 
 
6.6 SUMMARY AND CONCLUSIONS 
According to the results of these experiments – from the qualitative point of view – 
the data reported here is in line with previous published data from in vitro and in 
vivo studies for compounds from the same family (Tomy et al., 2004; Xu et al., 2004; 
Riddell et al., 2009; Fu et al., 2015). In this case, kinetics was not deeply studied as 
the experiments were just carried out for a short time period of two hours thus 
permitting only a qualitative perspective. 
Notwithstanding this, it is evident that there is rapid biotransformation of our target 
PFOS precursors to PFOS, via the stable and detectable intermediate FOSA. The 
mechanisms leading to the formation of PFOS do not occur in the same way for 
MeFOSA and MeFOSE. For MeFOSA, the demethylation to FOSA seems to be fast, 
with the conversion from FOSA to PFOS the limiting step to the final conversion to 
PFOS, while for MeFOSE the conversion to FOSA seems to be the limiting step, with 
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a faster conversion of FOSA to PFOS, both of them taking into account the relative 
abundance of the involved and detected compounds. This can be established just as 
a rough approximation due to the lack of knowledge of the real kinetics of the 
proposed mechanisms and the relatively short incubation times. 
On the other hand, FOSAA metabolites seem also to play an important role in the 
metabolic formation of PFOS when MeFOSE was studied, being detected and 
identified as another stable intermediate before FOSA formation, though the 
experiments carried out spiking FOSAA itself did not provide a clear pathway for a 
better understanding of the entire process. 
Overall, these experiments make an important contribution to testing the initial 
hypothesis of this thesis, by demonstrating that in vivo metabolism of precursors 
like FOSAs, FOSEs and FOSAAs to yield PFOS is viable. 
 
 
 169 
7. PFOS AND PFOS PRECURSORS IN HUMAN SERUM 
SAMPLES 
 
The main objective of this chapter is to determine concentrations of PFOS and PFOS 
precursors in human serum samples to evaluate the relative contribution of the 
external exposure to PFOS itself, as well as the indirect exposure to PFOS via FOSAs, 
FOSEs and FOSAAs via dust and food ingestion, already reported in previous 
chapters of this thesis. 
 
7.1 INTRODUCTION 
Perfluoroalkyl substances in blood samples have been studied and reported for 
years. Since fluorine was firstly identified by Taves (Taves, 1968a, 1968b), many 
papers have been reporting levels of PFOS in blood. Total PFOS – as a sum of linear 
and branched isomers and later years also individually – has been one of the most 
common PFAS analysed and detected together with PFOA, even after its restrictions 
in 2002 – by 3M Company phase out – and in 2009 – under the Stockholm 
Convention – (Zhou et al., 2014; Gebbink, Berger and Cousins, 2015; Gebbink, Glynn 
and Berger, 2015; Liu et al., 2015; Miralles-Marco and Harrad, 2015; Shan et al., 
2016). PFOS was a POP co be concerned about before 2009 (Ehresman et al., 2007; 
Ericson et al., 2007; Jin et al., 2007; Olsen, Burris, et al., 2007; Wilhelm et al., 2009), 
and it still is due to its ubiquity and persistence in human blood samples. 
Isomer patterns of PFOS started to be reported for environmental, external and 
internal exposure to PFOS in representative matrices. For environmental samples, 
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the percentage of branched isomers relative to linear PFOS is usually comparable to 
the ECF product isomer pattern, containing a mixture of linear and branched 
isomers around (70:30) (Butt et al., 2010; Beesoon et al., 2011; Esparza et al., 2011; 
Kärrman et al., 2011; Rahman, Peldszus and Anderson, 2014). Conversely, in human 
serum samples the ECF product composition of 70 % linear isomers is not true: the 
isomeric pattern tends to vary among individuals even from the same study, and 
most of them show an enrichment up to 50 % in PFOS branched isomers (Kärrman, 
Langlois, et al., 2007; Wang et al., 2011; Zhang et al., 2013; Gebbink, Glynn and 
Berger, 2015),while some other studies show the opposite tendency (see Table 10). 
The lack of an explanation for this fact evidences that the mechanisms causing this 
enrichment of branched isomers in blood have not been fully elucidated yet. On the 
other hand, differences in the isomeric profiles have been observed between 
humans and animals (Loveless et al., 2006; Benskin et al., 2009; Ross, Wong and 
Martin, 2012; Chen et al., 2015). 
Moreover, PFOS precursors such as FOSAs, FOSEs and FOSAAs have been reported 
in blood and serum samples, albeit in far fewer publications, as just direct exposure 
to environmental and external PFOS was considered (Fraser et al., 2013; Gebbink, 
Berger and Cousins, 2015; Poothong et al., 2017). The interest in these organic 
pollutants increased substantially after their identification in environmental 
samples, indoor microenvironments and food samples (Jahnke et al., 2007; Ahrens 
et al., 2011; Buck et al., 2011; Noorlander et al., 2011; Shoeib et al., 2011, 2016; 
Ericson Jogsten et al., 2012; Kim et al., 2012; Gebbink et al., 2015), their previously 
underestimated transfer from furniture, clothing and food packaging materials to 
air, dust or food items (Tittlemier, Pepper and Edwards, 2006; Ericson, Martí-Cid, et 
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al., 2008; Jogsten et al., 2009; Domingo, 2012), and the growing volume of studies 
suggesting routes of environmental degradation or metabolism from the precursors 
to PFOS (Xu et al., 2004; Wang et al., 2009; Xie et al., 2009; Asher et al., 2012; Peng 
et al., 2014; Chen et al., 2015). 
 
This chapter will present results relative to the human serum samples collected 
from the participants of the A-TEAM cohort. Nine PFASs – PFOS, FOSA, EtFOSA, 
MeFOSA, EtFOSE, MeFOSE, FOSAA, EtFOSAA and MeFOSAA – have been quantified 
and they will be presented here for the first time. 
 
7.2 LONG TERM EXPOSURE QUESTIONNAIRES 
Together with the indoor questionnaires and the food diaries, food frequency 
questionnaires (FFQ) were given to all the participants before the first of the two 
agreed sampling appointments, and they were collected during the second visit. The 
main difference between a FD and a FFQ is that the latter records data relating to 
long term exposure. The food diaries just collect accurate information about the food 
items consumed during the 48 hours of the sampling period – so are related to the 
food analysis directly linked to it – while the FFQ reflects eating habits over a longer 
period of time, covering a wider range of food items which are more representative 
for the long term food consumption exposure linked to internal exposure to 
persistent organic pollutants. Using this information, a rough screening of the 
relevant food items likely contaminated by PFASs and leading to higher levels in 
blood serum was carried out. 
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Dietary exposure to PFOS and PFOS precursors was estimated by the use of data 
generated by this study and the available food intake data. With this, generic 
parameters – as for the food results chapter – were considered as a first approach. 
The selected information extracted from food frequency questionnaires was: 
average weight of food and contents of carbohydrates, fats, sugar, proteins, fibres 
and energy consumed per participant. Descriptive statistics from these parameters 
are shown in Table 44, and represented in Figure 21 and Figure 22 from the food 
chapter, where both types of questionnaires were compared. The information from 
the food frequency questionnaires was divided in three groups of consumption for 
ANOVA test analysis: low, intermediate and high. 
The average weight of food consumed by a participant per day according to the FFQ, 
was 3,050 g, with the lowest consumption being 1,447 and the maximum 7,113 g. In 
terms of energy, the minimum consumption was 746 kcal, the maximum 5,338 kcal, 
and the average value 2,040 kcal. On the other side, the average fat consumption 
was 80.9 g (24.8 – 203.7 g), 240.4 g (84.9 – 671.6 g) for carbohydrates, 43.3 g for 
sugars (11.7 – 123.5 g), 29.8 g (7.7 – 78.3 g) for fibre and 80.4 g (38.7 – 195.3 g) for 
proteins. 
No information about the food packaging or the cooking utensils was available for 
the food frequency questionnaires. So, out of the large number of food items listed 
in the questionnaires (same groups as for the food diaries), just the animal-origin 
protein ones were considered as more relevant for the exposure of PFASs. Hence 
cheese, eggs, milk, mixed meat, shellfish and mixed fish will be further discussed 
together with concentrations of PFASs. 
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Table 44. Descriptive statistics extracted from the food frequency questionnaires 
  
Weight 
(g) 
Energy 
(kcal) 
Fat (g) 
Carbohydrates 
(g) 
Sugar 
(g) 
Fibre 
(g) 
Protein 
(g) 
Average 3,051 2,040 80.9 240.4 43.3 29.8 80.4 
Mean 2,898 1,928 76.5 221.3 38.0 27.4 77.0 
Median 2,891 1,880 78.1 210.9 39.4 26.7 74.7 
Min 1,447 746 24.8 84.9 11.7 7.7 38.7 
Max 7,113 5,338 203.7 671.6 123.5 78.3 195.3 
Q1 2,315 1,516 63.6 174.5 25.7 19.7 62.8 
Q3 3,522 2,413 93.5 291.2 52.2 35.4 91.2 
SD 1035.4 754.4 28.4 106.7 23.3 13.1 26.3 
% RSD 33.9 37.0 35.1 44.4 53.9 43.8 32.7 
Q1: 25th percentile. Q3: 75th percentile. SD = Standard deviation. RSD = Relative standard deviation 
 
Besides the FFQ, indoor questionnaires are also important when evaluating long 
term exposure to organic pollutants, and these already described and also 
mentioned when evaluating indoor dust exposure (see Figure 11 and Figure 12), will 
be included in this chapter as well. 
Finally, age and gender play a role in terms of accumulation and elimination of 
organic pollutants, so they are both important parameters to consider. As 
mentioned in the dust chapter, the participants ranged from 20 to 66 years old 
(average = 41.7 years), being 75.5 % of them female and the remaining 24.5 % male. 
Ages were divided in three groups for ANOVA evaluation: less than 30 years, 
between 30 and 50, and more than 50 years old. 
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7.3 CONCENTRATIONS IN SERUM SAMPLES 
From the 61 participants, 60 tubes containing human blood samples were collected, 
the serum extracted and shipped to Birmingham, so all the data presented onwards 
will relate to these 60 participants, including the information extracted from the 
questionnaires provided along this chapter. 
In this section, PFOS – linear and branched isomers – and PFOS precursors – FOSAs, 
FOSEs and FOSAAs – concentrations will be given and related to the different indoor 
and food questionnaires parameters mentioned previously. 
 
7.3.1 Total PFOS and PFOS Precursors 
Descriptive statistics from the serum samples where PFOS and PFOS precursors 
were analysed are shown in Table 45. Individual sample results are detailed in Table 
SM13. 
Statistical requirements for the analysis of the serum samples are the same as 
established for the other two matrices previously reported: minimum value of 30 % 
positive samples for a full statistical analysis, and a minimum of 10 % for t-test and 
ANOVA in scenarios when they were used for comparison of means with preceding 
studies. 
For the present set of samples, just ΣPFOS (86.7 % positive samples) met the 
criteria, with a mean concentration of 5.29 ng/mL (<LOQ – 16.52). The second most 
detected compound was MeFOSAA (23 % positive samples) with a mean 
concentration of 0.04 ng/mL (<LOD – 0.38). For the rest of the analytes, three 
samples were positive for EtFOSE (1.11, 3.73 and 0.61 ng/mL), two for MeFOSA 
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(0.013 and 0.005 ng/mL) and EtFOSAA (0.02 and 14.72 ng/mL), one for FOSA (0.003 
ng/mL) and MeFOSE (1.17 ng/mL), and no positive samples were found for EtFOSA 
and for FOSAA. Even though FOSAs and FOSEs were main contributors to dust and 
food exposure pathways, no statistical analysis could be conducted in serum 
samples as a consequence of their low detection frequencies. 
As with dust and food samples, the Shapiro-Wilk test for normality of data 
distribution was applied, showing skewed data. A comparison between non-
parametric statistics and parametric statistics with logarithmic transformed data 
was conducted, showing no significant differences on the data analysis. As a 
consequence of it, the dataset was normalised by the use of logarithmic transformed 
values for the statistical analysis. T-tests were run with a significance level of 95 % 
(p = 0.05), ANOVA tests with Scheffe post-hoc test with a significance level 95 % 
(p = 0.05), while for the correlations they were specified case by case (p = 0.01 or 
p = 0.05). 
Age and gender did not show significant differences either for ΣPFOS when ANOVA 
and t-test were applied, but mean values were higher for participants aged over 50 
years old, followed by these under 30 and lower concentrations for the participants 
aged between 30 and 50 years old (see Figure 30). Similarly, mean concentration 
values for males were higher than for women, as Figure 31 shows. 
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Figure 30. Box plots showing different concentrations of ΣPFOS in serum samples 
according to the age of the participants. No significant differences were found (p = 0.05) 
 
 
Figure 31. Box plots showing different concentrations of ΣPFOS in serum samples 
according to the gender of the participants. No significant differences were found (p = 0.05) 
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Figure 32. Box plots showing different concentrations of ΣPFOS in serum samples 
according to the gender of the female participants, followed by a scatter plot with trends of 
levels of PFOS in serum for female participants of the cohort according to age 
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Figure 33. Box plots showing significant differences (t-test, p < 0.05) for concentrations of 
ΣPFOS in serum samples according to the location –distance from busy traffic roads – and 
the presence/absence of pets in the house 
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The female subgroup of samples was selected (75.5 %) for further evaluation of the 
levels of ΣPFOS according to the three groups of ages, showing same pattern as when 
all the participants were selected. The highest levels were for oldest participants, 
followed by the youngest ones, with the lowest levels for those aged between 30 and 
50 years old (Figure 32) even though no significant differences were found for 
ANOVA and Pearson correlation tests. 
These findings strongly suggest – even with the lack of significant differences in the 
date – that age and gender do play a role when estimating internal exposure to PFOS 
(and by extension, to PFASs), further discussed in the conclusions section of this 
chapter. 
The same indoor parameters evaluated for the dust samples – age of the participants 
and their gender, the number of hours spent home, the type of residence, their 
location (distance) from the NIPH, from industrial areas and from busy traffic roads, 
the age, size and distribution of the residence, the presence of pets and smokers, the 
ventilation frequency, the recent renovation of the different rooms in the residence, 
the frequency the residence was vacuum cleaned, and the use of Gore-Tex® clothing 
of the participants (shoes and clothes) – were evaluated for the serum data. Just two 
significant differences were found: proximity to busy traffic roads, and the 
presence/absence of pets in the house, as represented in Figure 33. Mean values of 
ΣPFOS in serum were significantly higher for these participants living less than 50 
meters from a road with traffic (log ΣPFOS = 0.7207) when compared with those 
participants who were not (log ΣPFOS = 0.1661). Similarly, mean values of ΣPFOS 
were higher in participants living with one – or more animals – in the house (log 
ΣPFOS = 0.7321) compared to the ones who were not (log ΣPFOS = 0.2075). 
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The serum concentrations were also evaluated versus the parameters extracted 
from the food frequency questionnaires. Energy, fat, carbohydrates, sugar, fibre and 
protein consumption were the first parameters selected for evaluation. No 
significant differences were found when the ANOVA tests were performed, and just 
fat showed a positive correlation with ΣPFOS concentrations at p = 0.05, as 
represented in Figure SM04. In a second approach, specific food items, as fish (shell 
fish, lean fish, cooked fish, oily fish and all kind of fish combined), meat (chicken 
meat, read meat, and all kinds of meat combined), eggs, butter and milk were 
selected for significant differences among three different scenarios (low, 
intermediate and high consumption) and correlations. Egg consumption was the 
only parameter which showed a positive correlation with ΣPFOS concentrations at 
p = 0.05, but no statistical differences were identified among the three scenarios. 
 
7.3.2 PFOS Branched Isomers 
The expected ratio between linear and branched isomers for external exposure to 
PFOS via dust exposure is 70:30 = 2.33 as previously reported for dust samples. In 
contrast, for internal exposure the percentage of the linear isomer has been 
reported to be lower according to most of the papers (Kärrman et al., 2007b; Zhang 
et al., 2013; Beesoon et al., 2011; Liu et al., 2015) due to the different absorption and 
elimination rates for the multiple PFOS isomers (Benskin, Holt and Martin, 2009; De 
Silva et al., 2009; Peng et al., 2014), but also higher according to other authors (Ross, 
Wong and Martin, 2012). 
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In this section, some of the positive serum samples for total PFOS were re-analysed 
using the second of the methods detailed in the methodology chapter, and the levels 
of the samples sensitive enough for a proper quantification of the branched isomers 
are reported. As not all of the individual isomers could be elucidated and identified 
from the standard mixture, the sum of the branched isomers (ΣBr-PFOS) versus the 
linear one (n-PFOS) was selected for identification and quantitation. 
 
Table 46. Linear and branched PFOS isomers (%) in serum samples (n = 40) 
  n-PFOS / ΣBr-PFOS n-PFOS (%) ΣBr-PFOS (%)  
Average 2.46 69 31  
Mean 2.30 69 30  
Median 2.37 70 30  
Min 1.06 51 18  
Max 4.60 82 49  
5th percentile 1.208 55 18  
Q1 (25th percentile) 1.99 67 27  
Q3 (75th percentile) 2.70 73 33  
95th percentile 4.498 82 45  
SD 0.93 8.02 8.02  
% RSD 38.67 11.61 25.97  
SD = Standard deviation. RSD = Relative standard deviation 
 
Descriptive statistics from the serum samples where linear PFOS and branched 
PFOS isomers were analysed (n = 40) are shown in Table 46 and represented in 
Figure 34. Individual sample results are detailed in Table SM14. 
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Figure 34. Box plots representing the percentages of linear and branched PFOS isomers 
identified in the serum samples (n = 40), where the yellow lines represent the theoretical 
percentage of the commercial PFOS mixture (70 % linear and 30 % branched isomers) 
 
 
Figure 35. Box plots showing the percentages of branched PFOS isomers for male and 
female participants identified in the serum samples 
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Figure 36. Box plots relatives to the percentages of branched PFOS isomers identified in the 
serum samples from the entire set of participants (upper figure) and for the female 
participants (lower figure)according to age when ANOVA test (p = 0.05) were conducted. 
No significant differences were identified 
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According to what has been established in the introduction of this chapter, the most 
commonly reported in literature are samples showing increased proportions of the 
branched isomers, while still a small percentage showed the opposite tendency. The 
samples presented in this work presented linear:branched quotients ranging from 
1.06 to 4.60 (equivalent linear:branched ratios of 51:49 and 82:18, respectively), 
when compared to the ECF value of 2.33 (equivalent to linear:branched ratio of 
70:30). This results are consistent with initial assumptions and suggests that there 
is substantial inter-individual variation in both exposure to different PFOS isomers 
and (likely more importantly) their metabolism. 
In order to try to elucidate and discriminate among the participants according to 
their PFOS isomer ratios, age and gender were evaluated. 
No significant differences were identified when concentrations of ΣBr-PFOS and the 
gender of the participants was evaluated (t test, p = 0.05). Nevertheless, the 
representative box blots of the two subsets of participants showed some 
differences: mean value ΣBr-PFOS for males was 35.2 %, while the mean value for 
female participants was < 30 % (See Figure 35). 
As for gender, no significant differences were found when the participants were 
grouped by ages for ANOVA test. Still, some trends could be identified, albeit not 
statistically significant: the percentage of branched isomers in participants ranged 
between 30 and 50 years old (mean = 29 %) were lower than those reported for 
participants under 30 years old (mean = 32 %) and above 50 years old 
(mean = 31 %), as Figure 36 shows. The difference became slightly higher when just 
considering the female participants from the cohort (see Figure 36): the mean value 
of ΣBr-PFOS for female participants ranged from 30 to 50 years old was 27.7 %, 
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while they were 32.6 % and 33.1 % for female participants below 30 years old and 
for the ones older than 50 years old, respectively. 
 
The concentrations of PFOS branched isomers were also compared with the same 
parameters as total PFOS from the food frequency questionnaires: by groups of 
nutrients in a first approach (energy, fat, carbohydrates, sugar, fibre and protein 
consumption), and by specific food items in a second approach (fish, meat, eggs, 
butter and milk). 
None of the groups of nutrients showed significant differences, but different 
patterns were observed when the three scenarios (low, intermediate and high 
consumption) were compared. Participants reporting an average energy intake 
higher than 2,000 kcal/day showed higher percentage in ΣBr-PFOS (31.5 %) than 
the ones reporting lower caloric intakes (< 30 %), as Figure37 shows. Same pattern 
was observed for fibre, carbohydrates and for proteins, represented in Figure SM5. 
On the other side, fat consumption seemed not to contribute to enhance or reduce 
the percentage of PFOS isomers in serum. 
 
7.4 LINKING EXTERNAL AND INTERNAL EXPOSURE TO PFOS AND PFOS 
PRECURSORS 
Estimated daily intakes for the sum of food and dust ingestion for the Norwegian 
participants of the A-TEAM cohort, in medium bound and mean scenario 
respectively, are reported in Table SM15. Descriptive statistics are shown in Table 
47. 
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Figure 37. Box plots showing the percentages of branched PFOS isomers in the serum 
samples for different energy intakes reported by the participants. ECF ratio (30% branched 
isomers) is marked as reference 
 
 
Correlations between concentrations of ΣPFOS in serum versus PFOS, FOSA, EtFOSA, 
MeFOSE and EtFOSE in dust samples, versus ΣPFAS in food samples, and versus 
estimated daily intakes were evaluated. Positive correlations were identified for 
PFOS and for ΣPFAS when they were compared with ΣPFOS concentrations in serum 
samples. 
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Table 47. Calculated daily intakes of ΣPFAS (ng/day and ng/kg bw/day) through dust and 
food ingestion (n = 46) 
  Daily intake 
(mg/day) 
Daily intake 
(ng/kg bw/day) 
Average  16.314 0.265 
Mean  2.882 0.042 
Median  0.981 0.016 
Min  0.468 0.006 
Max  140.286 2.551 
5th percentile  0.495 0.007 
25th percentile  0.688 0.009 
75th percentile  18.455 0.271 
95th percentile  78.471 1.368 
SD  30.028 0.533 
%RSD  184.067 201.388 
SD = Standard deviation. RSD = Relative standard deviation 
 
 
Figure 38. Scatter plot showing the positive correlation (0.348) at p = 0.05 between the 
concentrations of FOSA in dust samples and the ones in blood for PFOS 
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A positive correlation (regression coefficient of 0.35) was identified for the 
concentrations of ΣPFOS in blood and the concentrations of FOSA in dust samples, 
as Figure 38 shows. A similar correlation (regression coefficient of 0.38) was 
identified for the estimated daily intakes of PFOS in dust, shown in Figure 39. 
Interestingly, no other positive correlation was identified for dust or food 
concentrations, neither for the sum of both of them, versus the reported levels of 
PFOS in serum. 
 
 
Figure 39. Scatter plot showing the positive correlation (0.38) at p = 0.05 between the 
estimated daily intakes of PFOS in mean scenario for dust ingestion and the concentrations 
in blood for PFOS 
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7.5 SUMMARY AND CONCLUSIONS 
Since 2001, the ubiquity of PFOS in the environment and its high levels reported in 
blood samples has been a fact and a cause of concern (Hansen et al., 2001). Now, 
decreasing patterns for internal exposure levels as a consequence of PFOS 
derivatives restriction are evident too (Kato et al., 2011), but still, many authors are 
reporting measurable levels of PFOS in blood samples in the order of ng/mL 
(Ericson et al., 2007; Fromme et al., 2009; Haug, Huber, Becher, et al., 2011). 
This study has shown that ΣPFOS is detectable in a high percentage of serum 
samples (87 %) from Norwegian population, clearly dominating the internal 
exposure levels with an average concentration of 5.3 ng/mL. MeFOSAA was 
identified as the second most detected compound (23 %), with an average 
concentration of 0.036 ng/mL, while the rest of the PFOS precursor were detected 
in much lower ranges: FOSA and MeFOSE were detected in one sample (0.003 and 
1.167 ng/mL respectively), MeFOSA was identified in two samples (0.013 and 0.05 
ng/mL), same as EtFOSAA (0.016 and 14. 71 ng/mL), while three samples were 
positive for EtFOSE (average = 0.131 ng/mL). EtFOSA and FOSAA were not detected 
in any of the serum samples. 
This study is not the first one reporting levels of FOSAAs in blood or serum samples. 
In 2015, Gebbink et al. (Gebbink, Glynn and Berger, 2015) reported FOSAAs 
concentrations in human serum samples from Swedish population collected 
between 1991 and 2012. On it, they showed how trends in FOSA and FOSAAs 
internal exposure decreased as for PFOS through the years, in a range of 
concentrations of 0.015 to 0.5 ng/g when considering individual concentrations of 
FOSAA, EtFOSAA and MeFOSAA. Other authors also reported levels in human serum 
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samples in the same order of magnitude for FOSAAs (Olsen et al., 2004; Lee and 
Mabury, 2011), for FOSAs (Haug, Thomsen and Becher, 2009a), and for FOSEs 
(Fraser et al., 2013), being and all of them 1-2 orders of magnitude lower than PFOS. 
In terms of exposure, Ullah et al. (Ullah et al., 2014) attributed internal levels of 
FOSAAs to direct exposure through food or dust ingestion, while other authors as 
Shoeib et al. (Shoeib et al., 2011) suggested indirect exposure to FOSEs via dust or 
food ingestion as the main source of FOSAAs. On the other side, detected levels of 
FOSAs in blood samples have been attributed to both, direct and indirect – via 
MeFOSA or EtFOSA – exposure to air, dust or food (Peng et al., 2014). 
Age and gender of the participants seemed to play a role in internal concentrations 
of ΣPFOS in serum, even when no statistical differences were identified. Participants 
aged over 50 years old showed higher concentrations than the rest of them, followed 
by the participants below 30 years old. Same pattern was detected for the female 
subset of participants. These differences could be attributed to different 
accumulation and elimination rates as consequence of menstruation, birth giving or 
breastfeeding of the female participants. 
For PFOS isomers, a slight enrichment for the sum of branched isomers was 
observed for the overall cohort, but remaining unclear if it is due to different 
patterns of exposure or – as most suggested – bioaccumulation. When male and 
female participants were compared, female participants showed a different pattern 
than the male ones, showing a percentage of branched isomers higher than 30 % for 
men, while it was lower than 30 % for women. Interestingly, when the sum of 
branched isomers was evaluated by age for the female participants, these between 
30 and 50 years old presented were the only ones showing percentages below 30 %, 
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while the other two groups of age showed mean values higher than 30 %. This 
finding suggest than the different uptakes and elimination rates of linear and the 
different branched PFOS isomers could be even more relevant when considering the 
factors of menstruation, maternity and breastfeeding mentioned above.  
The study presented in this thesis could not find strong correlations between levels 
of external exposure to PFOS precursors or PFOS – via dust and food ingestion when 
they were combined –and the internal ones, even when there are evidences 
supporting dust and food as the main sources of exposure. Still, two correlations – 
for FOSA and for ΣPFAS – were identified for dust exposure and intake, even when 
dust constituted around 2 % to the overall exposure presented in this thesis 
(average intake of 0.24 ng/kg bw/day for food in median bound versus 0.0045 
ng/kg bw/day for dust in medium scenario). 
Current findings point out the need to further investigate the link between their 
external and internal exposure patterns by the use of long term monitoring to 
properly evaluate trends and correlations. 
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8. CONCLUSIONS AND SUMMARY 
 
Major exposure to PFOS and PFOS related compounds is an every-day exposure for 
most of the population. According to the literature review (Vestergren et al., 2008; 
D’Eon J and Mabury, 2011; Gebbink, Berger and Cousins, 2015; Miralles-Marco and 
Harrad, 2015), main routes of exposure to these pollutants suggest diet as the first 
contributor (combination of food and drinking water), followed by dust ingestion as 
the second one, in all cases remarking the unavoidable daily exposure to these 
environmental pollutants. 
Direct exposure to PFOS has been long studied and widely reported. Recent years 
indirect exposure to PFOS precursors – such as FOSAs, FOSEs and FOSAAs – has 
been pointed out as the most feasible source of current internal levels of PFOS in 
human biomonitoring studies, especially after the 3M Company phase out (2002) 
and the later inclusion of PFOS as a POP under the Stockholm Convention (2009). 
Consequently, legacy routes of exposure to PFOS related compounds – clearly 
dominated by direct exposure to PFOS – changed, and new studies further 
investigating exposure and metabolism of the so-called PFOS precursors and their 
relative contribution to the overall body burdens of PFOS, started growing in 
number. 
 
This thesis was addressed to the idea of partially contribute to the understanding of 
the remaining unknowns related to real exposure and body burdens of PFOS – 
indirect sources of exposure inclusive – by the study of a reduced number of selected 
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PFASs suspected to be PFOS precursors in a small population group (n = 61), set as 
the Norwegian A-TEAM cohort. Concentrations, intakes, exposure patterns, 
correlations, and novel findings will be described and remarked along this 
conclusive chapter. 
 
8.1. RESULTS SYNOPSIS 
Diet, as a combination of food and drinking water, has been extensively suggested 
to constitute the most important external source of PFASs exposure. Due to these 
statements, food exposure – duplicate diet method– was studied and evaluated for 
the participants of the A-TEAM cohort. In agreement with what has been previously 
reported by some authors (Tittlemier, Pepper and Edwards, 2006; Vestergren et al., 
2008; D’Eon J and Mabury, 2011; Gebbink, Berger and Cousins, 2015), this study 
pointed diet as the main source of exposure to PFOS and PFOS precursors. Average 
daily intake for the sum of PFOS and PFOS precursors was estimated to be 0.23 
ng/kg bw/day (15.6 ng/day) for the combined exposure to both, solid and liquid 
food. Still, in this study just seven solid food composites showed detectable 
concentrations of PFOS, with an average value of 0.005 ng/g. FOSA (18 positive 
samples, 0.004 ng/kg), MeFOSE (9 positive samples, 1.902 ng/kg) and EtFOSE (19 
positive samples, 3.746 ng/kg) were identified in a larger number of samples and in 
higher concentrations (maximum amount of 53.1 ng/kg for EtFOSE for one of the 
reported samples) than PFOS, revealing PFOS precursors as higher contributors to 
solid food exposure than PFOS itself. Lower detection frequencies were reported for 
the liquid food composites, albeit water has been established as a source of PFASs 
(Loos et al., 2007; Ericson, Nadal, et al., 2008): 4 samples were positive for PFOS 
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(0.029 ng/L), three for FOSA (0.031 ng/L) and for MeFOSA (0.044 ng/L), two 
samples for FOSAA, MeFOSAA, one for EtFOSAA and for MeFOSEE, and none for 
EtFOSE and EtFOSAA. The underpinning reason behind the lack of positive samples 
derived from the liquid food analysis, could be attributed to the reduced volume of 
sample employed in the analysis (10 mL) when it is compared to the large volume 
of sample (up to one litre) of water employed in the papers reporting PFOS in high 
detection frequencies, introduced in Table 02. 
Home – as the most relevant indoor environment due to the number of hours spent 
in there – is commonly considered an important source of PFOS and PFOS related 
products, and dust, a representative matrix of indoor exposure for semi-volatile and 
non-volatile organic pollutants. Daily intakes reported in this thesis estimated 
average daily intakes of 4.5 and 59.7 pg/kg bw/day in mean and high scenarios 
respectively for the sum of the six PFASs investigated. The relative contribution to 
dust exposure was dominated by EtFOSA, with an average concentration of 30.9 
ng/g (average EDI in mean scenario of 1.9 pg/kg bw/day, DF = 96 %). EtFOSA 
constituted around 40 % of the overall dust exposure (see Figure 18), while PFOS 
was contributing around 12 %, with a reported average concentration of 8.9 ng/g 
(average EDI in mean scenario of 0.5 pg/kg bw/day, DF = 96 %). MeFOSE and 
EtFOSE were also identified as significant contributors to the overall PFASs, 
constituting the sum of them approximately the 50 % of the dust exposure to ΣPFAS 
reported in this thesis. They showed average concentrations of 24.4 (intake) and 
12.0 ng/g (EDI) for MeFOSE and EtFOSE respectively. 
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In view of the results obtained for the two selected matrices to evaluate external 
exposure to PFOS and PFOS related substances, can be concluded that both, dust and 
food are potential sources of PFOS and of PFOS precursors suspected to contribute 
to indirect exposure to PFOS, even more than to direct exposure to PFOS itself. As 
an overall, both routes of exposure combined represent an estimated daily intake of 
0.25 ng/kg bw/day (15.3 ng/day) of ΣPFAS, with a much larger contribution of diet 
(around 98 %) to this value. 
Finally, internal levels of PFOS in serum samples were evaluated. Serum samples 
showed expected patterns of exposure to PFOS and PFOS precursors when they 
were compared to literature (Ericson et al., 2007; Holzer et al., 2008; Kato et al., 
2011): PFOS was the main contributor to internal exposure to PFOS and PFOS 
related products. While it was detected in 87 % of the analysed samples showing an 
average value of 5.3 ng/mL, all the PFOS precursors but MeFOSAA (which showed 
23 % positive samples) were just detected in a few samples, either in none of them.  
PFOS branched isomeric ratio was also evaluated in these samples for which ΣPFOS 
was quantified. In dust samples, linear:branched ratio showed the expected pattern 
of 70 % of linear and 30 % of branched PFOS isomers. In serum ones, the calculated 
ratio revealed different composition (in percentage) than the one estimated in dust, 
and showing an important inter-individual variation, especially when age and 
gender were considered. 
And at this point, is were external and internal exposure merge and explanations to 
the different exposure profiles can be further understood: as reported in the in vitro 
chapter, two of the selected PFOS precursors (MeFOSA and MeFOSE) were fast 
metabolised (two hours) to the end up product – PFOS – , to a stable and well 
 197 
characterised intermediate (FOSA), or to some other intermediates which could or 
not lead to the final formation of PFOS, same way as for their previously reported 
ethylated analogues (Ericson et al., 2009; Ross, Wong and Martin, 2012; Chang et al., 
2017). This fast conversion, supported by previously reported data on in vitro and 
in vivo studies, would prevent reporting high levels of PFOS precursors in human 
biomonitoring studies – as presented here –, even when population is still externally 
exposed to them. 
 
8.2. CONCLUSIONS BY HYPOTHESES 
8.2.1. Indoor home dust is a significant source of exposure to long chain PFASs 
such as PFOS, FOSAs and FOSEs 
PFOS has shown to be still present at detectable levels – 12 years after its phase-out 
and 5 years after its inclusion as a POP – in indoor environments, as home dust 
concentrations (ranging from 0.41 to 70.7 ng/g,) presented in this thesis revealed. 
Still, when comparing concentrations in dust with previous studies, PFOS values 
reported here (average = 8.9 ng/g) for the Norwegian cohort are lower than the 49 
ng/g reported in 2009 by Bjorklund et al. (Björklund, Thuresson and De Wit, 2009) 
in Sweden, the 27 ng/g by Fraser et al. (Fraser et al., 2013) for the Czech Republic in 
2013, or the 144 ng/g by Goosey and Harrad (Goosey and Harrad, 2011) for the UK 
in 2011. Nowadays, levels of PFOS for Norwegian indoor floor dust are comparable 
to the ones reported in previous studies by Haug et al. (Haug, Huber, Becher, et al., 
2011) (average = 10.9 ng/g), even considering the one conducted in 2011 
corresponded to settled dust – usually cleaner and presenting lower concentrations 
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of environmental organic pollutants – and the present one, to vacuum cleaner floor 
dust samples. These findings are in line with recent studies stating that (direct) 
external exposure to PFOS through dust ingestion tend to decline, even though its 
ubiquity and prevalence in indoor dust reveal its exposure should still be considered 
and monitored. 
Contrary to reported information where just “traditionally characterised” 
perfluoroalkyl acids and sulfonates are analysed, dust exposure to the PFASs 
included in this thesis project showed a strong dominance of two PFOS precursors 
instead of PFOS: EtFOSA (40 %) and MeFOSE (32 %), while PFOS appeared to 
contribute around 12 % to the overall exposure (see Figure 18). Even though these 
precursors have been much less reported in indoor environments, concentrations 
up to 75,000 ng/g for EtFOSE (with detection frequencies of 100 % for EtFOSE and 
MeFOSE) by Shoeib et al. (Shoeib et al., 2005) in Canada, and up to 3,000 ng/g in 
Boston by Fraser et al. (Fraser et al., 2013) can be found in the literature. These 
extreme values represent 0.05 and 1.3 % respectively when compared to the 
approximated concentration of 36 ng/g ΣFOSE reported here. 
The nature of the vacuumed dust, its particle size, the longevity of the vacuum 
cleaner bag containing the dust together with the bag itself, and its storage location 
are also factors to consider: Unlike the presumable exposure to settled dust is via 
ingestion, it won’t likely be the equivalent for long term vacuum cleaned dust. 
Vacuum cleaned dust can give a better estimation of the potential exposure of all the 
residence or all the cleaned rooms, but it will not reflect the overall time spent 
indoors, neither accuracy in sampling time lines (Harrad et al., 2010), fact which 
could lead to an under or overestimations in daily dust ingestion rates estimated for 
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this study. Besides, factors as ventilation, location of the residence and daily routines 
would affect and interfere in the temporal/seasonal concentration of PFOS and 
PFOS precursors in indoor environments, fact that might completely change the 
distribution pattern of the pollutants, especially for the more volatile ones (FOSEs). 
Significant differences and correlations between – individual and combined – 
concentrations of PFOS and PFOS precursors were evaluated versus the variables 
extracted from the personal, demographic and indoor questionnaires. Just a reduced 
number of significant differences were identified: 
- Age of the participants versus concentrations of PFOS (p < 0.01), MeFOSE 
(p < 0.05 )and ΣPFAS (p < 0.01). 
- Location of the residences according to industrial areas versus 
concentrations of EtFOSA (p < 0.01)and EtFOSE (p < 0.05). 
- Recent renovation of the kitchen and concentrations of EtFOSA (p < 0.01) 
and ΣPFAS (p < 0.01). 
 
These statistical differences could be consequence of a combination of differences 
related to trends in lifestyle related to age, such as the cleaning and ventilation 
frequencies, the age of the Gore-Tex® or Teflon® utensils in the residence, the 
number of hours spent indoors, the age of the house and/or refurbishments, etc., 
even though they did not show statistical significances as individual parameters and 
no principal component analysis (PCA) could be conducted due to the low score 
obtained when the Kaiser-Meyer-Olkin (KMO) test for sampling adequacy was 
performed. 
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Surprisingly, some of the indoor environment related questions for which direct and 
strong significant differences and/or correlations would have been expected, such 
as the ventilation frequency (especially for FOSEs), the use of Gore-Tex® clothing 
and water proof sprays, or the use of Teflon® kitchen utensils, showed no statistical 
difference, neither correlation. On the other hand, some other parameters like age 
(pre or post phase-out) and origin (Europe/America or Asia) of the furniture, floor, 
carpets or the waterproof clothing were not included in the indoor questionnaires, 
some of which could contribute to a deeper knowledge of indoor exposure origin. 
Still, and even several uncertainties remain unclear about the sources of PFOS and 
PFOS precursors, this research revealed that their presence in indoor dust is 
ubiquitous, even years after the restriction of POSF related products. Moreover, the 
presence of positive correlations among the reported concentrations (pairs PFOS – 
FOSA and EtFOSE – MeFOSE), suggested common sources of indoor contamination 
with PFASs, even though they could not be fully elucidated. 
 
8.2.2. FOSAs and FOSEs contribute to the overall external exposure to PFASs 
via indoor dust ingestion 
According to Vestergren et al. (Vestergren et al., 2008), relative contributions of 
direct and indirect exposure are dependent on the level of exposure: the relative 
contribution of high exposure scenario can be dominated by indirect exposure via 
dust ingestion (40 – 60 %), while for Gebbink et al. (Gebbink, Glynn and Berger, 
2015), in a high scenario exposure indirect exposure to PFOS would contribute 
around 33 %. 
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Estimated daily intakes (body weight corrected) for adults and children were 
calculated for all the individual analytes, and for the combination of all of them in 
both, median and high scenarios. For PFOS in adult population, daily intakes were 
estimated to be 0.56 and 7.37 pg/bw kg/day for mean and high scenarios, while for 
the overall exposure to PFASs they were 4.51 and 59.7 pg/bw kg/day. As already 
described in the previous hypothesis, PFASs concentrations – and subsequently, 
exposure – was dominated by precursors, but PFOS. For children, estimated daily 
intakes of PFOS ranged from 0.005 ng/kg bw/day (mean scenario, 5th percentile, 
from 3 to 6 years old) to 0.548 ng/kg bw/day (high scenario, 95th percentile, from 1 
to 2 years old), while for ΣPFAS they ranged from 0.082 to 2.612 ng/kg bw/day for 
the same scenarios, percentiles and ages, respectively. Estimated daily intakes for 
children were reported to be two orders of magnitude higher than the estimated in 
the high exposed scenario for adult population. 
The estimations reported in this thesis clearly evidence how lower body weights – 
younger children –, besides the higher ingestion of dust due to hand to mouth 
contact, contribute to higher daily intake of dust, and so, to the associated risk 
assessment concerns of PFOS and PFOS related compounds, such as FOSAs and 
FOSEs present in indoor dust. In addition to it, this research project also evidenced 
that expected patterns of indoor dust exposure for “commonly analysed” PFASs 
might not be valid if precursors are not included in the exposure models, because as 
shown for PFOS precursors, they contribute in a much higher proportion (88 %) to 
the external exposure to the PFASs selected for this study than PFOS itself, so even 
direct exposure to PFASs might be significantly underestimated. 
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8.2.3. Diet is a significant source of exposure to long chain PFASs such as PFOS, 
FOSAs, FOSAAs and FOSEs 
PFOS has shown to be present at detectable levels in food composites, even though 
nowadays the exposure pattern is dominated by PFOS precursors, as the data 
reported in this thesis revealed. PFOS was detected in seven solid food samples in a 
range between <LOQ and 0.054 ng/kg, while FOSA was detected in 18 samples in a 
range between <LOQ and 0.051 ng/kg, MeFOSE in 9 samples between <LOQ and 
42.302 ng/kg, EtFOSE between <LOQ and 53.125 ng/kg and MeFOSAA between 
<LOQ and 0.045 ng/kg. Detection frequencies for liquid food samples were too low 
to be included in the statistical analysis, as mentioned along the thesis. For the sum 
of all the investigated PFASs, an average concentration of 5.2 ng/kg was calculated 
and employed for the statistical analysis. 
Unlike in dust samples, age and gender did not seem to play a role in the reported 
concentrations of ΣPFAS in solid food composites. Moreover, no significant 
differences and/or positive correlations were identified when the samples were 
compared to energy, water, proteins, fats, carbohydrates, starches, sugars and 
fibres. Because of it, individual food items derived from the food diaries were 
evaluated, showing positive correlations for three items: 
- ΣPFAS versus the consumption of fish with high content in fat (p < 0.01). 
- ΣPFAS versus raw vegetables consumption (p < 0.01) 
-  ΣPFAS versus tomatoes and cucumbers consumption (p < 0.05). 
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The suspicious sources of contamination for oily fish, vegetables, cucumbers and 
tomatoes were evaluated, and two main explanations were proposed: food 
packaging and bioaccumulation. The second one would be more likely to occur in 
big animals, carnivores and high content in protein food, as reported by Haug et al. 
(Haug et al., 2010). Otherwise, the first one would be linked to the sample 
manipulation, transference from cooking utensils or food packaging, more than to 
the composition of the food item itself (Tittlemier, Pepper and Edwards, 2006; 
Noorlander et al., 2011). In view of these results, fatty fish consumption was 
expected to show positive correlations with the concentrations of ΣPFAS, especially 
when these types of fish are widely consumed in Scandinavian countries. Moreover, 
this finding was in agreement with the higher than average reported levels in fish 
samples by other authors (Berger et al., 2009; Haug et al., 2010; Hrádková et al., 
2010), reporting them as high potential sources of PFOS dietary exposure. On the 
other hand, no significant correlations were found for food packaging (plastics, 
paper, etc.), cooking (Teflon® pans, plastic or wooden utensils, etc.) and storage 
(plastic, glass, etc.) which could be considered as a source to FOSAs and FOSEs. Still, 
the positive correlation could be a consequence of an earlier contamination from the 
production stages, derived from the fact of not washing or peeling the food items 
before consumption, of from a combination of these with the ones not reporting 
significant differences, even when they were not showing significant differences as 
individual parameters. Unfortunately, no PCA could be conducted to further 
investigate these sources, due to the low score obtained when the KMO test for 
sampling adequacy was evaluated. 
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Some other parameters such as protein content in general, or individual food items 
rich in proteins (e.g. meats, eggs, or other types of fish) were expected to show 
strong significant differences or correlations, known the fact that PFASs tend to bind 
proteins. On the other hand, dairies (e.g. milk or liquid yogurts) and water would 
have been expected to show also strong correlations for the liquid food samples too, 
but they could not be evaluated due to the dilution of all the liquids as a composite 
sample, together with the incapability of pre-concentration of the samples as much 
as usually conducted for water samples. 
 
8.2.4. FOSAs, FOSEs and FOSAAs contribute to the overall external exposure 
to PFASs via food consumption 
Food consumption is well known to be an important source of direct exposure to 
PFOS and PFOS precursors, according to reported values in different food items and 
composites (Martin et al., 2004; Ericson, Nadal, et al., 2008; Kärrman et al., 2009; 
Haug et al., 2010; Noorlander et al., 2011; van Asselt et al., 2011; Domingo, 2012; 
Klenow et al., 2013; Rahman, Peldszus and Anderson, 2014; Gebbink et al., 2015). 
The estimation of the food daily intakes was evaluated for lower and medium 
bounds, with reported comparable daily intakes for both of them. For the solid food 
composites (n = 113) average daily intake in medium bound was 0.26 ng/kg bw/day 
(17.24 ng/day), while for the combination of solid and food composites (n = 94), its 
average was 0.29 ng/kg bw/day (19.30 ng/day). Average daily intake when 
concentrations from both days were averaged, was 0.24 ng/kg bw/day (15.6 
ng/day) in medium bound approach. These reported values are two orders of 
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magnitude higher than the previously ones described for dust samples (which were 
4.5 and 60.0 pg/kg bw/day for mean and high scenario approaches).These findings 
revealed important information about the overall understanding of PFASs exposure: 
- PFOS contributed less than 5 % to the overall exposure to ΣPFAS reported in 
this thesis. 
- Food contributeed around 98 % to the total external exposure to ΣPFAS 
included in this study. 
Moreover – as predicted – food could be considered the main source of external 
exposure to PFOS and especially, to PFOS precursors. 
 
8.2.5. PFOS is ubiquitous in serum 
PFOS has been extensively reported in human blood and serum samples for the last 
ten years, with reported detection frequencies up to 100 % in some studies, as Table 
07 from the Introduction chapter reflected. Nowadays, trends show decreasing 
concentrations in general population – as for all the environmental and biological 
matrices were PFOS is analysed–, but still and after more than 10 years after its 
restriction, PFOS concentrations reported in high percentages of the studied 
populations. 
For the present set of serum samples, ΣPFOS was detected in the 87 % of the 
analysed samples in an average concentration of 5.29 ng/mL (<LOQ – 16.52). The 
second most detected compound was MeFOSAA (23 % positive samples) with a 
mean concentration of 0.04 ng/mL (<LOD – 0.38). None of the other compounds was 
identified in detected frequencies higher than 5 %. 
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As for dust and food samples, statistical analysis for PFOS concentrations was 
conducted to further evaluate significant differences and correlations, in this case, 
by comparison with personal, demographic, indoor and food frequency 
questionnaires. Age and gender of the participants did not show significant 
differences, albeit clear trends could be identified: mean values were higher for 
participants aged over 50 years old, followed by these under 30, while lower 
concentrations were identified for the participants aged between 30 and 50 years 
old (see Figure 30). Similarly, mean concentration values for males were higher than 
for female participants. Such differences were attributed to different accumulation 
and elimination patterns for the female participants between 30 to 50 years old, as 
consequence of menstruation, birth-giving or breastfeeding. 
Significant differences and correlations between concentrations of ΣPFOS versus the 
variables extracted from the personal, demographic and indoor questionnaires 
were evaluated, and just a reduced number of significant differences were 
identified: 
- Significantly higher concentrations for participants living less than 50 metres 
from busy traffic roads (p < 0.05). 
- Significantly higher concentrations for participants with one or more animals 
in the house (p < 0.05). 
Besides these two demographic and personal differences, just egg consumption 
showed a positive correlation versus ΣPFOS concentrations (p = 0.05) when 
individual food items extracted from the food frequency questionnaires were 
evaluated. Such correlation was attributed to the nature of the food item itself, rich 
in proteins, which tends to retain PFASs. Similar correlations and differences were 
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expected to be evidenced for other food items such as meat, fish, cheese or dairies, 
all of them content rich in animal origin protein. Conversely, no statistical 
differences or correlations were identified. Food packaging (plastics, paper, etc.), 
cooking utensils (Teflon® pans, plastic or wooden utensils, etc.) and food storage 
containers (plastic, glass, etc.) were not included in the food frequency 
questionnaires, so they could not be evaluated. 
Besides PFOS, MeFOSAA was the second most detected analyte in serum samples. 
Its levels in human serum samples reported here are comparable with other studies 
reporting FOSAAs (Olsen et al., 2004; Lee and Mabury, 2011). 
The exposure pattern identified for serum samples from the A-TEAM cohort – higher 
detection frequencies of PFOS in serum when compared with these reported for 
indoor dust and diet composites, and lower for PFOS precursors than the ones 
reported for external exposure – leaded to the hypothesis which suggested that 
PFOS precursors were not detected in blood samples due to their previous 
metabolism to PFOS in the human body. 
 
8.2.6. PFOS branched isomer ratios in serum differ from the reported for 
environmental external exposure 
The expected ratio between linear:branched isomers for external exposure to PFOS 
is 70:30 (%), as in the manufactured product (Houde et al., 2008; Buck et al., 2011; 
Beesoon and Martin, 2015a). In order to verify or discard isomer specific 
degradation of the monitored PFOS precursors to PFOS in the environment, PFOS 
linear and branched isomers were reported for dust samples, and showing average 
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percentages of 69 % linear PFOS versus 31 % branched PFOS, as would correspond 
to the absence of environmental degradation. When the same analysis was 
conducted for serum samples, a few differences were observed: while average value 
for the estimated percentage of linear isomers remained 69 %, the range of 
percentages observed for the entire set of samples varied from 51 to 82 %, showing 
much more variability than the ones reported for dust samples. Moreover, trends 
(but no significant differences) were identified according to age and gender of the 
participants: male participants reported higher percentages of linear PFOS than 
females, showing these last ones different patterns according to age and lower 
percentage of branched isomers for women aged between 30 and 50 years old. This 
finding could suggest that different uptakes and elimination rates of linear and the 
different branched PFOS isomers could be even more relevant when considering the 
factors of menstruation, maternity and breastfeeding mentioned above. 
In conclusion, the information extracted from the evaluation of PFOS branched 
isomers in serum samples showed large interpersonal variability, even though still 
remained unclear if they are due to different patterns of exposure or – as most 
suggested – bioaccumulation. Moreover, this variability could be strongly influenced 
in case of females by factors as maternity or menstruation. 
 
8.2.7. FOSAs and FOSEs are rapidly metabolised to PFOS 
During the last 15 years, papers reporting in vitro studies of potential PFOS 
precursors including FOSA (Benskin, Holt and Martin, 2009; Ross, Wong and Martin, 
2012; Chen et al., 2015), EtFOSA (Tomy et al., 2004; Fu et al., 2015) and EtFOSE (Xu 
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et al., 2004; Zhao et al., 2016; Chang et al., 2017) have been published. Moreover, a 
few in vivo studies and results have been reported showing different conversion 
rates for these same compounds (Xie et al., 2009; Chen et al., 2015; Chang et al., 
2017). Nevertheless, some other substances still require further study to confirm 
them as sources of human exposure to PFOS. For that reason, MeFOSA and MeFOSE 
were chosen for a qualitative study of phase I & II metabolism and plausible 
conversion to FOSA. 
According to the results of these experiments – from the qualitative point of view – 
the data reported here was in line with previous published data from in vitro and in 
vivo studies for compounds as EtFOSA, EtFOSE and FOSA. In this case, kinetic was 
not studied as the experiments were just carried out for a short time period of two 
hours thus permitting only a qualitative perspective. 
Notwithstanding this, it is evident that there was rapid biotransformation of the two 
selected target PFOS precursors to PFOS, via the stable and detectable intermediate 
FOSA. The mechanisms leading to the formation of PFOS did not seem to occur in 
the same way for MeFOSA and MeFOSE. For MeFOSA, the demethylation to FOSA 
seemed to be fast, with the conversion from FOSA to PFOS the limiting step to the 
final conversion to PFOS, while for MeFOSE the conversion to FOSA seemed to be 
the limiting step, with a faster conversion of FOSA to PFOS, both of them taking into 
account the relative abundance of the involved and detected compounds. This could 
be established just as a rough approximation due to the lack of knowledge of the real 
kinetics of the proposed mechanisms and the relatively short incubation times. 
Overall, these experiments would make a contribution to testing that in vivo 
metabolism of precursors like FOSAs, FOSEs and FOSAAs to yield PFOS is viable, and 
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further studies are needed to better understanding their metabolism pathways and 
the overall internal exposure to PFOS. 
 
8.3. SUMMARY AND FINAL REMARKS 
In summary, findings from this thesis can be briefly listed as: 
- Food ingestion can be considered the primary source of direct exposure to 
PFOS precursors, via bioaccumulation or migration from food packaging, 
with an estimated daily intakes of 0.24 pg/kg bw/day for Norwegian adult 
population. 
- Dust can be considered as well a significant source of direct exposure to PFOS 
precursors and to PFOS itself, with estimated daily intakes for the studied 
population ranging from 4.5 to 60.0 pg/kg bw/day for mean and high 
scenarios, from which just 12 % is due to PFOS contamination. 
- Methylated PFOS precursors, as MeFOSA and MeFOSE are in vitro 
metabolised to PFOS, both via FOSA, a stable and well characterised 
intermediate during the metabolism to PFOS. 
- PFOS is the main contributor to the internal exposure to PFOS, with a 
reported average concentration for Norwegian population of 5.3 ng/mL in 
serum. 
- As a consequence of PFOS precursors metabolism and their significant 
presence in dust and food, these two matrices can be considered a significant 
source of indirect exposure to PFOS, with a relative contribution of 98 % 
from diet and 2 % from dust ingestion. 
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- PFOS branched isomers need further study. Different patterns in 
accumulation and elimination rates of the different isomers can lead to 
enrichment of sum of branched isomers in the human body. 
- Daily intake of PFOS and PFOS precursors for Norwegians has been 
estimated to be around 0.265 ng/kg bw/day for adult population when dust 
and food ingestion pathways were combined. Even though several 
uncertainties remain, these values can be considered safe according to the 
TDI of 150 ng/kg bw/day established by EFSA. 
 
8.4. RECOMMENDATIONS AND FUTURE WORK 
The elucidation of direct and indirect sources of exposure to PFOS, the 
understanding of the substances called PFOS precursors, together with the 
evaluation of the metabolism pathways leading to a better knowledge of PFOS body 
burdens are not an easy task. Several uncertainties remain unclear despite the 
growing number of available research moving towards their better understanding. 
 
According to the experience earned through the project development, some 
recommendations for future research projects within the same context this thesis 
was addressed would be: 
- The selection of a more representative cohort. The A-TEAM cohort was 
entirely constituted by workers from the NIPH, a research institute focused 
on health safety, and so, with poor representation of the general population 
in terms of educational level, concern and knowledge about exposure to 
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environmental pollutants, and socio-economical level. These parameters 
could lead to biased results and conclusions, being just representative of a 
specific part of the overall population. 
- To sample drinking water in an independent way than (liquid) food. Water is 
considered a very clean matrix and thus, easy to pre-concentrate in larger 
factors than any other liquid food item, such as juice or milk, which would 
require entirely different sample treatments. 
- The specific and independent analysis – besides the generic food composites 
– of relevant food items such as meat, fish, eggs, dairies and alternative 
sources of protein, to a better evaluation of PFOS precursors and PFOS 
isomers exposure in such matrices. 
- Food frequency questionnaires should include information relative to food 
packaging and cooking ware, to allow a better estimation of suspected 
migration from them to the food items. 
- Information about the age and the origin of specific clothes items, furniture, 
and other relevant materials could help to better understand suspected 
migration from them to dust. 
 
Consequently, further research should be addressed towards: 
- The analysis of current levels of FOSAs, FOSEs and FOSAAs in environmental 
matrices, indoor environments, food and human samples. They would 
provide a better estimation of real external exposure to pollutants which 
could potentially be metabolised to PFOS. 
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- The analysis of individual isomers of PFOS and PFOS precursors in 
representative matrices for internal exposure to PFOS. It would conduct to a 
better knowledge of their specific accumulation and elimination rates and so, 
to a better understanding of the behaviour of the individual PFOS isomers. 
- The instrumental development and the analysis of chiral signatures of PFOS 
isomers in both, external and internal exposure representative matrices. 
- The specific study of contamination derived from the migration of PFASs 
from food packing materials and cooking utensils, as well as the effect of 
washing, peeling and other cooking related processes, and the mechanisms 
involved. 
- The specific study of contamination derived from abrasion processes and 
aging of clothing, furniture and materials commonly present in indoor 
environments, their migration, and the mechanism involved. 
- The further study of the in vitro and in vivo metabolism of PFOS precursors 
(FOSAs and FOSEs) with the support of in silico approaches, which would 
allow a better understanding of the real kinetics and of the intermediate 
metabolites involved in the metabolic pathways leading to PFOS. 
- The better comprehension of the relative human metabolism and toxicity of 
individual PFOS isomers. 
- The evaluation of alternative sources of both, external and internal exposure 
to PFOS, e.g. the study of non-invasive internal exposure matrices. 
- The evaluation of the impact derived from the restricted use of long chain 
PFASs pro the short chain ones, such as perfluoroether carboxylic acids 
(PFECAs) and perfluoroether sulfonic acids (PFESAs). 
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SUPPLEMENTARY MATERIAL 
 
SUPPLEMENTARY TABLES 
Table SM01. Individual concentrations (ng/g) of PFASs in vacuum cleaner bag samples 
(n = 57) 
Sample  ΣPFOS FOSA MeFOSA EtFOSA MeFOSE EtFOSE 
01 2.347 0.331 <LOQ 45.939 2.574 <LOQ 
02 2.582 0.200 <LOQ 11.339 <LOQ <LOQ 
03 2.699 0.284 <LOQ 21.148 <LOQ <LOQ 
04 0.410 0.198 <LOQ <LOQ <LOQ <LOQ 
05 4.653 <LOQ 0.077 69.143 <LOQ 2.869 
06 3.267 0.327 <LOQ 21.586 <LOQ <LOQ 
07 3.316 0.263 <LOQ 44.137 <LOQ <LOQ 
08 5.974 0.221 <LOQ 83.522 <LOQ 4.688 
09 17.535 0.385 <LOQ 38.602 3.689 <LOQ 
10 3.359 0.447 <LOQ 73.070 <LOQ <LOQ 
11 3.958 0.149 5.528 11.538 <LOQ 1.465 
12 3.686 0.336 <LOQ 8.050 7.492 1.652 
13 0.823 0.103 <LOQ <LOQ <LOQ <LOQ 
14 3.591 0.517 5.695 142.788 13.053 3.076 
15 28.482 0.597 1.682 25.511 <LOQ 1.738 
16 11.375 0.131 <LOQ 33.144 <LOQ <LOQ 
17 1.977 0.183 <LOQ 46.599 <LOQ <LOQ 
18 3.393 0.208 <LOQ 56.777 <LOQ <LOQ 
19 4.270 0.468 <LOQ 33.113 <LOQ 5.441 
20 1.988 0.119 <LOQ 12.584 <LOQ <LOQ 
21 4.865 0.175 2.917 26.118 <LOQ 1.966 
22 0.714 0.165 <LOQ 69.960 <LOQ <LOQ 
23 5.683 0.212 0.106 39.703 <LOQ <LOQ 
24 1.522 0.381 <LOQ 24.183 <LOQ <LOQ 
25 17.537 0.726 <LOQ 39.431 <LOQ <LOQ 
26 70.716 0.585 <LOQ 15.807 <LOQ <LOQ 
27 4.054 0.467 <LOQ 30.647 9.630 <LOQ 
28 1.816 0.397 <LOQ 10.123 11.003 <LOQ 
29 2.552 0.516 <LOQ 19.762 <LOQ <LOQ 
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Sample ΣPFOS FOSA MeFOSA EtFOSA MeFOSE EtFOSE 
30 10.204 1.049 <LOQ 23.835 <LOQ <LOQ 
31 4.765 0.580 <LOQ 10.500 <LOQ <LOQ 
32 9.775 0.511 <LOQ 49.340 <LOQ 4.265 
33 11.998 0.929 <LOQ 35.312 <LOQ <LOQ 
34 4.154 0.632 <LOQ 62.702 <LOQ <LOQ 
35 28.963 2.501 <LOQ 11.636 <LOQ 11.836 
36 12.188 0.330 <LOQ 8.122 21.605 51.790 
37 17.015 0.479 <LOQ 8.772 99.795 <LOQ 
38 6.522 0.452 <LOQ 32.425 <LOQ 10.154 
39 3.676 0.344 <LOQ 8.791 <LOQ <LOQ 
40 40.454 0.863 4.005 61.700 <LOQ <LOQ 
41 8.521 0.191 <LOQ 31.784 <LOQ <LOQ 
42 1.469 0.438 <LOQ 30.776 10.311 <LOQ 
43 23.062 0.391 <LOQ 29.062 <LOQ 1.531 
44 3.978 0.358 0.077 34.153 3.555 <LOQ 
45 3.311 0.779 <LOQ 42.303 4.386 3.383 
46 3.758 0.398 <LOQ 23.998 <LOQ <LOQ 
47 6.863 0.574 <LOQ 26.057 86.011 122.808 
48 5.121 0.526 <LOQ 29.228 66.626 <LOQ 
49 5.453 0.240 <LOQ 45.873 839.095 231.684 
50 6.723 0.487 <LOQ 12.231 25.951 <LOQ 
51 5.180 0.447 <LOQ 24.973 24.360 83.423 
52 2.116 0.535 <LOQ 8.751 <LOQ <LOQ 
53 5.024 0.360 0.639 4.687 <LOQ 5.817 
54 4.449 0.341 <LOQ 18.156 33.594 87.307 
55 0.925 <LOQ <LOQ 2.780 63.479 13.676 
56 8.531 0.376 <LOQ 16.793 <LOQ <LOQ 
57 46.785 0.485 <LOQ 13.166 <LOQ <LOQ 
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Table SM2. Individual ratios of linear:branched PFOS isomers in vacuum cleaner bag 
samples (n = 57) 
Sample n-PFOS / ΣBr-PFOS n-PFOS (%) ΣBr-PFOS (%)    
01 2.16 68.33 31.67    
02 2.35 70.18 29.82    
03 2.88 74.24 25.76    
04 1.99 66.54 33.46    
05 2.39 70.48 29.52    
06 2.11 67.79 32.21    
07 2.68 72.81 27.19    
08 2.25 69.27 30.73    
09 2.15 68.28 31.72    
10 1.99 66.59 33.41    
11 2.03 66.98 33.02    
12 2.29 69.60 30.40    
13 1.91 65.59 34.41    
14 2.30 69.67 30.33    
15 1.89 65.37 34.63    
16 1.88 65.31 34.69    
17 1.89 65.37 34.63    
18 1.71 63.06 36.94    
19 2.22 68.92 31.08    
20 2.05 67.17 32.83    
21 1.77 63.94 36.06    
22 2.25 69.27 30.73    
23 2.51 71.51 28.49    
24 2.77 73.49 26.51    
25 2.22 68.95 31.05    
26 2.64 72.55 27.45    
27 2.14 68.13 31.87    
28 2.31 69.81 30.19    
29 2.95 74.67 25.33    
30 3.41 77.33 22.67    
31 2.17 68.45 31.55    
32 2.50 71.43 28.57    
33 2.57 72.00 28.00    
34 1.82 64.59 35.41    
35 2.87 74.19 25.81    
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Sample n-PFOS / ΣBr-PFOS n-PFOS (%) ΣBr-PFOS (%)    
36 2.42 70.75 29.25    
37 1.75 63.63 36.37    
38 2.50 71.43 28.57    
39 1.84 64.74 35.26    
40 1.96 66.27 33.73    
41 1.88 65.28 34.72    
42 2.51 71.53 28.47    
43 1.92 65.70 34.30    
44 2.46 71.12 28.88    
45 3.05 75.33 24.67    
46 3.12 75.71 24.29    
47 2.58 72.07 27.93    
48 2.21 68.82 31.18    
49 2.63 72.46 27.54    
50 1.67 62.58 37.42    
51 1.98 66.44 33.56    
52 2.59 72.12 27.88    
53 3.13 75.77 24.23    
54 1.89 65.42 34.58    
55 1.84 64.75 35.25    
56 2.39 70.49 29.51    
57 2.12 67.94 32.06    
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Table SM03. Individual estimated daily intakes of total PFOS and PFOS precursors 
(ng/kg bw/day) through dust ingestion for adults in mean scenario (4.15 mg 
dust/day) (n = 57) 
Sample ΣPFOS FOSA MeFOSA EtFOSA MeFOSE EtFOSE ∑PFAS 
01 1.60E-04 2.26E-05 3.38E-06 3.13E-03 1.76E-04 5.98E-05 3.55E-03 
02 1.60E-04 1.24E-05 3.07E-06 7.04E-04 1.08E-04 5.44E-05 1.04E-03 
03 3.05E-05 1.47E-05 3.68E-06 5.67E-05 1.29E-04 6.51E-05 3.00E-04 
04 3.12E-04 2.37E-06 5.18E-06 4.64E-03 1.17E-04 1.92E-04 5.27E-03 
05 1.60E-04 1.60E-05 2.42E-06 1.06E-03 8.51E-05 4.29E-05 1.36E-03 
06 3.45E-04 1.28E-05 2.86E-06 4.83E-03 1.01E-04 2.71E-04 5.56E-03 
07 1.20E-03 2.63E-05 3.38E-06 2.63E-03 2.52E-04 5.98E-05 4.17E-03 
08 2.89E-04 1.09E-05 4.03E-04 8.42E-04 1.27E-04 1.07E-04 1.78E-03 
09 2.43E-04 2.22E-05 3.27E-06 5.32E-04 4.95E-04 1.09E-04 1.40E-03 
10 4.96E-05 6.23E-06 2.98E-06 4.60E-05 1.05E-04 5.29E-05 2.63E-04 
11 2.67E-04 3.84E-05 4.23E-04 1.06E-02 9.70E-04 2.29E-04 1.25E-02 
12 1.72E-03 3.60E-05 1.01E-04 1.54E-03 1.05E-04 1.05E-04 3.60E-03 
13 6.96E-04 7.99E-06 3.03E-06 2.03E-03 1.06E-04 5.36E-05 2.89E-03 
14 1.27E-04 1.17E-05 3.17E-06 2.98E-03 1.11E-04 5.61E-05 3.29E-03 
15 2.08E-04 1.28E-05 3.03E-06 3.47E-03 1.06E-04 5.36E-05 3.86E-03 
16 1.18E-04 7.05E-06 2.94E-06 7.48E-04 1.03E-04 5.21E-05 1.03E-03 
17 2.44E-04 8.75E-06 1.46E-04 1.31E-03 8.72E-05 9.86E-05 1.89E-03 
18 5.60E-05 1.29E-05 3.89E-06 5.49E-03 1.37E-04 6.88E-05 5.77E-03 
19 4.30E-04 1.60E-05 7.98E-06 3.00E-03 1.32E-04 6.63E-05 3.65E-03 
20 8.29E-04 3.43E-05 2.34E-06 1.86E-03 8.22E-05 4.14E-05 2.85E-03 
21 2.91E-04 3.35E-05 3.55E-06 2.20E-03 6.91E-04 6.29E-05 3.28E-03 
22 1.08E-04 2.36E-05 2.94E-06 6.02E-04 6.54E-04 5.21E-05 1.44E-03 
23 1.45E-04 2.94E-05 2.82E-06 1.13E-03 9.91E-05 5.00E-05 1.45E-03 
24 7.39E-04 3.87E-05 3.74E-06 3.73E-03 1.32E-04 3.23E-04 4.97E-03 
25 6.93E-04 5.37E-05 2.86E-06 2.04E-03 1.01E-04 5.07E-05 2.94E-03 
26 2.23E-03 1.93E-04 3.81E-06 8.96E-04 1.34E-04 9.12E-04 4.37E-03 
27 3.01E-04 2.09E-05 2.29E-06 1.50E-03 8.04E-05 4.69E-04 2.37E-03 
28 1.66E-04 1.55E-05 2.24E-06 3.98E-04 7.87E-05 3.96E-05 7.00E-04 
29 3.18E-04 2.86E-05 6.13E-06 2.73E-03 2.84E-04 7.01E-05 3.44E-03 
30 1.14E-04 2.68E-05 1.70E-06 1.45E-03 1.51E-04 1.16E-04 1.86E-03 
31 2.70E-04 2.85E-05 3.55E-06 1.72E-03 1.25E-04 6.29E-05 2.21E-03 
32 1.47E-04 3.71E-05 3.43E-06 6.07E-04 1.21E-04 6.08E-05 9.75E-04 
33 3.67E-04 2.63E-05 4.67E-05 3.42E-04 1.27E-04 4.25E-04 1.33E-03 
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Sample ΣPFOS FOSA MeFOSA EtFOSA MeFOSE EtFOSE ∑PFAS 
34 1.84E-04 1.94E-05 3.38E-06 1.44E-03 1.19E-04 5.98E-05 1.83E-03 
35 2.38E-04 1.88E-05 3.55E-06 3.17E-03 1.25E-04 6.29E-05 3.61E-03 
36 2.73E-04 2.99E-05 3.17E-06 2.12E-03 1.11E-04 3.48E-04 2.89E-03 
37 1.17E-04 2.94E-05 3.81E-06 1.86E-03 1.34E-04 6.75E-05 2.21E-03 
38 3.59E-03 2.97E-05 2.51E-06 8.02E-04 8.82E-05 4.45E-05 4.55E-03 
39 6.15E-04 6.33E-05 2.98E-06 1.44E-03 1.05E-04 5.29E-05 2.28E-03 
40 1.64E-04 2.19E-05 2.42E-06 3.58E-03 8.51E-05 4.29E-05 3.89E-03 
41 3.25E-04 3.96E-05 3.38E-06 7.16E-04 1.19E-04 5.98E-05 1.26E-03 
42 2.47E-04 3.76E-05 2.94E-06 3.73E-03 1.03E-04 5.21E-05 4.17E-03 
43 5.76E-04 1.56E-05 2.34E-06 3.84E-04 1.02E-03 2.45E-03 4.45E-03 
44 7.37E-04 2.08E-05 2.14E-06 3.80E-04 4.32E-03 3.80E-05 5.50E-03 
45 1.77E-03 3.78E-05 1.75E-04 2.70E-03 7.62E-05 3.84E-05 4.80E-03 
46 5.63E-04 1.26E-05 3.27E-06 2.10E-03 1.15E-04 5.79E-05 2.85E-03 
47 7.64E-05 2.28E-05 2.57E-06 1.60E-03 5.36E-04 4.56E-05 2.28E-03 
48 1.37E-03 2.32E-05 2.94E-06 1.73E-03 1.03E-04 9.10E-05 3.32E-03 
49 4.53E-04 3.79E-05 3.27E-06 1.72E-03 5.68E-03 8.11E-03 1.60E-02 
50 2.84E-04 2.92E-05 2.75E-06 1.62E-03 3.70E-03 4.86E-05 5.68E-03 
51 2.84E-04 1.25E-05 2.57E-06 2.39E-03 4.36E-02 1.20E-02 5.84E-02 
52 4.00E-04 2.89E-05 2.94E-06 7.27E-04 1.54E-03 5.21E-05 2.75E-03 
53 3.59E-04 3.10E-05 3.43E-06 1.73E-03 1.69E-03 5.78E-03 9.60E-03 
54 2.98E-04 2.29E-05 3.32E-06 1.22E-03 2.25E-03 5.86E-03 9.65E-03 
55 3.08E-05 1.18E-06 1.65E-06 9.25E-05 2.11E-03 4.55E-04 2.69E-03 
56 4.61E-04 2.03E-05 2.67E-06 9.07E-04 9.40E-05 4.74E-05 1.53E-03 
57 2.67E-03 2.76E-05 2.82E-06 7.50E-04 9.91E-05 5.00E-05 3.60E-03 
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Table SM04. Individual estimated daily intakes of total PFOS and PFOS precursors 
(ng/kg bw/day) through dust ingestion for adults in high scenario (55 mg dust/day) 
(n = 57) 
Sample ΣPFOS FOSA MeFOSA EtFOSA MeFOSE EtFOSE ∑PFAS 
01 2.12E-03 2.98E-04 4.46E-05 4.14E-02 2.32E-03 7.91E-04 4.70E-02 
02 2.12E-03 1.64E-04 4.06E-05 9.31E-03 1.43E-03 7.20E-04 1.38E-02 
03 4.03E-04 1.94E-04 4.86E-05 7.50E-04 1.71E-03 8.61E-04 3.97E-03 
04 4.13E-03 3.14E-05 6.85E-05 6.13E-02 1.54E-03 2.54E-03 6.97E-02 
05 2.11E-03 2.12E-04 3.20E-05 1.40E-02 1.13E-03 5.67E-04 1.80E-02 
06 4.56E-03 1.69E-04 3.78E-05 6.38E-02 1.33E-03 3.58E-03 7.35E-02 
07 1.58E-02 3.47E-04 4.46E-05 3.48E-02 3.33E-03 7.91E-04 5.51E-02 
08 3.82E-03 1.44E-04 5.33E-03 1.11E-02 1.68E-03 1.41E-03 2.35E-02 
09 3.22E-03 2.94E-04 4.32E-05 7.03E-03 6.54E-03 1.44E-03 1.86E-02 
10 6.56E-04 8.24E-05 3.95E-05 6.09E-04 1.39E-03 6.99E-04 3.47E-03 
11 3.53E-03 5.07E-04 5.59E-03 1.40E-01 1.28E-02 3.02E-03 1.66E-01 
12 2.27E-02 4.76E-04 1.34E-03 2.03E-02 1.39E-03 1.39E-03 4.76E-02 
13 9.20E-03 1.06E-04 4.00E-05 2.68E-02 1.41E-03 7.09E-04 3.83E-02 
14 1.67E-03 1.55E-04 4.19E-05 3.94E-02 1.47E-03 7.42E-04 4.35E-02 
15 2.74E-03 1.69E-04 4.00E-05 4.59E-02 1.41E-03 7.09E-04 5.10E-02 
16 1.56E-03 9.32E-05 3.89E-05 9.89E-03 1.37E-03 6.89E-04 1.36E-02 
17 3.22E-03 1.16E-04 1.93E-03 1.73E-02 1.15E-03 1.30E-03 2.50E-02 
18 7.41E-04 1.71E-04 5.14E-05 7.26E-02 1.81E-03 9.10E-04 7.63E-02 
19 5.68E-03 2.12E-04 1.06E-04 3.97E-02 1.74E-03 8.77E-04 4.83E-02 
20 1.10E-02 4.54E-04 3.09E-05 2.46E-02 1.09E-03 5.48E-04 3.77E-02 
21 3.84E-03 4.43E-04 4.69E-05 2.91E-02 9.13E-03 8.31E-04 4.34E-02 
22 1.43E-03 3.12E-04 3.89E-05 7.95E-03 8.64E-03 6.89E-04 1.91E-02 
23 1.92E-03 3.89E-04 3.73E-05 1.49E-02 1.31E-03 6.61E-04 1.92E-02 
24 9.78E-03 5.11E-04 4.95E-05 4.93E-02 1.74E-03 4.26E-03 6.57E-02 
25 9.17E-03 7.09E-04 3.78E-05 2.70E-02 1.33E-03 6.70E-04 3.89E-02 
26 2.95E-02 2.55E-03 5.04E-05 1.19E-02 1.77E-03 1.21E-02 5.78E-02 
27 3.99E-03 2.76E-04 3.02E-05 1.98E-02 1.06E-03 6.21E-03 3.14E-02 
28 2.20E-03 2.06E-04 2.96E-05 5.26E-03 1.04E-03 5.24E-04 9.25E-03 
29 4.21E-03 3.79E-04 8.11E-05 3.61E-02 3.76E-03 9.27E-04 4.55E-02 
30 1.50E-03 3.54E-04 2.25E-05 1.92E-02 1.99E-03 1.54E-03 2.46E-02 
31 3.56E-03 3.77E-04 4.69E-05 2.28E-02 1.65E-03 8.31E-04 2.92E-02 
32 1.94E-03 4.91E-04 4.54E-05 8.02E-03 1.59E-03 8.04E-04 1.29E-02 
33 4.85E-03 3.47E-04 6.17E-04 4.52E-03 1.68E-03 5.61E-03 1.76E-02 
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Sample ΣPFOS FOSA MeFOSA EtFOSA MeFOSE EtFOSE ∑PFAS 
34 2.43E-03 2.56E-04 4.46E-05 1.91E-02 1.57E-03 7.91E-04 2.42E-02 
35 3.14E-03 2.49E-04 4.69E-05 4.19E-02 1.65E-03 8.31E-04 4.78E-02 
36 3.61E-03 3.96E-04 4.19E-05 2.80E-02 1.47E-03 4.60E-03 3.81E-02 
37 1.55E-03 3.89E-04 5.04E-05 2.46E-02 1.77E-03 8.93E-04 2.93E-02 
38 4.74E-02 3.92E-04 3.32E-05 1.06E-02 1.17E-03 5.88E-04 6.02E-02 
39 8.13E-03 8.37E-04 3.95E-05 1.90E-02 1.39E-03 6.99E-04 3.01E-02 
40 2.17E-03 2.89E-04 3.20E-05 4.73E-02 1.13E-03 5.67E-04 5.15E-02 
41 4.30E-03 5.23E-04 4.46E-05 9.47E-03 1.57E-03 7.91E-04 1.67E-02 
42 3.26E-03 4.97E-04 3.89E-05 4.93E-02 1.37E-03 6.89E-04 5.51E-02 
43 7.62E-03 2.06E-04 3.09E-05 5.08E-03 1.35E-02 3.24E-02 5.88E-02 
44 9.75E-03 2.75E-04 2.84E-05 5.03E-03 5.72E-02 5.02E-04 7.28E-02 
45 2.34E-02 5.00E-04 2.32E-03 3.57E-02 1.01E-03 5.08E-04 6.35E-02 
46 7.44E-03 1.67E-04 4.32E-05 2.77E-02 1.52E-03 7.65E-04 3.77E-02 
47 1.01E-03 3.01E-04 3.40E-05 2.12E-02 7.09E-03 6.03E-04 3.02E-02 
48 1.81E-02 3.07E-04 3.89E-05 2.28E-02 1.37E-03 1.20E-03 4.39E-02 
49 5.99E-03 5.01E-04 4.32E-05 2.27E-02 7.51E-02 1.07E-01 2.12E-01 
50 3.76E-03 3.86E-04 3.63E-05 2.14E-02 4.89E-02 6.43E-04 7.51E-02 
51 3.75E-03 1.65E-04 3.40E-05 3.15E-02 5.77E-01 1.59E-01 7.72E-01 
52 5.28E-03 3.82E-04 3.89E-05 9.61E-03 2.04E-02 6.89E-04 3.64E-02 
53 4.75E-03 4.10E-04 4.54E-05 2.29E-02 2.23E-02 7.65E-02 1.27E-01 
54 3.95E-03 3.02E-04 4.39E-05 1.61E-02 2.98E-02 7.75E-02 1.28E-01 
55 4.07E-04 1.56E-05 2.18E-05 1.22E-03 2.79E-02 6.02E-03 3.56E-02 
56 6.09E-03 2.69E-04 3.54E-05 1.20E-02 1.24E-03 6.26E-04 2.03E-02 
57 3.52E-02 3.65E-04 3.73E-05 9.92E-03 1.31E-03 6.61E-04 4.75E-02 
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Table SM07. Individual daily intakes of ΣPFAS for lower and medium bounds (ng/day 
and ng/kg bw/day) through solid food consumption (n = 113) 
 
Sample 
 
Day 
Daily intake 
(ng/day) 
lower bound 
Daily intake 
(ng/kg bw/day) 
lower bound 
∑PFAS 
(ng/kg) 
lower 
Daily intake 
(ng/day) 
medium bound 
Daily intake 
(ng/kg bw/day) 
medium bound 
∑PFAS (ng/kg) 
medium 
01FS15 1 0.038 0.0006 0.022 0.338 0.0055 0.198 
01FS25 2 0.000 0.0000 0.000 0.245 0.0040 0.178 
02FS15 1 0.045 0.0007 0.016 0.551 0.0082 0.192 
02FS25 2 0.000 0.0000 0.000 0.312 0.0047 0.178 
03FS15 1 0.000 0.0000 0.000 0.450 0.0080 0.178 
03FS25 2 0.000 0.0000 0.000 0.577 0.0103 0.178 
03FS25 2 47.398 0.8464 14.611 47.867 0.8548 14.756 
04FS15 1 0.026 0.0004 0.009 0.554 0.0089 0.185 
04FS25 2 0.000 0.0000 0.000 0.410 0.0066 0.178 
05FS15 1 0.053 0.0006 0.016 0.628 0.0074 0.192 
05FS25 2 0.000 0.0000 0.000 0.156 0.0018 0.178 
06FS15 1 0.037 0.0005 0.013 0.527 0.0073 0.189 
07FS15 1 0.228 0.0037 0.073 0.766 0.0126 0.245 
08FS15 1 0.205 0.0036 0.072 0.693 0.0122 0.245 
08FS25 2 0.000 0.0000 0.000 0.376 0.0066 0.178 
09FS15 1 0.092 0.0015 0.027 0.701 0.0111 0.203 
10FS15 1 0.000 0.0000 0.000 0.487 0.0071 0.178 
10FS25 2 0.000 0.0000 0.000 0.532 0.0077 0.178 
11FS15 1 0.012 0.0002 0.003 0.601 0.0107 0.179 
11FS25 2 0.000 0.0000 0.000 0.268 0.0048 0.178 
12FS15 1 0.035 0.0005 0.014 0.468 0.0068 0.190 
12FS25 2 0.000 0.0000 0.000 0.336 0.0049 0.178 
13FS15 1 0.028 0.0004 0.009 0.591 0.0087 0.185 
13FS25 2 0.000 0.0000 0.000 0.379 0.0056 0.178 
14FS15 1 0.018 0.0003 0.005 0.619 0.0095 0.181 
14FS25 2 0.000 0.0000 0.000 0.347 0.0053 0.178 
15FS15 1 3.271 0.0454 2.013 3.498 0.0486 2.153 
15FS25 2 0.000 0.0000 0.000 0.119 0.0017 0.178 
16FS25 2 0.000 0.0000 0.000 0.242 0.0030 0.178 
17FS15 1 1.787 0.0263 0.979 1.983 0.0292 1.086 
17FS25 2 0.000 0.0000 0.000 0.291 0.0043 0.178 
18FS15 1 65.402 0.9343 20.374 65.847 0.9407 20.513 
19FS15 1 0.000 0.0000 0.000 0.776 0.0094 0.178 
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Sample 
 
Day 
Daily intake 
(ng/day) 
lower bound 
Daily intake 
(ng/kg bw/day) 
lower bound 
∑PFAS 
(ng/kg) 
lower 
Daily intake 
(ng/day) 
medium bound 
Daily intake 
(ng/kg bw/day) 
medium bound 
∑PFAS (ng/kg) 
medium 
20FS25 2 23.848 0.4500 14.577 24.084 0.4544 14.722 
21FS15 1 157.046 2.8554 46.095 157.314 2.8603 46.174 
21FS25 2 0.000 0.0000 0.000 0.453 0.0082 0.178 
22FS15 1 41.007 0.4660 16.562 41.360 0.4700 16.704 
22FS25 2 0.033 0.0004 0.013 0.487 0.0055 0.187 
23FS15 1 0.008 0.0001 0.005 0.309 0.0053 0.181 
23FS25 2 0.000 0.0000 0.000 0.338 0.0058 0.178 
24FS15 1 0.000 0.0000 0.000 0.565 0.0081 0.178 
24FS25 2 0.000 0.0000 0.000 0.612 0.0087 0.178 
25FS15 1 174.814 2.3947 57.962 175.039 2.3978 58.037 
25FS25 2 0.000 0.0000 0.000 0.407 0.0056 0.178 
26FS05 2 0.000 0.0000 0.000 0.259 0.0047 0.178 
26FS15 1 0.000 0.0000 0.000 0.436 0.0079 0.178 
26FS25 2 0.000 0.0000 0.000 0.259 0.0036 0.178 
27FS15 1 0.000 0.0000 0.000 0.508 0.0071 0.178 
27FS25 2 0.000 0.0000 0.000 0.412 0.0076 0.178 
28FS15 1 61.038 1.1303 24.069 61.238 1.1340 24.147 
28FS25 2 0.000 0.0000 0.000 0.444 0.0049 0.178 
29FS15 1 0.000 0.0000 0.000 0.710 0.0079 0.178 
29FS25 2 18.051 0.1492 5.559 18.521 0.1531 5.704 
30FS15 1 0.000 0.0000 0.000 0.681 0.0074 0.178 
31FS15 1 0.000 0.0000 0.000 0.256 0.0049 0.178 
32FS15 1 0.000 0.0000 0.000 0.790 0.0065 0.178 
32FS25 2 0.000 0.0000 0.000 0.866 0.0149 0.178 
33FS15 1 0.000 0.0000 0.000 0.481 0.0083 0.178 
33FS25 2 0.000 0.0000 0.000 0.446 0.0074 0.178 
34FS15 1 417.347 6.9558 73.671 417.794 6.9632 73.750 
34FS25 2 0.000 0.0000 0.000 0.529 0.0093 0.178 
35FS15 1 0.000 0.0000 0.000 0.554 0.0097 0.178 
35FS25 2 0.000 0.0000 0.000 0.361 0.0059 0.178 
36FS15 1 0.000 0.0000 0.000 0.381 0.0062 0.178 
36FS25 2 0.000 0.0000 0.000 0.243 0.0042 0.178 
37FS15 1 0.000 0.0000 0.000 0.364 0.0063 0.178 
37FS25 2 0.000 0.0000 0.000 0.412 0.0063 0.178 
38FS15 1 0.000 0.0000 0.000 0.665 0.0102 0.178 
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Sample 
 
Day 
Daily intake 
(ng/day) 
lower bound 
Daily intake 
(ng/kg bw/day) 
lower bound 
∑PFAS 
(ng/kg) 
lower 
Daily intake 
(ng/day) 
medium bound 
Daily intake 
(ng/kg bw/day) 
medium bound 
∑PFAS (ng/kg) 
medium 
39FS15 1 0.000 0.0000 0.000 0.295 0.0055 0.178 
39FS25 2 0.000 0.0000 0.000 0.306 0.0057 0.178 
40FS15 1 0.000 0.0000 0.000 0.492 0.0060 0.178 
40FS25 2 0.027 0.0004 0.012 0.439 0.0064 0.186 
41FS15 1 0.000 0.0000 0.000 0.690 0.0100 0.178 
41FS25 2 0.049 0.0006 0.021 0.452 0.0053 0.196 
42FS15 1 0.000 0.0000 0.000 0.615 0.0072 0.178 
42FS25 2 0.000 0.0000 0.000 0.539 0.0088 0.178 
43FS15 1 0.000 0.0000 0.000 0.834 0.0137 0.178 
43FS25 2 131.949 2.1631 29.765 132.590 2.1736 29.910 
44FS15 1 22.220 0.3174 8.439 22.515 0.3216 8.551 
44FS25 2 0.000 0.0000 0.000 0.397 0.0057 0.178 
45FS15 1 0.000 0.0000 0.000 0.456 0.0052 0.178 
45FS25 2 0.000 0.0000 0.000 0.495 0.0056 0.178 
46FS15 1 0.000 0.0000 0.000 0.981 0.0102 0.178 
46FS25 2 153.615 1.6002 48.490 154.073 1.6049 48.634 
47FS15 1 0.000 0.0000 0.000 0.686 0.0072 0.178 
47FS25 2 85.696 0.9021 42.720 85.986 0.9051 42.865 
48FS15 1 199.095 3.1602 52.393 199.395 3.1650 52.472 
48FS25 2 0.000 0.0000 0.000 0.546 0.0087 0.178 
49FS15 1 0.029 0.0004 0.010 0.520 0.0065 0.186 
49FS25 2 96.272 1.2034 38.309 96.470 1.2059 38.388 
50FS15 1 0.000 0.0000 0.000 0.562 0.0080 0.178 
50FS25 2 0.000 0.0000 0.000 0.465 0.0066 0.178 
51FS15 1 0.000 0.0000 0.000 0.435 0.0069 0.178 
51FS25 2 0.000 0.0000 0.000 0.276 0.0044 0.178 
52FS15 1 0.000 0.0000 0.000 0.596 0.0080 0.178 
52FS25 2 0.000 0.0000 0.000 0.433 0.0058 0.178 
53FS15 1 38.893 0.4986 21.875 39.150 0.5019 22.019 
54FS15 1 0.000 0.0000 0.000 0.640 0.0080 0.178 
54FS25 2 0.000 0.0000 0.000 0.645 0.0081 0.178 
55FS15 1 96.852 1.3836 18.665 97.602 1.3943 18.809 
55FS25 2 0.000 0.0000 0.000 0.392 0.0056 0.178 
56FS15 1 0.000 0.0000 0.000 0.503 0.0084 0.178 
56FS25 2 44.692 0.7449 12.543 45.207 0.7534 12.688 
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Sample 
 
Day 
Daily intake 
(ng/day) 
lower bound 
Daily intake 
(ng/kg bw/day) 
lower bound 
∑PFAS 
(ng/kg) 
lower 
Daily intake 
(ng/day) 
medium bound 
Daily intake 
(ng/kg bw/day) 
medium bound 
∑PFAS (ng/kg) 
medium 
58FS15 1 0.000 0.0000 0.000 0.410 0.0066 0.178 
58FS25 2 0.000 0.0000 0.000 0.339 0.0055 0.178 
59FS15 1 0.065 0.0005 0.023 0.563 0.0045 0.197 
59FS25 2 0.000 0.0000 0.000 0.609 0.0049 0.178 
60FS15 1 0.000 0.0000 0.000 0.224 0.0029 0.178 
60FS25 2 16.502 0.2143 19.078 16.571 0.2152 19.157 
61FS15 1 0.000 0.0000 0.000 0.168 0.0021 0.178 
61FS25 2 0.000 0.0000 0.000 0.148 0.0018 0.178 
62FS15 1 0.000 0.0000 0.000 0.595 0.0081 0.178 
62FS25 2 0.000 0.0000 0.000 0.347 0.0047 0.178 
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Table SM08. Individual daily intakes of ΣPFAS for lower and medium bounds (ng/day and 
ng/kg bw/day) through liquid food consumption (n = 120) 
 
Sample 
 
Day 
Daily intake 
(ng day) 
lower bound 
Daily intake 
(ng/kg bw/day) 
lower bound 
∑PFAS 
(ng/L) 
lower 
Daily intake 
(ng day) 
medium bound 
Daily intake 
(ng/kg bw/day) 
medium bound 
∑PFAS 
(ng/L) 
medium 
01FL15 1 0.018 0.0003 0.022 0.050 0.0008 0.061 
01FL25 2 0.000 0.0000 0.000 0.034 0.0006 0.045 
02FL15 1 0.000 0.0000 0.000 0.062 0.0009 0.045 
02FL25 2 0.000 0.0000 0.000 0.041 0.0006 0.045 
03FL15 1 0.000 0.0000 0.000 0.077 0.0014 0.045 
03FL25 2 0.000 0.0000 0.000 0.083 0.0015 0.045 
04FL15 1 0.000 0.0000 0.000 0.079 0.0013 0.045 
04FL25 2 0.000 0.0000 0.000 0.062 0.0010 0.045 
05FL15 1 0.000 0.0000 0.000 0.087 0.0010 0.045 
05FL25 2 0.000 0.0000 0.000 0.038 0.0004 0.045 
06FL15 1 0.000 0.0000 0.000 0.072 0.0010 0.045 
06FL25 2 0.000 0.0000 0.000 0.060 0.0008 0.045 
07FL15 1 0.000 0.0000 0.000 0.107 0.0018 0.045 
07FL25 2 0.000 0.0000 0.000 0.084 0.0014 0.045 
08FL15 1 0.000 0.0000 0.000 0.066 0.0011 0.045 
08FL25 2 0.000 0.0000 0.000 0.046 0.0008 0.045 
09FL15 1 0.000 0.0000 0.000 0.080 0.0013 0.045 
09FL25 2 0.000 0.0000 0.000 0.060 0.0010 0.045 
10FL15 1 0.000 0.0000 0.000 0.092 0.0013 0.045 
10FL25 2 0.000 0.0000 0.000 0.092 0.0013 0.045 
11FL15 1 0.000 0.0000 0.000 0.122 0.0022 0.045 
11FL25 2 0.000 0.0000 0.000 0.050 0.0009 0.045 
12FL15 1 0.000 0.0000 0.000 0.078 0.0011 0.045 
12FL25 2 0.000 0.0000 0.000 0.052 0.0007 0.045 
13FL15 1 0.000 0.0000 0.000 0.085 0.0012 0.045 
13FL25 2 0.000 0.0000 0.000 0.069 0.0010 0.045 
14FL15 1 0.000 0.0000 0.000 0.107 0.0016 0.045 
14FL25 2 0.000 0.0000 0.000 0.074 0.0011 0.045 
15FL15 1 0.000 0.0000 0.000 0.033 0.0005 0.045 
15FL25 2 0.000 0.0000 0.000 0.053 0.0007 0.045 
16FL15 1 0.021 0.0003 0.015 0.083 0.0010 0.058 
16FL25 2 0.000 0.0000 0.000 0.056 0.0007 0.045 
17FL15 1 0.000 0.0000 0.000 0.055 0.0008 0.045 
17FL25 2 0.000 0.0000 0.000 0.035 0.0005 0.045 
18FL15 1 0.000 0.0000 0.000 0.079 0.0011 0.045 
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Sample 
 
Day 
Daily intake 
(ng day) 
lower bound 
Daily intake 
(ng/kg bw/day) 
lower bound 
∑PFAS 
(ng/L) 
lower 
Daily intake 
(ng day) 
medium bound 
Daily intake 
(ng/kg bw/day) 
medium bound 
∑PFAS 
(ng/L) 
medium 
18FL25 2 0.000 0.0000 0.000 0.140 0.0020 0.045 
19FL15 1 0.000 0.0000 0.000 0.152 0.0018 0.045 
19FL25 2 0.000 0.0000 0.000 0.142 0.0017 0.045 
20FL15 1 0.000 0.0000 0.000 0.069 0.0013 0.045 
20FL25 2 0.000 0.0000 0.000 0.027 0.0005 0.045 
21FL15 1 0.000 0.0000 0.000 0.102 0.0019 0.045 
21FL25 2 0.000 0.0000 0.000 0.071 0.0013 0.045 
22FL15 1 0.000 0.0000 0.000 0.085 0.0010 0.045 
22FL25 2 0.012 0.0001 0.006 0.096 0.0011 0.051 
23FL16 1 0.000 0.0000 0.000 0.036 0.0006 0.045 
23FL25 2 0.000 0.0000 0.000 0.056 0.0010 0.045 
24FL15 1 0.000 0.0000 0.000 0.099 0.0014 0.045 
24FL25 2 0.000 0.0000 0.000 0.096 0.0014 0.045 
25FL15 1 0.000 0.0000 0.000 0.083 0.0011 0.045 
25FL25 2 0.004 0.0001 0.003 0.076 0.0010 0.047 
26FL15 1 0.000 0.0000 0.000 0.098 0.0018 0.045 
26FL25 2 0.000 0.0000 0.000 0.057 0.0010 0.045 
27FL15 1 0.000 0.0000 0.000 0.079 0.0011 0.045 
27FL25 2 0.000 0.0000 0.000 0.080 0.0011 0.045 
28FL15 1 0.000 0.0000 0.000 0.063 0.0012 0.045 
28FL25 2 0.000 0.0000 0.000 0.070 0.0013 0.045 
29FL15 1 0.000 0.0000 0.000 0.116 0.0013 0.045 
29FL25 2 0.000 0.0000 0.000 0.093 0.0010 0.045 
30FL15 1 0.000 0.0000 0.000 0.059 0.0006 0.045 
30FL25 2 0.000 0.0000 0.000 0.076 0.0008 0.045 
31FL15 1 0.000 0.0000 0.000 0.037 0.0007 0.045 
31FL25 2 0.000 0.0000 0.000 0.023 0.0004 0.045 
32FL15 1 0.000 0.0000 0.000 0.138 0.0011 0.045 
32FL25 2 0.000 0.0000 0.000 0.190 0.0016 0.045 
33FL15 1 0.000 0.0000 0.000 0.081 0.0014 0.045 
33FL25 2 0.000 0.0000 0.000 0.081 0.0014 0.045 
34FL15 1 0.000 0.0000 0.000 0.180 0.0030 0.045 
34FL25 2 0.000 0.0000 0.000 0.110 0.0018 0.045 
35FL15 1 0.000 0.0000 0.000 0.089 0.0016 0.045 
35FL25 2 0.000 0.0000 0.000 0.056 0.0010 0.045 
36FL15 1 0.000 0.0000 0.000 0.047 0.0008 0.045 
36FL25 2 0.000 0.0000 0.000 0.025 0.0004 0.045 
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Sample 
 
Day 
Daily intake 
(ng day) 
lower bound 
Daily intake 
(ng/kg bw/day) 
lower bound 
∑PFAS 
(ng/L) 
lower 
Daily intake 
(ng day) 
medium bound 
Daily intake 
(ng/kg bw/day) 
medium bound 
∑PFAS 
(ng/L) 
medium 
37FL15 1 0.198 0.0034 0.131 0.251 0.0043 0.166 
37FL25 2 0.000 0.0000 0.000 0.070 0.0012 0.045 
38FL15 1 0.000 0.0000 0.000 0.073 0.0011 0.045 
38FL25 2 0.000 0.0000 0.000 0.071 0.0011 0.045 
39FL15 1 0.038 0.0007 0.032 0.090 0.0017 0.076 
39FL25 2 0.000 0.0000 0.000 0.047 0.0009 0.045 
40FL15 1 0.000 0.0000 0.000 0.065 0.0008 0.045 
40FL25 2 0.000 0.0000 0.000 0.062 0.0008 0.045 
41FL15 1 0.043 0.0006 0.015 0.170 0.0025 0.059 
41FL25 2 0.000 0.0000 0.000 0.080 0.0012 0.045 
42FL15 1 0.216 0.0025 0.147 0.280 0.0033 0.191 
42FL25 2 41.044 0.4829 19.545 41.087 0.4834 19.565 
43FL15 1 0.000 0.0000 0.000 0.138 0.0023 0.045 
43FL25 2 0.000 0.0000 0.000 0.148 0.0024 0.045 
44FL15 1 0.000 0.0000 0.000 0.071 0.0010 0.045 
44FL25 2 0.000 0.0000 0.000 0.063 0.0009 0.045 
45FL15 1 0.000 0.0000 0.000 0.072 0.0008 0.045 
45FL25 2 0.000 0.0000 0.000 0.093 0.0011 0.045 
46FL15 1 0.000 0.0000 0.000 0.177 0.0018 0.045 
46FL25 2 0.000 0.0000 0.000 0.115 0.0012 0.045 
47FL15 1 0.000 0.0000 0.000 0.088 0.0009 0.045 
47FL25 2 0.000 0.0000 0.000 0.047 0.0005 0.045 
48FL15 1 0.000 0.0000 0.000 0.126 0.0020 0.045 
48FL25 2 0.000 0.0000 0.000 0.129 0.0020 0.045 
49FL15 1 0.000 0.0000 0.000 0.091 0.0011 0.045 
49FL25 2 0.000 0.0000 0.000 0.077 0.0010 0.045 
50FL15 1 0.932 0.0133 0.365 1.044 0.0149 0.409 
50FL25 2 0.000 0.0000 0.000 0.079 0.0011 0.045 
51FL15 1 0.000 0.0000 0.000 0.082 0.0013 0.045 
51FL25 2 0.000 0.0000 0.000 0.021 0.0003 0.045 
52FL15 1 0.000 0.0000 0.000 0.113 0.0015 0.045 
52FL25 2 0.000 0.0000 0.000 0.079 0.0011 0.045 
53FL15 1 3.904 0.0500 2.767 3.964 0.0508 2.809 
53FL25 2 0.000 0.0000 0.000 0.038 0.0005 0.045 
54FL15 1 0.000 0.0000 0.000 0.083 0.0010 0.045 
54FL25 2 0.000 0.0000 0.000 0.081 0.0010 0.045 
55FL15 1 0.000 0.0000 0.000 0.129 0.0018 0.045 
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Sample 
 
Day 
Daily intake 
(ng day) 
lower bound 
Daily intake 
(ng/kg bw/day) 
lower bound 
∑PFAS 
(ng/L) 
lower 
Daily intake 
(ng day) 
medium bound 
Daily intake 
(ng/kg bw/day) 
medium bound 
∑PFAS 
(ng/L) 
medium 
55FL25 2 0.000 0.0000 0.000 0.057 0.0008 0.045 
56FL15 1 0.000 0.0000 0.000 0.083 0.0014 0.045 
56FL25 2 0.000 0.0000 0.000 0.100 0.0017 0.045 
58FL15 1 0.000 0.0000 0.000 0.051 0.0008 0.045 
58FL25 2 0.000 0.0000 0.000 0.057 0.0009 0.045 
59FL15 1 0.000 0.0000 0.000 0.092 0.0007 0.045 
59FL25 2 0.000 0.0000 0.000 0.133 0.0011 0.045 
60FL15 1 0.000 0.0000 0.000 0.024 0.0003 0.045 
60FL25 2 0.000 0.0000 0.000 0.024 0.0003 0.045 
61FL25 2 0.000 0.0000 0.000 0.040 0.0005 0.045 
62FL25 2 0.000 0.0000 0.000 0.055 0.0007 0.045 
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Table SM09. Individual daily intakes of ΣPFAS for lower and medium bounds (ng/day and 
ng/kg bw/day) through combined solid and food consumption when the average 
concentrations of day 1 and day 2 were considered (n = 47) 
 
Sample 
Daily intake 
(ng/day) 
lower bound 
Daily intake 
(ng/kg bw/day) 
lower bound 
∑PFAS 
(ng/kg) 
lower 
Daily intake 
(ng/day) 
medium bound 
Daily intake 
ng/kg bw/day 
medium bound 
∑PFAS 
(ng/kg) 
medium 
01FS15 0.0 0.000 0.022 0.3 0.005 0.241 
02FS15 0.0 0.000 0.008 0.4 0.006 0.229 
04FS15 0.0 0.000 0.004 0.5 0.009 0.226 
05FS15 0.0 0.000 0.008 0.4 0.007 0.230 
08FS15 0.1 0.001 0.036 0.5 0.006 0.256 
10FS15 0.0 0.000 0.000 0.5 0.008 0.222 
11FS15 0.0 0.000 0.002 0.5 0.008 0.223 
12FS15 0.0 0.000 0.007 0.4 0.007 0.229 
13FS15 0.0 0.000 0.004 0.5 0.008 0.226 
14FS15 0.0 0.000 0.003 0.5 0.008 0.224 
15FS15 1.1 0.019 1.007 1.3 0.023 1.210 
17FS15 0.7 0.010 0.490 0.9 0.013 0.676 
21FS15 56.8 0.835 23.047 57.2 0.841 23.220 
22FS15 18.4 0.283 8.290 18.9 0.290 8.493 
23FS15 0.0 0.000 0.002 0.3 0.004 0.224 
24FS15 0.0 0.000 0.000 0.6 0.008 0.222 
25FS15 63.7 0.937 28.982 64.1 0.942 29.153 
26FS15 0.0 0.000 0.000 0.4 0.006 0.222 
27FS15 0.0 0.000 0.000 0.5 0.006 0.222 
28FS15 24.1 0.439 12.034 24.5 0.445 12.207 
29FS15 8.3 0.151 2.780 8.9 0.162 2.985 
32FS15 0.0 0.000 0.000 0.9 0.011 0.222 
33FS15 0.0 0.000 0.000 0.5 0.008 0.222 
34FS15 139.4 1.991 36.836 140.0 2.000 37.009 
35FS15 0.0 0.000 0.000 0.5 0.006 0.222 
36FS15 0.0 0.000 0.000 0.3 0.005 0.222 
37FS15 0.1 0.002 0.066 0.5 0.007 0.283 
39FS15 0.0 0.000 0.016 0.3 0.006 0.238 
40FS15 0.0 0.000 0.006 0.5 0.005 0.227 
41FS15 0.0 0.001 0.018 0.6 0.007 0.238 
42FS15 24.8 0.476 9.846 25.3 0.486 10.056 
43FS15 57.8 0.478 14.883 58.6 0.484 15.088 
44FS15 8.3 0.143 4.219 8.7 0.149 4.409 
45FS15 0.0 0.000 0.000 0.5 0.008 0.222 
46FS15 92.4 1.621 24.245 93.2 1.635 24.451 
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Sample 
Daily intake 
(ng/day) 
lower bound 
Daily intake 
(ng/kg bw/day) 
lower bound 
∑PFAS 
(ng/kg) 
lower 
Daily intake 
(ng/day) 
medium bound 
Daily intake 
ng/kg bw/day 
medium bound 
∑PFAS 
(ng/kg) 
medium 
47FS15 39.9 0.654 21.360 40.3 0.661 21.566 
48FS15 82.5 1.423 26.197 83.1 1.432 26.370 
49FS15 43.5 0.669 19.160 43.8 0.675 19.332 
50FS15 0.5 0.009 0.183 1.0 0.019 0.405 
51FS15 0.0 0.000 0.000 0.4 0.004 0.222 
52FS15 0.0 0.000 0.007 0.6 0.009 0.229 
54FS15 0.0 0.000 0.000 0.6 0.007 0.222 
55FS15 27.0 0.443 9.332 27.6 0.453 9.538 
56FS15 16.4 0.235 6.272 17.0 0.242 6.477 
58FS15 0.0 0.000 0.000 0.4 0.004 0.222 
59FS15 0.0 0.000 0.011 0.7 0.007 0.232 
60FS15 7.6 0.080 9.539 7.8 0.082 9.712 
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 283 
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Table SM14. Individual ratios of linear:branched PFOS isomers in serum samples (n = 40) 
Sample n-PFOS / ΣBr-PFOS n-PFOS (%) ΣBr-PFOS (%)    
01 1.22 54.87 45.13    
02 1.06 51.41 48.59    
03 4.49 81.79 18.21    
04 2.59 72.15 27.85    
05 2.40 70.62 29.38    
06 2.64 72.56 27.44    
07 1.99 66.56 33.44    
08 4.60 82.15 17.85    
09 2.15 68.23 31.77    
10 3.02 75.12 24.88    
11 1.26 55.74 44.26    
12 2.09 67.64 32.36    
13 2.88 74.20 25.80    
14 2.14 68.14 31.86    
15 1.75 1.99 36.35    
16 2.62 2.17 27.64    
18 2.37 1.82 29.66    
19 2.21 2.42 31.17    
20 2.51 1.75 28.49    
21 3.53 77.93 22.07    
22 1.22 54.87 45.13    
23 1.06 51.41 48.59    
24 4.49 81.79 18.21    
25 2.59 72.15 27.85    
26 2.40 70.62 29.38    
27 2.64 72.56 27.44    
28 1.99 66.56 33.44    
29 4.60 82.15 17.85    
30 2.15 68.23 31.77    
31 3.02 75.12 24.88    
32 1.26 55.74 44.26    
33 2.09 67.64 32.36    
34 2.88 74.20 25.80    
35 2.14 68.14 31.86    
36 1.75 63.65 36.35    
37 2.62 72.36 27.64    
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Sample n-PFOS / ΣBr-PFOS n-PFOS (%) ΣBr-PFOS (%)    
38 2.37 70.34 29.66    
39 2.21 68.83 31.17    
40 1.82 64.51 35.49    
41 3.53 77.93 22.07    
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Table SM15. Individual daily intakes of ΣPFAS (ng/day and ng/kg bw/day) through dust 
and food ingestion (n = 46) 
Sample 
Sum dust + food 
(ng/day) 
Sum dust + food 
(ng/kg bw/day) 
01 0.497 0.008 
02 0.468 0.007 
04 0.494 0.009 
05 0.746 0.012 
08 0.877 0.012 
10 0.880 0.010 
11 0.589 0.010 
12 0.504 0.008 
13 0.514 0.007 
14 1.231 0.022 
17 1.176 0.017 
21 57.391 0.883 
22 18.923 0.270 
23 0.468 0.006 
24 0.917 0.017 
25 64.287 1.169 
26 0.530 0.010 
27 0.738 0.008 
28 24.861 0.303 
29 9.093 0.157 
32 1.084 0.016 
33 0.569 0.009 
34 140.286 2.551 
35 0.679 0.009 
36 0.577 0.008 
37 0.764 0.014 
39 0.862 0.009 
40 0.666 0.007 
41 0.713 0.008 
42 25.734 0.271 
43 58.794 0.933 
44 8.841 0.111 
45 0.735 0.011 
46 93.366 1.796 
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Sample 
Sum dust + food 
(ng/day) 
Sum dust + food 
(ng/kg bw/day) 
47 40.527 0.335 
48 83.199 1.434 
49 44.853 0.712 
50 1.448 0.019 
51 5.019 0.063 
52 0.794 0.011 
54 1.183 0.020 
55 27.667 0.461 
56 17.050 0.299 
58 0.968 0.016 
59 0.995 0.008 
60 7.881 0.102 
 
 
  
SUPPLEMENTARY FIGURES 
 
Figure SM01. Box plot showing significant differences (p < 0.05) found among the three 
groups of ages when the concentrations of individual MeFOSE in dust was considered 
 
Figure SM02. Box plot showing increasing concentrations of FOSA according to the age of 
the participants in dust samples, even though no significant differences were found 
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Figure SM03. Box plot showing significant differences (p < 0.05) between the participants 
whose residences were close to industrial areas the ones not when the concentrations of 
individual EtFOSE in dust samples were considered 
 
Figure SM04. Scatter plot with trends of levels of PFOS in blood for female participants of 
the cohort according to age 
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Figure SM5. Scatter plots with trends of percentages of branched PFOS in blood according 
to their fat, fibre, carbohydrates and proteins from the FFQ. No significant differences were 
identified 
 
5 
 
Figure 02. Sources of PFOS and PFOS precursors according to their synthesis processes 
 
PFASs synthesis routes have been well described by Lehmler et al. (Lehmler et al., 
2010). The two main processes are electro-chemical fluorination (ECF) (3M, 1999), 
and telomerisation (Schulz et al., 2011), with POSF synthesised via ECF. In this 
process, a straight chain hydrocarbon is reacted with H and F atoms and electricity 
to substitute all of the hydrogen atoms with fluorine (Kissa, 2001) in a reaction 
common for different chain length as shown in Equation 01, where n is the number 
of carbons in the alkyl chain. Reaction yields are chain-length dependent, being 
lower as the number of carbons increases. This constitutes the main process of POSF 
synthesis (around 12 % yield), generating about 70 % of the straight chain product 
with the remainder comprised of branched and cyclic isomers (Paul, Jones and 
Sweetman, 2009). POSF can then be used in a series of reactions via N-methyl and 
N-ethyl perfluorooctane sulfonamide (N-MeFOSA and N-EtFOSA) to yield N-methyl 
and N-ethyl perfluorooctane sulfonamidoethanols (N-MeFOSE and N-EtFOSE), 
25 
 
Figure 03. Schematic overview of the processes leading to PFOS from PFOS precursors 
exposure 
 
1.5 HUMAN BIOMONITORING DATA 
With respect to human biomonitoring, concentrations of PFASs in human blood 
(whole blood, plasma and serum) in the general population have been reviewed 
recently (Fromme et al., 2009; Angerer et al., 2011) (Table 07). Most human 
biomonitoring studies are not carried out on whole blood, but on serum. The first 
reported concentrations of PFOS in blood were published by Hansen et al. (Hansen 
et al., 2001). This study showed 100 % of the blood samples contained PFOS at 
concentrations ranging from 6.7 to 81.5 ng/mL. Following this seminal report, 
concern about how PFOS enters and remains in the human body increased, leading 
to the publication of a number of studies, each based on the analysis of a large 
number of blood samples. Amongst the most relevant of these are those of Calafat et 
al. and Kato et al. (Calafat, Kuklenyik, et al., 2007; Calafat, Wong, et al., 2007; Kato et 
45 
composites, liquid food composites and serum. I will also report their concentration 
in the representative matrices. I will study the in vitro metabolism of selected PFOS 
precursors and propose pathways for their internal conversion to PFOS. Finally, I 
will combine all the exposure data and I will evaluate whether the levels at which 
PFOS and PFOS precursors are present in external matrices contribute to the body 
burdens of PFOS. 
 
 
Figure 05. Graphical overview of the main objectives of the A-TEAM project 
 
 
 
Figure 06. Graphical overview of the main goals of the present thesis project 
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Figure 07. Schematic overview of the sample treatment employed for the analysis of dust 
samples. The shadowing indicates which parts of the sample preparation and acquisition 
methods have been improved and optimised from previously published methods, or 
developed for the first time 
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Figure 08. Schematic overview of the sample treatment employed for the analysis of solid 
food samples. The shadowing indicates which parts of the sample preparation and 
acquisition methods have been improved and optimised from previously published 
methods, or developed for the first time 
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Figure 09. Schematic overview of the sample treatment employed for the analysis of liquid 
food samples. The shadowing indicates which parts of the sample preparation and 
acquisition methods have been improved and optimised from previously published 
methods, or developed for the first time 
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Figure 10. Schematic overview of the sample treatment employed for the analysis of serum 
samples. The shadowing indicates which parts of the sample preparation and acquisition 
methods have been improved and optimised from previously published methods, or 
developed for the first time 
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Figure 18. Different exposure profiles, expressed as percentage of ΣPFAS, for PFOS, FOSAs 
and FOSEs , where n = 45 (Goosey & Harrad), n = 41 (Haug et al.) and n = 57 (this study). 
The relative abundances differ substantially among the three studies 
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of such software, the increasing number of database sets available, together with the 
availability of HRMS techniques and methodologies allow the identification of: a) 
predicted metabolites generated by the in silico software by a targeted 
quantification or targeted screening approaches, and b) “unpredicted” metabolites 
by non targeted screening and even retrospective screening (Ballesteros-Gómez et 
al., 2015; Negreira et al., 2016). 
The growing in silico approaches together with the current uncertainties related to 
the metabolism of the selected perfluoroalkyl compounds provide evidence about 
the need to further study of these PFOS precursors substances. However, to date 
only a few papers examining in vitro and in vivo metabolism pathways of FOSAs and 
FOSEs leading to PFOS have been published. On this paper, qualitative evaluation of 
phase I and phase II metabolism of MeFOSA, MeFOSA and MeFOSAA incubated with 
human liver microsomes is presented (see Figure 25). 
 
 
Figure 25. General workflow used for the study of phase I & II metabolism for MeFOSA, 
MeFOSE and MeFOSAA incubated with human liver microsomes 
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M9 intermediate by an oxidative dealkylation of MeFOSE M6 intermediate – 
detected – formed as a consequence of a previous demethylation of the parent 
compound. 
 
 
Figure 26. Overlapped XIC chromatograms of the main metabolites detected for MeFOSE 
 
 
 
Figure 27. Suggested possibilities for the observed metabolism of MeFOSE 
  
 166 
identified compound did not seem to have relation with the other discovered 
metabolites, so was discarded. 
 
 
Figure 28 Overlapped XIC chromatograms of the main metabolites detected for MeFOSA 
 
 
Figure 29. Suggested possibilities for the observed metabolism of MeFOSA 
 
Figure 29 shows the scheme of the two suggested routes for MeFOSA metabolism, 
one of them leading to PFOS as end-product, and the second one leading to a second 
product M29, without possibility to track its possible conversion to PFOS. For the 
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Figure 34. Box plots representing the percentages of linear and branched PFOS isomers 
identified in the serum samples (n = 40), where the yellow lines represent the theoretical 
percentage of the commercial PFOS mixture (70 % linear and 30 % branched isomers) 
 
 
Figure 35. Box plots showing the percentages of branched PFOS isomers for male and 
female participants identified in the serum samples 
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Figure 02. Sources of PFOS and PFOS precursors according to their synthesis processes 
 
PFASs synthesis routes have been well described by Lehmler et al. (Lehmler et al., 
2010). The two main processes are electro-chemical fluorination (ECF) (3M, 1999), 
and telomerisation (Schulz et al., 2011), with POSF synthesised via ECF. In this 
process, a straight chain hydrocarbon is reacted with H and F atoms and electricity 
to substitute all of the hydrogen atoms with fluorine (Kissa, 2001) in a reaction 
common for different chain length as shown in Equation 01, where n is the number 
of carbons in the alkyl chain. Reaction yields are chain-length dependent, being 
lower as the number of carbons increases. This constitutes the main process of POSF 
synthesis (around 12 % yield), generating about 70 % of the straight chain product 
with the remainder comprised of branched and cyclic isomers (Paul, Jones and 
Sweetman, 2009). POSF can then be used in a series of reactions via N-methyl and 
N-ethyl perfluorooctane sulfonamide (N-MeFOSA and N-EtFOSA) to yield N-methyl 
and N-ethyl perfluorooctane sulfonamidoethanols (N-MeFOSE and N-EtFOSE), 
25 
 
Figure 03. Schematic overview of the processes leading to PFOS from PFOS precursors 
exposure 
 
1.5 HUMAN BIOMONITORING DATA 
With respect to human biomonitoring, concentrations of PFASs in human blood 
(whole blood, plasma and serum) in the general population have been reviewed 
recently (Fromme et al., 2009; Angerer et al., 2011) (Table 07). Most human 
biomonitoring studies are not carried out on whole blood, but on serum. The first 
reported concentrations of PFOS in blood were published by Hansen et al. (Hansen 
et al., 2001). This study showed 100 % of the blood samples contained PFOS at 
concentrations ranging from 6.7 to 81.5 ng/mL. Following this seminal report, 
concern about how PFOS enters and remains in the human body increased, leading 
to the publication of a number of studies, each based on the analysis of a large 
number of blood samples. Amongst the most relevant of these are those of Calafat et 
al. and Kato et al. (Calafat, Kuklenyik, et al., 2007; Calafat, Wong, et al., 2007; Kato et 
45 
composites, liquid food composites and serum. I will also report their concentration 
in the representative matrices. I will study the in vitro metabolism of selected PFOS 
precursors and propose pathways for their internal conversion to PFOS. Finally, I 
will combine all the exposure data and I will evaluate whether the levels at which 
PFOS and PFOS precursors are present in external matrices contribute to the body 
burdens of PFOS. 
 
 
Figure 05. Graphical overview of the main objectives of the A-TEAM project 
 
 
 
Figure 06. Graphical overview of the main goals of the present thesis project 
  
62 
 
Figure 07. Schematic overview of the sample treatment employed for the analysis of dust 
samples. The shadowing indicates which parts of the sample preparation and acquisition 
methods have been improved and optimised from previously published methods, or 
developed for the first time 
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Figure 08. Schematic overview of the sample treatment employed for the analysis of solid 
food samples. The shadowing indicates which parts of the sample preparation and 
acquisition methods have been improved and optimised from previously published 
methods, or developed for the first time 
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Figure 09. Schematic overview of the sample treatment employed for the analysis of liquid 
food samples. The shadowing indicates which parts of the sample preparation and 
acquisition methods have been improved and optimised from previously published 
methods, or developed for the first time 
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Figure 10. Schematic overview of the sample treatment employed for the analysis of serum 
samples. The shadowing indicates which parts of the sample preparation and acquisition 
methods have been improved and optimised from previously published methods, or 
developed for the first time 
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Figure 18. Different exposure profiles, expressed as percentage of ΣPFAS, for PFOS, FOSAs 
and FOSEs , where n = 45 (Goosey & Harrad), n = 41 (Haug et al.) and n = 57 (this study). 
The relative abundances differ substantially among the three studies 
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of such software, the increasing number of database sets available, together with the 
availability of HRMS techniques and methodologies allow the identification of: a) 
predicted metabolites generated by the in silico software by a targeted 
quantification or targeted screening approaches, and b) “unpredicted” metabolites 
by non targeted screening and even retrospective screening (Ballesteros-Gómez et 
al., 2015; Negreira et al., 2016). 
The growing in silico approaches together with the current uncertainties related to 
the metabolism of the selected perfluoroalkyl compounds provide evidence about 
the need to further study of these PFOS precursors substances. However, to date 
only a few papers examining in vitro and in vivo metabolism pathways of FOSAs and 
FOSEs leading to PFOS have been published. On this paper, qualitative evaluation of 
phase I and phase II metabolism of MeFOSA, MeFOSA and MeFOSAA incubated with 
human liver microsomes is presented (see Figure 25). 
 
 
Figure 25. General workflow used for the study of phase I & II metabolism for MeFOSA, 
MeFOSE and MeFOSAA incubated with human liver microsomes 
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M9 intermediate by an oxidative dealkylation of MeFOSE M6 intermediate – 
detected – formed as a consequence of a previous demethylation of the parent 
compound. 
 
 
Figure 26. Overlapped XIC chromatograms of the main metabolites detected for MeFOSE 
 
 
 
Figure 27. Suggested possibilities for the observed metabolism of MeFOSE 
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identified compound did not seem to have relation with the other discovered 
metabolites, so was discarded. 
 
 
Figure 28 Overlapped XIC chromatograms of the main metabolites detected for MeFOSA 
 
 
Figure 29. Suggested possibilities for the observed metabolism of MeFOSA 
 
Figure 29 shows the scheme of the two suggested routes for MeFOSA metabolism, 
one of them leading to PFOS as end-product, and the second one leading to a second 
product M29, without possibility to track its possible conversion to PFOS. For the 
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Figure 34. Box plots representing the percentages of linear and branched PFOS isomers 
identified in the serum samples (n = 40), where the yellow lines represent the theoretical 
percentage of the commercial PFOS mixture (70 % linear and 30 % branched isomers) 
 
 
Figure 35. Box plots showing the percentages of branched PFOS isomers for male and 
female participants identified in the serum samples 
